/start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/anvandaradministration/2019-05-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/car-t-cellsprovtagning/2025-04-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/origami-2/2025-04-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pereli/2025-04-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/quantum-wild-ac220-168/2025-04-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/on-call/2025-04-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dellphi-306-studien/2025-04-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/noac-9/2025-04-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mevpro-2/2025-04-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/codebreak301/2025-04-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mevpro-1/2025-03-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/orig-ami-3/2025-03-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/direktstart/2025-02-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/galaxies-lung-301-gsk4428859a/2025-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/treat-ctdna/2025-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/destiny-her2-low/2025-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/correct-/2025-02-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/origami-3/2025-02-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/akir-001/2025-02-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tilvance-301-studien/2025-02-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dareon-7/2025-01-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/melody/2025-01-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/orig-ami2/2025-01-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/uso---bc/2024-12-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/qpl---brostcancer/2024-12-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/swe-switch/2024-12-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imcode004--bo45230/2024-12-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fourlight-2-c4391025/2024-12-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ipa-studien/2024-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sgndv-001kn-d74/2024-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gsk-222730-spartacus--b7-h4/2024-11-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk2870-010/2024-11-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hyperion/2024-11-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/grand-slam/2024-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/temozolomide-plus-lomustine-versus-temozolomide-for--mgmt-promoter-methylated-glioblastoma/2024-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/artscan-vi/2024-11-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/magstage/2024-11-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/allvos/2024-11-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/efs-frailty-in-lung-cancer/2024-11-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sarong-/2024-11-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/jazz--zanihertwo/2024-11-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/solucom/2024-11-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk3543/2024-11-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/alxn1210-tma-313/2024-10-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scandium-iii/2024-10-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lion/2024-10-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/adiuvo-2/2024-10-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bellwave-011-mk1026-011/2024-10-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/seqcureneo/2024-10-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/golseek-1--ca073-1020/2024-10-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sprintr-real/2024-10-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/trofuse-020/2024-09-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sgncea5c-001-ceacam5/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/odx-mm-001/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/idunn/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/chro761a12101-michro/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/medal/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/guide.mrd2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/robocop/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fatigue-pet-studie/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/rocknrol-1/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/channel/2024-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imcode-003/2024-09-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cmlstop/2024-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/espac-6/2024-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prisma-prism-mel-301/2024-09-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/relativity-127/2024-08-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/beamion-lung-2/2024-08-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/jade-studien--219885/2024-08-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-2870-009/2024-08-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-2870-005/2024-08-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bgb-11417-301/2024-08-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/golden-gate-20190360/2024-08-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mdt-bridge/2024-08-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/selsa/2024-08-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/waveline-006/2024-05-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cartitude-6/2024-05-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/carma-01/2024-05-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/v940-005/2024-05-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/omaha-004/2024-05-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/omaha-003/2024-05-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/abbvie-m18-868/2024-04-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bi1808-studien/2024-04-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/veritac-2/2024-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ewall/2024-03-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/predict-hpv-hnc/2024-03-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/monumental-6/2024-03-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pipn/2024-03-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/teneriffa-/2024-03-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/caaa617a12402/2024-03-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/arastep-21492/2024-02-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/22-bi-1910-01/2024-02-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/beamion-lung-1-1479-0001/2024-02-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/important/2024-02-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/melbank-studien/2024-01-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pred-hh-markstudien/2024-01-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/azur2/2024-01-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/meteroid/2024-01-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/horizon-01/2024-01-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/merlin/2024-01-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/onkovir/2024-01-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/-m20-621/2024-01-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/breton-bgb-16673-101/2024-01-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cardiocare/2024-01-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/andromeda-studien/2023-12-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bnt-113-01-studien/2023-12-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/triplex-studien/2023-11-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/haitils-studien/2023-11-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bo44426---krascendo-lung-170---studien/2023-11-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fortitude101-amgen-552-studien/2023-11-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bio-me-studien/2023-11-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/-f8394-201-fore/2023-11-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/swecraniol/2023-10-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/svep53-studien/2023-10-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/v940-001-studien/2023-10-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/harbor-blu263-1201/2023-10-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/effipec/2023-10-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/eris/2023-10-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/kartos-studien-/2023-10-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/kandova/2023-10-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keyvibe-010/2023-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dwell-time/2023-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/piscatin/2023-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/commodore-bo42161/2023-08-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scan-all/2023-08-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/decidualcellstudien2/2023-08-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/providhe/2023-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ariadne-studien/2023-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/k-sab/2023-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imole/2023-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/peak-/2023-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tropion-breast032/2023-08-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/spc11-01-110/2023-07-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ac220-a-u202/2023-07-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/asf-bc/2023-07-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/itcc-101apal2020d/2023-07-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/profertil/2023-06-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mesacapp/2023-06-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ca055-026/2023-06-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ld-venex-studien/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mimir-studien-89zr-atezolizumab-petct/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-6482-022/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cloudin-6-bnt211-01/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nmdsg14-b-2/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fapi-46fapi-pet/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/zuma-4/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/19-bi-1808-01/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/eros/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prevent-a-call/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bi-1206-03-monkey/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cctl019g2201j--cassiopeja/2023-06-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/libretto-432-studien/2023-06-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/firefly-2/2023-06-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prodigyn/2023-05-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/arm/2023-05-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bnt122-01/2023-05-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/destiny-12/2023-05-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/salfladmet/2023-05-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/espac-4/2023-05-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ascend--4/2023-05-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/eucharis/2023-05-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ascape/2023-05-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/i-conic-studien/2023-04-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/optimering-infor-stor-kolorektalcancer-kirurgi/2023-04-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/majestec-9/2023-04-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prias/2023-04-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/optunebehandling-for-patienter-med-glioblastom--patienternas-narstaendes-och-personalens-uppfattning-av-behandlingen---en-kvalitativ-intervju-samt-enkat-studie/2023-04-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fibroneer/2023-04-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ironman/2023-04-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/primordium/2023-04-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cancerrehabilitering-vid-matstrups-eller-magsackscancer/2023-03-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/advantage/2023-03-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/serom/2023-03-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/first-rly-4008-101/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/asc4first/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sirpa-ca059-001/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/allovir-adeno-alvr105-/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/magnetismm-7-studien/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/certis-1/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/majestec-7/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/neogap-neogap-crc-01/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biwac-bi-1403-0001--brightline/2023-03-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/in-mind/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/loxo-20022-btk/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dovacc/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/asab/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk2140-004/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/postmonarche/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/neo-act/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bgb3111-lte1-roll-overstudie/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/seamark/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/xnk-urotelialcancer/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/columbus-ad/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/brightline-1/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sensi-ex/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bio-melanom/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/avanzar/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gemore/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/-isga-studien-pre-gat01/2023-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pro-glio/2023-03-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tabanetoc/2023-03-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/colon-z/2023-03-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/crlm-z/2023-03-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dragon-sarcopenia-/2023-03-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mariposa-2/2023-03-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/taormina-studien/2023-03-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/preopanc-3/2023-03-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scanpan-1/2023-02-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/t-rex/2023-02-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/palbociclib/2023-01-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nsgo-ctu-hero-/2023-01-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cnis793b12301/2023-01-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/relativity-123/2023-01-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keyform-008/2023-01-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/popcorn/2022-11-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/metro/2022-11-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-c93gog-3064engot-en15/2022-11-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lidera/2022-11-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/halo/2022-10-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biobladder/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tropics-04/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk6482-012/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pris/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pelvex-ii-studien/2023-07-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/breakwater/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cirkos/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/costar/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/g-definer/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sens-studien/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prep-studien/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/axsana/2022-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/star-trec/2022-10-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/salflac/2022-08-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/incb81776-101-axl-mer/2022-08-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mo41552/2022-08-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/rm26/2022-08-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sgns40-002-seasam/2022-08-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/kartlaggning-av-hematologiska-maligniteter-hos-patienter-med-mojlig-arftlig-predisposition/2022-07-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/en-fas-1b2-first-in-human-doseskalerings--och-expansionsstudie-av-xmt-1536-hos-patienter-med-solida-tumorer-som-sannolikt-uttrycker-napi2b/2022-06-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/script-aml-studying-conditioning-regimen-in-pediatric-transplantation-aml/2022-06-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/telepik2/2022-05-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/miltenyi-/2022-05-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cc-90010-gbm-002/2022-05-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hypo-m1/2022-05-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/start-net/2022-05-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ago-ovar-2.292022-04-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/inotuzumab/2022-03-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ludo-n/2022-03-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/carfilzomib/2022-03-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ponatinib/2022-03-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/polargo/2022-03-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/inform2-nivent/2022-03-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ipmn/2022-03-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/parpanc/2022-03-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/relativity-098/2022-03-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/altamira/2022-03-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lbl-2018/2022-02-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/b-nhl-2013/2022-02-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/en-undersokning-om-smartrelaterade-erfarenheter-hos-svenska-vuxna-med-cancer/2022-02-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ccs1477-02/2022-02-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ccs1477-01/2022-02-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/onc001-cl-001/2022-02-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/psmaddition/2022-02-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gct3013-01/2022-02-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/modelle-001/2022-01-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/soulmate/2022-01-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/asac/2022-01-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/timepoint/2021-12-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-365/2021-12-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/enrgy/2021-11-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/transcend/2021-11-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/evi-3/2021-11-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cell-protect---isa-hc-nk/2021-11-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/loxo-btk-18001/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/immu-lc/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tinca-ii--njurcancer/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mypal/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dsa-ll-studien/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gct-3013-05/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ros-studien/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/immunologisk-aktivitet-hos-melanomtumorer/2021-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nex-18/2021-11-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fas-i-studie-incb-99318-122-incyte/2021-11-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/swedish-anal-carcinoma-study/2021-11-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sgntuc-016/2021-10-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ruby-del-2/2021-10-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/destiny-breast09/2021-10-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bite-u-20190505/2021-10-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ipcm/2021-10-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scan-mi/2021-09-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/magsnow/2021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sentineo/2021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/postmagmri/2021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/erfarenheter-av-vakuumassisterade-excisioner-av-forandringar-i-brost-vae/2021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/magtotal/2021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/breastcc/2021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sentinot-2.02021-09-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/paced/2021-09-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/summist/2021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scandium-ii/2021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-b21-gog.30532021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/psma-fore/2021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-b49/2021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nipu-studien--ca209-7h4/2021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biobanksstudien-lungcancer/2021-09-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk6482-015/2021-08-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gct-3013-022/2021-07-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/spencer/2021-07-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk6482-005/2021-07-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hexabody-01/2021-07-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/capitello-292/2021-07-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/listo/2021-06-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prevalence/2021-06-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scout/2021-05-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pdm-mbc-/2021-05-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bio-muse/2021-05-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/proper-2/2021-04-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/navigate/2021-04-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pcr1001/2021-04-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prommel-studien/2021-04-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/covaxid-kll/2021-04-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prorect-studien/2021-04-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pacos/2021-03-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/amplitude/2021-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gsk-209012/2021-03-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/transform-2/2021-02-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/transform-1/2021-02-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/zeal-1l-/2021-02-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prepec-studien/2021-02-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mermaid-1/2021-01-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mr-divide/2021-01-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-866/2020-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/code-break-200/2020-12-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/exclaim2/2020-12-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/phys-can-styrketraningsstudie/2020-12-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/genomikstudien-brost/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/induce-4/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/blu-667-2303/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bite-cc93269-mm-001/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/heat-aml/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/momentum-sra-mmb-301/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/adore/2020-12-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/re-screen/2020-11-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/neo-aegis/2020-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/needs/2020-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/optima/2020-11-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/destiny06/2020-11-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ameera/2020-11-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tas-120-202-soffa/2020-11-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tak788-3001/2020-11-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/webbaserad-symtomovervaktning-vid-avancerad-lungcancer/2020-10-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/megalit/2020-10-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ho156-aml/2020-10-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/polar-bear/2020-10-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-a18--engot-cx11/2020-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nordictripnbg-19-01-swebcg-19-01/2020-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biolungstudien/2020-09-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/rhovac/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dalia/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ipla/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cccs-covid-cast-studien/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cor10012/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/induce-3/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/effect/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-7339-007-agent/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/thyro-nuke/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ruby/2020-08-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/advance-ii/2020-07-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-76k-ca20976k/2020-06-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/the-fiol-study-/2020-05-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ho150-aml/2020-05-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/assure/2020-05-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pro-hodgkin/2020-04-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nordcml013/2020-04-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hd21/2020-04-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/beatcc/2020-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/breclim/2020-03-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/psma-recidiv/2020-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/direct/2020-02-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lokon003/2020-02-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-73l-/2020-02-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lxh254x2102/2020-02-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nivo-ilp/2019-12-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pcia-laserstudie/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/artscan-iv/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/psff-blodburna-vavnadsprov/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/exintric/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pantumime/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/down-stagingstudie-lever/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/orchard/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/karmma-3/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mbg453-mds/2019-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/kllvacc-2017/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tatoo2/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/relapc/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ator-1017/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pcyc-1145/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/synkron-studien/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/vigas/2019-12-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imfdhac_impact-of-fixed-dentures-in-head-and-neck-cancer-/2019-11-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dbcg-rt-natural-studien/2019-11-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-937/2019-11-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/intrigue-studien/2019-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/alltogether-/2019-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dream-5/2019-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/canopy-1/2019-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ca209-171/2019-11-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-905/2019-11-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prove-studien/2019-11-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bh-studien/2019-11-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mateeo/2019-11-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/talapro-2/2019-11-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ace-cl-311/2019-10-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/205801-entree/2019-10-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/canova/2019-10-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/capitello-290/2019-10-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/athena/2019-10-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nucog-vi/2019-10-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bgg-311-305/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bob/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/brigatinib-3001/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/brigatinib-2002/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-555/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/transform/2020-01-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/kiadis/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/graphite/2019-09-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/a.r.r.o.w-22019-09-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/destiny/2019-09-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/clee011a2207/2019-08-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/commands-ace-536-mds-002/2019-07-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/probio2/2019-07-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/voc/2019-07-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fight-302/2019-07-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bosupeg/2019-07-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/norpact-12/2019-06-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biome-studien/2019-06-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/viden/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/entree/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mir-studien/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/racc/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/iloc/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/solstice/2019-06-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/predix-ii-her2/2019-06-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/panfam1/2019-06-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ctc---cirkulerande-tumorcellsstudien/2019-06-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ipep/2019-06-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tadpole-g/2019-05-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gen-esofagus-studie/2019-05-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pilgrim/2019-05-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pavo-mmy1004/2019-05-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bright-b1371019/2019-05-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/iso-cc-007-agent/2019-04-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biobank-esofagusventrikel/2019-04-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cando/2019-04-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cyst-studie-saliv-studie/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cyststud/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fimmun-pancreas-tumor/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/frosenor/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/adoele/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-7902-003/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/predicting-fatigue-after-allo-hsct/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/matterhorn/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/-pneu-stem-v114-022/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hapirect/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/qolicol/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/watch-and-wait/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/con-studien/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nmdsg14b/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nmdsg14a/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pci-32765can3001/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/2215-cl-0302/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tempo-studien/2019-04-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/zeus/2019-04-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/magnitude/2019-04-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/onconova-04-302/2019-04-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/54767414amy3001/2019-04-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bo39813/2019-04-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/allopurinol-all2.02019-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/seal-studien/2019-03-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/methronomic/2019-03-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/asa-crclm-2014/2019-03-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nmsg2415-ked/2019-03-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ird-nmsg2315/2019-03-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bcma-mmy1001/2019-03-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-7902-004/2019-03-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nor-graspall-2016-akut-lymfatiskt-leukemi-all/2019-03-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/phrancesca-mo40628/2019-03-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prothym/2019-02-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biolymph/2019-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/expacd/2019-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/psma-primar-prostatacancer2/2019-02-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ben-r/2019-02-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ben-c/2019-02-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/c16029-takeda-millenium/2019-02-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/impower030/2019-02-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ator-1015/2019-02-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/eortc-vu34/2019-02-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/exceptional-responders/2019-02-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/canfour/2019-02-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/artscan-v/2019-01-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-9132/2019-01-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/stop-gist-ssg-xxv/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ibru-on-off-studien/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/valeria/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/citadel-203/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nz-dtx-001/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-3475-587/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/atevacc2/2019-01-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/melanom-provtagning/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/glow-cll3011/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/can3001/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/javelin-blasa/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/proceed2/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/vision/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/psma-pet-studien/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/embark-mdv-3100-12/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/combi-aplus3/2019-01-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/intense/2019-01-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/zuma-7/2019-01-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pemborlizumab-mk-3475-051/2019-01-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/graspanc/2018-12-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/17403-bay-1163877/2018-12-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/achiles/2018-12-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/who-cares/2018-11-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/larct-us/2018-10-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bemp/2018-10-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/secombit/2018-10-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/illuminate/2018-10-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/opinion/2018-10-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bgb-3111-304/2018-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/act-on-me/2018-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/s-ramp/2018-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/trust2/2018-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/az-odin-pet2/2018-09-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/scan-b/2018-09-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pemdac/2018-09-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/affibody-3/2018-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/genmab-gct1015-04/2018-09-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/embrace-ii/2018-09-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/17-bi-1206-02/2018-09-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ca224-047/2018-08-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-789/2018-07-02 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cat-studien/2018-06-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pac203/2018-05-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tulip/2018-05-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/repomed/2018-04-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/car-19/2018-04-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hovon-141/2018-03-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/b-701-u21/2018-03-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imagyn050/2018-03-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cpkc412a2408/2018-03-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lokon002/2018-02-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ca017-003/2018-02-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/enrich/2018-02-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imroz/2018-02-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-908/2018-02-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/aurora/2018-01-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/monarche/2018-01-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-5222/2018-01-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tahoe-_-m16-2892/2017-12-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/adaura/2017-12-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/asteroid/2017-12-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bold-1/2017-11-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prodat/2017-11-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-901-ca209-901/2017-11-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/combi-i/2017-11-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/secar-i/2017-10-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dastop-2/2017-10-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/artemids-cc-4047-mm-015/2017-10-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nmsg-2013/2017-10-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/opacin/2017-10-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dursab/2017-10-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pasiphae2/2017-10-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/glag/2017-10-04 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/panorama-3-clbh589d2222/2017-09-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prefer-preserve-fertility/2017-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/onconova-04-30/2017-08-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/quazar-aza-mds-003/2017-08-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/javelin-renal-1018/2017-08-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/exelixis-xl184-401/2017-06-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/trim/2017-06-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/direktstudien/2017-06-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/prima-_-pr-30-5017-c/2017-05-31 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/auto-lymfom/2017-05-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sakk-3514/2017-05-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/compleement-1/2017-05-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/iliad/2017-05-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/arasens/2017-05-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/profound/2017-05-17 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cv006-studien/2017-05-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/geometry-mono-cinc280a2201/2017-05-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-522/2017-05-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/inspire_onconova-04-30/2017-04-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-602-ca209-602/2017-04-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pallas/2017-03-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pepacaka/2017-03-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-714/2017-03-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/puma-ner-1301/2017-03-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/preben/2017-03-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/viable/2017-03-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/solar-1/2017-03-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/panorama_3/2017-03-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cpdr001e2201/2017-03-07 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-057/2017-02-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mastiff/2017-02-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mars/2017-02-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-051/2017-02-16 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lasec-studien-lymphedema-after-surgery-for-endometrial-cancer2/2017-02-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/alt-gist/2017-02-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/podec/2017-02-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lume-bionis/2017-02-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/proper/2017-02-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-274/2017-02-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/spcg-17-pcastt/2017-01-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/triangle/2017-01-25 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/livskvalitet-for-patienter-med-malignt-melanom/2017-01-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/c-inc280-a2108/2017-01-24 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/swea-studien4/2017-01-18 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pet-boost/2017-01-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/pro-cns/2017-01-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nordic-8/2017-01-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nordic-9/2017-01-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/testiscab/2017-01-03 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/avanova/2016-12-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/melmart/2016-12-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/melanomprovtagning/2016-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cirkulerande-tumor-dna/2016-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/icap/2016-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/arches-/2016-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/titan-pcr3002-/2016-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/embark--mdv-3100-13/2016-12-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/rethink/2016-12-22 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tumorfaktorers-betydelse-vid-behandling-av-malignt-melanom/2016-12-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/minimalinvasiv-isolerad-hyperterm-perfusion-mi-ilp/2016-12-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/analys-av-exosomer-i-samband-med-isolerad-hyperterm-perfusion-for-behandling-av-metastaserande-malignt-melanom/2016-12-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/immunologiska-effekter-vid-behandling-av-metastaser-fran-malignt-melanom/2016-12-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/aramis/2016-12-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/iobt-kohortstudie/2016-12-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/physsurg-b/2016-12-19 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-451-ca209-451/2016-12-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mistral/2016-12-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/artscan-iii/2016-12-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bayer/2016-12-08 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/dna-pkinhib2/2016-11-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/roar2/2016-11-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/galahad/2016-11-30 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fandango/2016-11-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/abc-se/2016-11-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/morris2/2016-11-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/gen701/2016-11-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/i4t-mc-jvcz2/2016-11-10 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-170-pmbcl-och-richter-phase-ii/2016-11-01 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/maverric/2016-10-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ca209238/2016-10-21 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/palaestra/2016-10-20 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/phys-can/2016-10-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mateo/2016-10-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sirt-net/2016-10-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-177/2016-10-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/jsbf/2016-10-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/iluminet/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/et-nec/2016-10-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/spcg-15/2016-10-05 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/altaii/2016-09-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tailordose-ii/2016-09-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/trem/2016-09-29 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ca209067/2016-09-28 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/male-breast-cancer-study/2016-09-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/breast-cancer-in-pregnancy/2016-09-27 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/micro-rnactc/2019-06-11 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-3475-181/2016-09-26 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/the-scandium-studien/2016-09-23 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/neape_nordic-extended-abdominoperineal-excision-study--/2016-09-14 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/paola-1/2016-09-13 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nt-probnp/2016-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/engot-ov-23ewoc-1/2016-09-12 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/kaitlin/2016-09-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/grace/2016-09-09 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/alascca/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-199/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/abc-studien/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-3475-252-keynote-252/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-ca-209-548/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-ca209-498/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/atlas/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/checkmate-209-401/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/m12-914-brocade/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ssgxx/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nintedanib/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-204/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mk-3475-048-keynote-048/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hovon-132-aml/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lymrit-3701/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/senomic/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/antibiotika-studien/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/adm-studien/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/b-cap/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bevmar/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/im-201/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ici-pcrb/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/sandpiper/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/alpharadinabiraterone/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/vinsor/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/modul/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/fluoheart/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-100-mk-3475/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/ip-ov/2019-05-15 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/engot/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-173-fas-i/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/keynote-119/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/olympia/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cobc/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/predix-her-2/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bi-breeast/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/picc-pac/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/neptune/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/thora/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/oligo/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/repac/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/odx-003/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/artforce-headneck/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/cetmet2/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/imilt/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/rosett/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/phoneme/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/mat02/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/senomac/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/tarzel/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/lumb/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/bevpac/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/impassion-130/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/flt-pet.mr2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/predix-luma/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/hilus/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/nucog-i-vingem/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/paraply/2016-09-06 /start/samverkan/vara-uppdrag/forskning/cancerstudier-i-sverige/studier/biomarkorer-under-behandling-av-prostatacancer/2016-09-06 /start/norr/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 /start/stockholm-gotland/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 /start/syd/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 /start/sydost/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 /start/mellansverige/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 /start/vast/vara-uppdrag/forskning/cancerstudier-i-sverige/2024-11-06 https://kunskapsbanken.cancercentrum.se/2024-06-18 https://kunskapsbanken.cancercentrum.se/prenumerationer/2020-02-28 https://kunskapsbanken.cancercentrum.se/importera-referenslista/2021-02-25 https://kunskapsbanken.cancercentrum.se/importera-ordlistan/2026-04-24 https://kunskapsbanken.cancercentrum.se/mina-sidor/2022-02-10 https://kunskapsbanken.cancercentrum.se/logga-in/2020-01-28 https://kunskapsbanken.cancercentrum.se/logga-in/glomt-losenord/2020-01-24 https://kunskapsbanken.cancercentrum.se/logga-in/skapa-konto/2025-05-06 https://kunskapsbanken.cancercentrum.se/logga-in/aterstall-losenord/2020-01-24 https://kunskapsbanken.cancercentrum.se/om-kunskapsbanken/2022-02-10 https://kunskapsbanken.cancercentrum.se/om-kunskapsbanken/om-vardprogram/2025-05-19 https://kunskapsbanken.cancercentrum.se/om-kunskapsbanken/om-vardforlopp/2022-02-10 https://kunskapsbanken.cancercentrum.se/om-kunskapsbanken/integritetspolicy/2025-07-01 https://kunskapsbanken.cancercentrum.se/tillganglighetsredogorelse/2021-11-16 https://kunskapsbanken.cancercentrum.se/om-kakor/2022-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/alarmsymtom/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/sammanfattning/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/inledning/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/mal-med-vardprogrammet/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/bakgrund-och-orsaker/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/arftlighet/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/symtom-och-tidig-utredning/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/diagnostik/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kategorisering-av-tumoren/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/prognosfaktorer/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/multidisciplinar-konferens/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/diffust-storcelligt-b-cellslymfom/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/hogmalignt-b-cellslymfom/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/primart-mediastinalt-storcelligt-b-cellslymfom/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/primart-diffust-storcelligt-b-cellslymfom-i-cns/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/burkittlymfom/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/posttransplantations-relaterad-lymfoproliferativ-sjukdom-ptld/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/ovriga-former-av-aggressiva-b-cellslymfom/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/car-t-cellsbehandling-vid-aggressiva-b-cellslymfom/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/responskriterier/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/understodjande-vard/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/hemofagocyterande-lymfohistiocytos-hlh/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/omvardnad-och-rehabilitering/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/egenvard/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/palliativ-vard-och-insatser/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/uppfoljning/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/underlag-for-nivastrukturering/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/uppfoljning-av-cancervarden/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/cytostatikaregimer/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/referenser/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/vardprogramgruppen/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/2021-03-31 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/provtagningsanvisning/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/anamnestisk-remissinformation/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/analyser/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/aggressiva-b-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/koder-och-beteckningar/2025-04-03 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/sammanfattning/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/inledning/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/mal-med-vardprogrammet/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bakgrund-och-orsaker/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/arftlighet/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/symtom-och-tidig-utredning/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/diagnostik/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/kategorisering-av-leukemin-och-prognosfaktorer/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/multidisciplinar-konferens/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/primar-behandling/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/ph-negativ-b-all-och-t-all/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/ph-positiv-all/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/burkitt-leukemi/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/lymfoblastlymfom/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/allogen-stamcellstransplantation-allo-hsct/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/autolog-hematopoetisk-stamcellstransplantation/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/behandling-av-aterfall-och-refraktar-sjukdom/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/understodjande-vard/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/palliativ-vard-och-insatser/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/omvardnad-och-rehabilitering/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/egenvard/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/uppfoljning/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/underlag-for-nivastrukturering/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/kvalitetsregister/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/Kvalitetsindikatorer-och-malnivaer/2025-06-10 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/referenser/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/forslag-pa-fordjupning/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/vardprogramgruppen/2020-06-29 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-1--blinatumomab-i-primarterapi-vid-ph-neg-b-all/2026-01-23 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-2-forbehandling/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-3-ph-negativ-all.--dosreduktion-av-nopho-all-20082025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-4-ph-negativ-all--dosreduktion-av-nopho-all-2008-med-och-utan-blinatumomab/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilag-5-ph-negativ-all-behandlingsprotokoll-for-patienter-over-70-ar-och-kurativ-intention/2026-01-23 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-6-ph-positiv-all-behandlingsprotokoll-yngre-patienter/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-7-ph-positiv-all-behandlingsprotokoll-aldre-patienter---svallewall/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-8-kurer-vid-behandlingssviktaterfall-med-remissionssyfte/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-9-cns-leukemi/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-10-testikelengagemang/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-11-bulky-disease-mediastinalt/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-12-behandling-med-hogdos-metotrexat-055-gmdygn/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-13-leukovorinfolinsyra-rescue/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-14-patientinformation-om-registrering-av-personuppgifter-i-blodcancerregistret/2025-06-10 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-lymfatisk-leukemi-all/vardprogram/bilaga-15-funktionsstatus-enligt-who/2025-06-10 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-leukemi/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-leukemi/vardforlopp/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-leukemi/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/sammanfattning/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/inledning/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/mal-med-vardprogrammet/2023-12-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/bakgrund-och-orsaker/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/arftlighet/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/Symtom-och-tidig-utredning/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/diagnostik/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/klassificering-och-remissionskriterier/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/riskgruppering-och-indikationer-for-allo-sct-i-cr-1/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/mrd--measurable-residual-disease/2022-06-22 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/multidisciplinara-konferenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/primar-behandling/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/akut-promyelocytleukemi-apl/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/blastisk-plasmacytoid-dendritcellsneoplasi-bpdcn/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/handlaggning-av-nagra-speciella-kliniska-situationer/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/allo-sct-vid-aml/2022-06-22 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/asct/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/underhallsbehandling/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/behandling-av-aterfall/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/understodjande-vard/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/omvardnad-och-rehabilitering/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/egenvard/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/palliativ-vard-och-insatser/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/uppfoljning/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/underlag-for-nivastrukturering/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/uppfoljning-av-cancervarden/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/kvalitetsindikatorer-och-malnivaer/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/referenser2/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/forslag-pa-fordjupning/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/vardprogramgruppen/2021-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/funktionsstatus-enligt-who/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/provtagningsanvisning-for-benmarg-och-blod/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/provtagningsanvisning-for-benmarg-och-blod/referenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/klassifikation-av-aml-enligt-who/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/klassifikation-av-aml-enligt-who/referenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/klassifikation-av-aml-enligt-icc-2022/2023-12-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/klassifikation-av-aml-enligt-icc-2022/referenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/genetiska-avvikelser-vid-aml/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/genetiska-avvikelser-vid-aml/referenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/antracykliner/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/antracykliner/1.1-val-av-antracyklinpreparat-och-dosering2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/antracykliner/1.2-kumulativ-kardiotoxicitet2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/antracykliner/1.3-atgarder-vid-extravasering-av-antracyklinpreparat2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/2.-cytarabin2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/2.-cytarabin/2.1-dosering-och-administrationsform2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/2.-cytarabin/2.2-cerebellar-toxicitet-och-dosering-till-aldre-samt-vid-nedsatt-njurfunktion2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/3.amsakrin2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/4.-etoposid2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/5.-purinanaloger2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/Azacitidin/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/decitabin/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/7.-Gemtuzumab-ozogamicin2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/8.-Kinasinhibitorer2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/8.-Kinasinhibitorer/gilteritinib/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/9.-vyxeos2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/venetoclax/2023-12-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/idh-hammare/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/glasdegib/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/cc-486-peroral-hypometylerare/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/tagraxofusp/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/AML-specifik-behandling/referenser/2023-12-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/hereditara-myeloiska-maligniteter/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/hereditara-myeloiska-maligniteter/referenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/patientinformation/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/summary-of-the-swedish-national-aml-care-program-for-adult-patients/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/the-care-program/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/initial-management/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/intensive-treatment/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/allogeneic-stem-cell-transplantation/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/measurable-residual-disease-mrd-determination/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/other-treatments/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/special-problems/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/health-care-requirements/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/quality-indicators/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/aml-registry/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/aml/vardprogram/summary-in-english/referenser/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/2020-03-25 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/sammanfattning/2023-04-17 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/inledning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/mal-med-vardprogrammet/2023-04-17 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/symtomoversikt/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/anemi-malignitetsassocierad/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/6-akut-forvirringstillstand/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/blodning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/8-frakturrisk-eller-patologisk-fraktur/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/hjarnmetastas-eller-hjarntumor/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/hyperkalcemi/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/immunrelaterade-biverkningar-vid-behandling-med-checkpointhammare/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/biverkningar-vid-behandling-med-car-t-celler-och-bispecifika-antikroppar/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/kolit2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/luftvagsobstruktion2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/neutropen-febersepsis2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/perforation-av-mag-tarmkanalen/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/perikardvatska-malign2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/pleuravatska-malign2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/ryggmargskompression2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/suicidrisk2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/tarmobstruktion2/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/venos-trombos-eller-lungemboli/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/tumorlyssyndrom2/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/vena-cava-superior-syndrom2/2020-01-02 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/vardprogramgruppen2/2026-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/bakgrund/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/riskfaktorer-for-trombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-djup-ventrombos-dvt-i-nedre-extremitet/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-djup-ventrombos-dvt-i-nedre-extremitet/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-djup-ventrombos-dvt-i-nedre-extremitet/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-djup-ventrombos-dvt-i-nedre-extremitet/vardniva-riskstratifiering/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-djup-ventrombos-dvt-i-nedre-extremitet/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/djup-ventrombos-i-ovre-extremitet-inklusive-venos-trombos-i-anslutning-till-olika-typer-av-centrala-venosa-infarter/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/djup-ventrombos-i-ovre-extremitet-inklusive-venos-trombos-i-anslutning-till-olika-typer-av-centrala-venosa-infarter/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/djup-ventrombos-i-ovre-extremitet-inklusive-venos-trombos-i-anslutning-till-olika-typer-av-centrala-venosa-infarter/orsak/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/djup-ventrombos-i-ovre-extremitet-inklusive-venos-trombos-i-anslutning-till-olika-typer-av-centrala-venosa-infarter/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/djup-ventrombos-i-ovre-extremitet-inklusive-venos-trombos-i-anslutning-till-olika-typer-av-centrala-venosa-infarter/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-lungemboli/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-lungemboli/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-lungemboli/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-lungemboli/vardniva-riskstratifiering/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/cancerassocierad-lungemboli/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/vena-cava-inferior-trombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/vena-cava-inferior-trombos/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/vena-cava-inferior-trombos/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/vena-cava-inferior-trombos/behandling/2023-04-17 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/mesenterialvenstrombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/mesenterialvenstrombos/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/mesenterialvenstrombos/utlosande-faktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/mesenterialvenstrombos/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/mesenterialvenstrombos/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/portavenstrombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/portavenstrombos/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/portavenstrombos/utlosande-faktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/portavenstrombos/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/portavenstrombos/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/levervenstrombos-vena-hepatica-budd-chiaris-syndrom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/levervenstrombos-vena-hepatica-budd-chiaris-syndrom/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/levervenstrombos-vena-hepatica-budd-chiaris-syndrom/utlosande-faktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/levervenstrombos-vena-hepatica-budd-chiaris-syndrom/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/levervenstrombos-vena-hepatica-budd-chiaris-syndrom/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/njurvenstrombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/njurvenstrombos/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/njurvenstrombos/utlosande-faktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/njurvenstrombos/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/njurvenstrombos/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/sinustrombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/sinustrombos/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/sinustrombos/utlosande-faktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/sinustrombos/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/sinustrombos/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/ovarialvenstrombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/ovarialvenstrombos/symtom-och-diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/ovarialvenstrombos/riskfaktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/ovarialvenstrombos/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/tromboflebit-ytlig-ventrombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/tromboflebit-ytlig-ventrombos/symtom/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/tromboflebit-ytlig-ventrombos/riskfaktorer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/tromboflebit-ytlig-ventrombos/diagnostik/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/venos-trombos/venos-trombos-pa-ovanliga-stallen/tromboflebit-ytlig-ventrombos/behandling/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/formaksflimmer-och-cancer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/mekanisk-klaffprotes-och-cancer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/val-av-behandling-doak-eller-lmh/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/behandlingstid/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/recidiv-av-venos-trombos-under-pagaende-behandling-med-antikoagulantia/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/profylax-av-venos-trombos/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/hepariner/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/warfarin/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/doak/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/doak/lakemedelsinteraktioner-mellan-doak-och-antitumorala-lakemedel/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/doak/lakemedelsinteraktioner-mellan-doak-och-antitumorala-lakemedel/onkologiska-lakemedel-som-har-kanda-farmakokinetiska-interaktioner-med-doak/2023-10-05 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/doak/lakemedelsinteraktioner-mellan-doak-och-antitumorala-lakemedel/ovriga-granskade-onkologiska-preparat-utan-kanda-farmakokinetiska-interaktioner-med-doak/2023-04-21 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/behandling-med-antikoagulantia-vid-cancerassocierad-venos-trombos/doak/lakemedelsinteraktioner-mellan-doak-och-antitumorala-lakemedel/onkologiska-lakemedel-med-kanda-farmakodynamiska-interaktioner-med-doak/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/handlaggning-och-behandling-av-blodningar-hos-patienter-med-cancer/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/handlaggning-och-behandling-av-blodningar-hos-patienter-med-cancer/handlaggning-av-blodningar-hos-patienter-med-cancer-som-behandlas-med-antitrombotiska-lakemedel/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/handlaggning-och-behandling-av-blodningar-hos-patienter-med-cancer/lakemedel-som-kan-anvandas-vid-blodning/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/atgard-infor-ingrepp-och-operationer-avseende-antitrombotisk-behandling-hos-cancerpatienter/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/referenser/2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/arbetsgrupp-bilaga-trombos-och-blodning/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/arbetsgrupp-bilaga-trombos-och-blodning/arbetsgruppens-medlemmar/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/arbetsgrupp-bilaga-trombos-och-blodning/jav-och-andra-bindningar/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/akut-onkologi/vardprogram/bilaga-1--trombos-och-blodning/arbetsgrupp-bilaga-trombos-och-blodning/bilagans-forankring/2023-04-18 https://kunskapsbanken.cancercentrum.se/diagnoser/allvarliga-ospecifika-symtom/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/allvarliga-ospecifika-symtom/vardforlopp/2023-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/allvarliga-ospecifika-symtom/forkortat-vardforlopp/2025-11-17 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/sammanfattning/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/inledning/2020-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/mal-med-vardprogrammet/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/incidens-riskfaktorer-och-prognos/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/primarprevention/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/screening/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/arftlighet/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/symtom-och-tidig-utredning/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/klinisk-diagnostik/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/patologisk-diagnostik/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/multidisciplinar-konferens/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/primarbehandling/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/behandling-av-resttumor-och-aterfall/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/understodjande-vard-omvardnad-och-rehabilitering/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/omvardnad-och-rehabilitering/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/egenvard/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/Uppfoljning/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/palliativ-vard-och-insatser/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/underlag-for-nivastrukturering/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/kvalitetsregister-och-malnivaer/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/indikatorer-och-malnivaer/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/referenser2/2024-02-21 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardprogram/vardprogramgruppen/2020-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/vardforlopp/2023-08-10 https://kunskapsbanken.cancercentrum.se/diagnoser/analcancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/2024-11-07 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/sammanfattning/2024-10-28 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/inledning/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/mal-med-vardprogrammet/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bakgrund-och-orsaker/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/primar--och-sekundarprevention/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/arftlighet/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/symtom/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/diagnostik/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/kategorisering-av-tumoren/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/multidisciplinar-konferens/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/behandling/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/omvardnad-och-rehabilitering/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/egenvard/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/palliativ-vard-och-insatser/2024-10-25 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/uppfoljning/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/nivastrukturering/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/uppfoljning-av-cancervarden/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/referenser/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/vardprogramgruppen/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/arftliga-syndrom-med-forhojd-risk-for-basalcellscancer-bcc/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/gorlins-syndrom--kompletterande-information-om-kontroller/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/bap1-tumor-predispositionssyndrom-bap1-tpds/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/xeroderma-pigmentosum/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/bazex-dupre-christols-syndrom/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/okulokutan-albinism/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/curry-jones-och-happle-tinscherts-syndrom/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/familjer-med-multipla-bcc/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-1-arftlighet--fordjupningsmaterial/referenser-bilaga-1/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-2-stralbehandling-vid-basalcellscancer-fordjupningsmaterial/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-2-stralbehandling-vid-basalcellscancer-fordjupningsmaterial/praktiskt-genomforande-av-stralbehandling/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-2-stralbehandling-vid-basalcellscancer-fordjupningsmaterial/behandlingsrekommendationer/2024-10-25 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-2-stralbehandling-vid-basalcellscancer-fordjupningsmaterial/referenser-bilaga-2/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-3-praktiskt-tillvagagangssatt-vid-kryokirurgisk-teknik/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-3-praktiskt-tillvagagangssatt-vid-kryokirurgisk-teknik/open-cone-spray-teknik/2024-10-25 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-3-praktiskt-tillvagagangssatt-vid-kryokirurgisk-teknik/kyrettage/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-3-praktiskt-tillvagagangssatt-vid-kryokirurgisk-teknik/bedovning/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/basalcellscancer/vardprogram/bilaga-3-praktiskt-tillvagagangssatt-vid-kryokirurgisk-teknik/referenser-bilaga-3/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/2022-02-10 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/2021-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/sammanfattning/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/inledning/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/mal-med-vardprogrammet/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/primar-prevention/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/arftlighet/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/utredning-enligt-standardiserat-vardforlopp/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kategorisering-av-tumoren/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/multidisciplinar-konferens-mdk/2023-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/incidentalom/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/binjuremetastaser/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kortisolproducerande-binjuretumorer/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/aldosteronproducerande-binjuretumorer/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/feokromocytom-och-paragangliom/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/binjurebarkscancer-acc/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/palliativ-vard-och-insatser/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/omvardnad-och-rehabilitering/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/egenvard/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/underlag-for-nivastrukturering/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsregister/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/referenser/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/vardprogramgruppen/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/patologins-roll-i-den-diagnosiska-processen/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/klassificering-av-tumoren/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/analyser/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/feokromocytom-samt-abdominala-paragangliom/2023-01-16 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/koder-och-beteckningar/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/kvalitetsarbete-for-patologin/2020-03-02 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/kvalitetsdokument-for-patologi/referenser/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/avseende-adrenala-incidentalom-ai/2023-01-16 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/bakgrund/2023-01-16 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/dt-teknik-vid-karakteristik-av-binjureincidentalom/2023-01-16 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/nationella-rekommendationer/2023-01-16 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/for-svensk-forening-for-bild--och-funktionsmedicin-och-svensk-uroradiologisk-forening/2023-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/binjuretumorer/vardprogram/radiologiskt-appendix-till-vardprogram-binjuretumorer/referenser/2023-01-16 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/2020-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/sammanfattning/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/inledning/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/mal-med-vardprogrammet/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/bakgrund-och-orsaker/2024-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/primar-prevention/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/screening/2024-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/arftlighet/2024-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/symtom-och-tidig-utredning/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/diagnostik/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kategorisering-av-tumoren2/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/multidisciplinar-konferens/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/12-preoperativ-behandling/2024-07-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kirurgisk-behandling/2024-07-06 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/postoperativ-stralbehandling/2025-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/Postoperativ-medicinsk-behandling/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/brostcancer-och-graviditet/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/fertilitetsbevarande-atgarder-och-preventivmedel/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/brostcancerbehandling-av-aldre2/2024-10-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/behandling-av-metastaserad-sjukdom2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/brostcancer-hos-man/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kardioonkologi/2024-10-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/handlaggning-av-speciella-kliniska-situationer/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/understodjande-behandling2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/omvardnad-och-rehabilitering2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/egenvard2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/palliativ-vard-och-palliativa-insatser/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/uppfoljning2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/uppfoljning-av-cancervarden/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsindikatorer-och-malnivaer2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/vardprogramgruppen2/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/referenser/2025-02-24 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/forord/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar/2022-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar/preparat-med-cancer-invasiv-ocheller-in-situ/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/preparat-utan-pavisad-cancer/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/mikroskopisk-undersokning-och-bedomning/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/mikroskopisk-undersokning-och-bedomning/gradering-av-in-situ-cancer-och-subtypning/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/mikroskopisk-undersokning-och-bedomning/gradering-av-invasiv-brostcancer/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/mikroskopisk-undersokning-och-bedomning/stadieindelning/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/biomarkoranalyser--grundpanel-for-alla-invasiva-tumorer/2022-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/biomarkoranalyser--grundpanel-for-alla-invasiva-tumorer/sammanfattning/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/biomarkoranalyser--grundpanel-for-alla-invasiva-tumorer/ostrogen--och-progesteronreceptorstatus--immunhistokemisk-metod/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/biomarkoranalyser--grundpanel-for-alla-invasiva-tumorer/proliferationsmarkor-ki67--immunhistokemisk-metod/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/biomarkoranalyser--grundpanel-for-alla-invasiva-tumorer/her2-status--analysmetoder/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/ovriga-analyser/2022-05-25 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/ovriga-analyser/tumorinfiltrerande-lymfocyter-stil/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/ovriga-analyser/utvardering-av-neoadjuvant-behandlingssvar/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/ovriga-analyser/pd-l1-analys/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/ovriga-analyser/genexpressionsprofilering/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/ovriga-analyser/genomisk-profilering--dna-analys/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2022-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/preoperativa-prover/2025-11-12 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/operationspreparat/2025-11-12 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/koder-och-beteckningar/2022-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/koder-och-beteckningar/snomed-kodning/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/kvalitetsindikatorer/2025-11-12 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/forfattare-kvast-gruppen-for-brostpatologi/2024-07-12 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/kvalitetsdokument-for-patologi/referenser/2024-02-07 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/syfte/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/inledning/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/target-och-riskorgan/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/forberedelser-och-verifikation/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/begreppsforklaringar/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/stralbehandling-mot-brost/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/partiell-stralbehandling-mot-brost/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/stralbehandling-mot-brost-eller-brostkorgsvagg-och-regionala-lymfkortlar/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/faltexempel-och-beams-eye-view-bev-pa-dosplaner/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/referenser/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/riktlinjer-for-volymer-och-teknik-vid-stralbehandling-av-brostcancer/appendix-1-rekommendationer-vid-andningsanpassad-stralbehandling-av-brostcancer/2025-02-27 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/bilaga-3/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/bilaga-3/introduktion/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/bilaga-3/risk-for-uppgradering-till-malignitet/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/bilaga-3/handlaggning-och-uppfoljning-av-b3-lesioner/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/bilaga-3/referenser/2025-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardforlopp/2020-01-30 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/2024-11-03 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/sammanfattning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/inledning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/mal-med-vardprogrammet/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/socialstyrelsens-foreskrifter-och-allmanna-rad/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/definition-av-malpopulation-och-cancer-i-relation-till-screeningen/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/epidemiologi/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/screening--principer-och-effekter/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/screeningprogrammets-utveckling/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/screeningprocess-och-ansvarsfordelning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/kallelsehantering-och-deltagande/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bildtagning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bildgranskning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/svarshantering/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/kommunikation-och-information/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/kvalitetsregister/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/referenser/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/forslag-pa-fordjupning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/vardprogramgruppen/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-1-positionering/2024-10-28 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-1-positionering/vardering-av-undersokning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-1-positionering/vardering-av-undersokning/presentation-av-undersokningen/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-1-positionering/ergonomi/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/2024-10-18 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/inledning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/inledning/fordelar-och-nackdelar-med-brostcancerscreening/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/informationspaket/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/konsekvent-ordval/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/information-i-kallelse-och-svarsbrev/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/fordjupad-information-pa-1177.se2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/sarskilda-informationsinsatser/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/sarskilda-informationsinsatser/for-kvinnor-som-inte-deltar/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/sarskilda-informationsinsatser/for-personer-med-brost-som-inte-far-en-kallelse/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/sarskilda-informationsinsatser/strategier-for-okad-kunskap-hos-allmanhet-profession-och-beslutsfattare/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/kommunikationsstrategi/oversikt/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/budskap-malgrupper-och-kanaler/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/budskap-malgrupper-och-kanaler/tydliga-budskap/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/malgrupper-och-ambassadorer/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/informations--och-kommunikationskanaler/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancerscreening/vardprogram/bilaga-2-underlag-till-kommunikationsplan/ansvarsfordelning/2024-10-01 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/2025-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/sammanfattning/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/inledning/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/mal-med-vardprogrammet/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/bakgrund-och-orsaker/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/primar-prevention/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/arftlighet/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/symtom-och-tidig-utredning/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/diagnostik/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kategorisering-av-tumoren/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/multidisciplinar-konferens-mdk/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/primar-behandling/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/behandling-av-aterfall-och-avancerad-sjukdom/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/nutrition/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/palliativ-vard-och-insatser/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/omvardnad-och-rehabilitering/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/egenvard/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/uppfoljning/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/underlag-for-nivastrukturering/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsregister/2023-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsindikatorer/2023-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/referenser/2023-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/vardprogramgruppen/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar-och-hantering-av-prover-pa-laboratorium/2022-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/hantering-av-resektat/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2022-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/immunhistokemi/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/molekylarpatologi/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/histopatologisk-diagnos-vid-retroperitoneala-och-intra-abdominella-sarkom-forutom-gist-och-gynsarkom/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/histologisk-gradering-av-sarkom/2022-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/kvalitetsdokument-for-patologi/kvalitetsarbete-for-patologin/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/sammanfattning/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/bakgrund-och-orsaker/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/bakgrund-och-orsaker/epidemiologi/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/bakgrund-och-orsaker/etiologi/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/symtom--uterussarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/2022-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/bilddiagnostik/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/bilddiagnostik/kvalificerat-ultraljud/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/bilddiagnostik/3-fas-dt/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/bilddiagnostik/mrt/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/bilddiagnostik/pet-dt/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/utredning--uterussarkom/bilddiagnostik/pet-mrt/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/patologins-roll-i-den-diagnostiska-processen/2023-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/figo-stadieindelning-for-uterussarkom-2009/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/figo-stadieindelning-for-uterussarkom-2009/leiomyosarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/figo-stadieindelning-for-uterussarkom-2009/adenosarkom-endometriestromasarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/klassificering-av-tumoren/2023-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/klassificering-av-tumoren/diagnoser-inkl.-snomedkoder2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/klassificering-av-tumoren/immunhistokemiska-fargningar-som-kan-vara-till-hjalp-vid-tumortypning/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/kategorisering-av-tumoren/klassificering-av-tumoren/molekylaranalyser-vid-gynekologiska-sarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/smooth-muscle-tumor-of-uncertain-malignant-potential-stump/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/kirurgi/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/postoperativ-behandling-av-uterussarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/postoperativ-behandling-av-uterussarkom/lms/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/postoperativ-behandling-av-uterussarkom/laggradigt-ess-hoggradigt-ess-ous-eller-as/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/postoperativ-behandling-av-uterussarkom/laggradigt-ess/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/postoperativ-behandling-av-uterussarkom/hoggradigt-ess-och-ous/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/primar-behandling/postoperativ-behandling-av-uterussarkom/as/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/aterfall/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/kirurgi/2022-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/medicinsk-behandling/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/medicinsk-behandling/lms/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/medicinsk-behandling/laggradigt-ess/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/behandling-av-aterfall-och-primart-avancerad-sjukdom/medicinsk-behandling/hoggradigt-ess-oes-och-as/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/omvardnad-och-rehabilitering/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/uppfoljning/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/uppfoljning/klimakteriella-symtom-efter-behandling/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/referenser/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/arbetsgrupp-bilaga-gynekologiska-sarkom/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/arbetsgrupp-bilaga-gynekologiska-sarkom/arbetsgruppens-medlemmar/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/arbetsgrupp-bilaga-gynekologiska-sarkom/tidigare-medlem-i-arbetsgruppen/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/arbetsgrupp-bilaga-gynekologiska-sarkom/jav-och-andra-bindningar/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/gynekologiska-sarkom/arbetsgrupp-bilaga-gynekologiska-sarkom/bilagans-forankring/2022-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/bilddiagnostik/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/bilddiagnostik/3-fas-dt/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/bilddiagnostik/mrt/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/Vardprogram/bilddiagnostik/hybridmodaliteter/2020-10-22 https://kunskapsbanken.cancercentrum.se/diagnoser/buksarkom/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/2021-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/sammanfattning/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/inledning/2021-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/mal-med-vardprogrammet/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bakgrund/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/screening/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/arftlighet-och-kontrollprogram-for-familjar-pankreascancer/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/intraduktal-papillar-mucinos-neoplasi-ipmn/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/symtom-och-tidig-utredning/2021-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/diagnostik/2021-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/histologisk-kategorisering-av-tumoren/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/multidisciplinar-konferens/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/val-av-behandling/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/kurativt-syftande-behandling/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/palliativt-syftande-cancerbehandling/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/behandling-av-aterfall/2024-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/understodjande-vard/2024-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/palliativ-vard-och-palliativa-insatser/2024-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/omvardnad-och-rehabilitering/2021-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/egenvard/2024-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/uppfoljning/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/nivastrukturering/2024-10-02 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/kvalitetsregister/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-10-02 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/referenser2/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/vardprogramgruppen/2021-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilddiagnostik-vid-pankreascancer/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilddiagnostik-vid-pankreascancer/dt-pankreas-protokollforslag-oversiktlig/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilddiagnostik-vid-pankreascancer/dt-pankreas-protokollforslag-i-detalj/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilddiagnostik-vid-pankreascancer/checklista-for-radiologisk-bedomning-av-pankreascancer-infor-mdk/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilddiagnostik-vid-pankreascancer/referenser/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/innehall/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/i.-instruktioner-for-preparathantering-fore-formalinfixering2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/ii.-klinisk-information2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering2021-09-08 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering/orientering-och-inspektion/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering/identifiering-och-tuschmarkning-av-resektionsytorna/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering/axiell-skivningsteknik/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering/inspektion-av-det-uppskivade-preparatet/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering/tillvaratagande-av-material-till-mikroskopi/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iii.-instruktioner-for-utskarning-av-operationspreparat-efter-formalinfixering/baddning-och-lokalisering-av-lymfknutor/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/iv.-hantering-av-pankreasbiopsier2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet2021-09-08 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/duktalt-adenokarcinom-och-dess-varianter/2024-06-24 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/pankreatisk-intraepitelial-neoplasi-panin/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/intraduktal-papillar-mucinos-neoplasi-ipmn/2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/mucinos-cystisk-neoplasi-mcn/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/serost-cystadenom-sca/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/solid-pseudopapillar-tumor-spt/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/endokrina-tumorer-och-blandad-neuroendokrin-icke-neuroendokrin-neoplasi-minen/2021-09-08 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/acinarcellskarcinom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/v.-information-som-ska-inga-i-patologutlatandet/kronisk-pankreatit/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/vi.-rekommendationer-for-rapportering2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/vii.-snomed-koder2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/viii.-referenser2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/ix.-lista-over-forkortningar2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/x.-medlemmar-i-kvast-studiegruppen2024-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardprogram/bilaga-2-kvalitetsdokument-for-patologi/bilaga-till-kvast-dokumentet/2021-09-08 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/bukspottkortelcancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/sammanfattning/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/inledning/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/mal-med-vardprogrammet/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/allman-bakgrund/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/kartlaggning-och-bedomning-av-patientens-rehabiliteringsbehov/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/mag-tarmbesvar2/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/sexuell-och-hormonell-dysfunktion/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/urinvagsbesvar/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/smarta2/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/lymfodem2/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/kvalitetsarbete/2023-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/vardprogramgruppen/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/referenser2/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/backencancerrehabilitering/vardprogram/bilaga-1---lankbibliotek/2025-04-30 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/2022-03-09 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/sammanfattning/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/inledning/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/mal-med-vardprogrammet/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bakgrund-och-orsaker/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/5-arftlighet/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/6-symtom-och-diagnostik/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/kategorisering-av-tumoren/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/8-multidisciplinar-konferens-mdk/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/primar-behandling/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/10-kirurgi-vid-cup/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/omvardnad-och-rehabilitering/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/egenvard/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/13-palliativ-vard-och-insatser/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/14-uppfoljning/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/15-nivastrukturering/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/uppfoljning-av-cancervarden/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/referenser/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/vardprogramgruppen/2020-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/inledning/2021-03-24 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/i.-anvisningar-for-provtagarens-hantering-av-provet2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/ii.-anamnestisk-remissinformation2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/iii.-utskarningsanvisningar2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/iv.-analyser2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/v.-information-i-remissens-svarsdel2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/vi.-rekommendationer-for-utformning-av-svarstext2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/vii.-administrativt2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/allmant/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/1-pavisa-malignitet-i-biopsin--hog-diagnostisk-sakerhet/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/2-klassa-tumoren-som-carcinom-melanom-lymfom-sarkom-eller-mesoteliom--hog-diagnostisk-sakerhet/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/3-om-tumoren-ar-malign-och-epitelial-carcinom-ska-tumoren-klassas-som-germinalcellstumor-skivepitelcancer-urotelial-cancer-neuroendokrin-tumor-kortelbildandeinte-kortelbildande-adenocarcinom--mattlig-till-hog-diagnostisk-traffsakerhet/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/4-adenocarcinom--varierande-diagnostisk-traffsakerhet/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/5-specialfall--varierande-diagnostisk-traffsakerhet/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/histopatologisk-och-cytopatologisk-diagnostik-av-cup/6-bestamning-av-prediktiva-markorer--hog-diagnostik-traffsakerhet/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/patologisk-och-molekylar-diagnostik-vid-cup/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/patologisk-och-molekylar-diagnostik-vid-cup/molekylarpatologisk-karakterisering-vid-cup/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/viii.-klassificering-av-tumoren/patologisk-och-molekylar-diagnostik-vid-cup/tissue-of-origin-vid-cup-som-utgangspunkt-for-terapi/2025-11-19 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardprogram/bilaga-1-kvast-cup--cancer-utan-kand-primartumor/referenser/2021-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/vardforlopp/2020-01-27 https://kunskapsbanken.cancercentrum.se/diagnoser/cancer-utan-kand-primartumor-cup/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/sammanfattning/2023-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/inledning/2023-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/mal-med-vardprogrammet/2023-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/definitioner/2023-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/rehabiliteringsprocessen/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/prehabilitering/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/symtom-och-biverkningar-som-kan-paverka-funktionsformaga/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/fysiska-insatsomraden/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/psykiska-insatsomraden/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/sociala-insatsomraden/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/existentiella-insatsomraden/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/langvariga-eller-sena-komplikationer/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/komplementar--och-integrativ-medicin-kim/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/referenser/2023-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/vardprogramgruppen/2023-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering/vardprogram/bilaga-1--insatstabell/2023-11-02 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/2024-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/sammanfattning/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/inledning/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/mal-med-vardprogrammet/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bakgrund-och-orsaker/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/nivastruktur-och-teamarbete/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/barncancer/2024-03-15 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/psykisk-halsa/2024-03-15 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/sociala-konsekvenser/2024-03-15 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/forskola-och-skola/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/kroppsuppfattning-sexuell-halsa-och-fertilitet/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/smarta/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/somn/2024-04-10 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/nutrition/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/mag-tarmkanal-och-urinvagar/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/mun--och-tandhalsa/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/fysisk-funktionsformaga-aktivitetsformaga-och-fysisk-aktivitet/2024-03-15 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/fatigue/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/kognition/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/tal-sprak-och-kommunikation/2024-04-10 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/horsel/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/syn/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/stod-vid-overgang-fran-barn--till-vuxenvard/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/uppfoljning-av-cancervarden/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/forslag-pa-fordjupning/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/vardprogramgruppen/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/referenser/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/tidig-akut-rehabilitering-efter-behandling/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/tidig-akut-rehabilitering-efter-behandling/preoperativ-bedomning/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/tidig-akut-rehabilitering-efter-behandling/postoperativ-inneliggande-rehabilitering/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/tidig-akut-rehabilitering-efter-behandling/rehabilitering-efter-postoperativ-sjukhusvistelse/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsuppfoljning-efter-avslutad-medicinsk-behandling/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsuppfoljning-efter-avslutad-medicinsk-behandling/beskrivning-av-multiprofessionell-uppfoljning/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsuppfoljning-efter-avslutad-medicinsk-behandling/tidpunkter-for-utredning-och-stod-for-barn-med-cns-tumor/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsatgarder/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsatgarder/neurokognitiv-rehabilitering/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsatgarder/skolinterventioner/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsatgarder/fysisk-aktivitet/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/rehabiliteringsatgarder/familjebehandling/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/overforing-till-vuxenlivet/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-1--riktlinjer-for-att-utreda-och-rehabilitera-barn-med-tumor-i-centrala-nervsystemet/referenser/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/bakgrund/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/bakgrund/definitioner/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/arbetssatt-for-psykosocialt-stod/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/arbetssatt-for-psykosocialt-stod/psykosocialt-team/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/arbetssatt-for-psykosocialt-stod/basstandard-for-resurser-tidigt-i-vardprocessen/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/arbetssatt-for-psykosocialt-stod/basstandard-for-resurser-under-behandling/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/arbetssatt-for-psykosocialt-stod/basstandard-for-resurser-efter-avslutad-behandling/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/arbetssatt-for-psykosocialt-stod/ovriga-aktiviteter/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/kuratorns-uppgifter/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-2--basstandard-for-psykosocialt-stod-till-barn-och-familjer-inom-barncancervarden/referenser/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/ha-kannedom-om-vanliga-reaktioner/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/minska-stress/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/underlatta-kanslomassigt-stod/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/kom-ihag-familjen-och-kompisar/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/framja-halsosamma-och-vardagliga-rutiner/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-3--forebyggande-psykosociala-insatser-vid-cancer/referenser/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/blodning/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/efterfoljande-cancer/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/gvhd-relaterade-och-immunterapirelaterade-slemhinneskador/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/infektion/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/karies-och-gingivit/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/kirurgisk-paverkan-pa-munhala/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/kraniofacial-utvecklingspaverkan/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/mukosit/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/muntorrhet/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/osteonekros/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/smakforandring/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/smarta/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/tandutvecklingsstorningar/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/trismus/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-4--akuta-och-sena-komplikationer-i-munhalan-relaterade-till-onkologisk-behandling/referenser/2024-03-13 https://kunskapsbanken.cancercentrum.se/diagnoser/cancerrehabilitering-for-barn-och-ungdom/vardprogram/bilaga-5--nordic-protocol-for-neuropsychological-follow-up-of-children-treatedfor-brain-tumor--revision-2023/2024-03-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/forkortningar-och-definitioner/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/sammanfattning/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/inledning/2020-01-03 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/mal-med-vardprogrammet/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/bakgrund-och-orsaker/2019-12-02 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/uppfoljning-vid-gallblasepolyper-psc-och-koledokuscystor/2019-12-02 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/arftlighet/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/symtom-kliniska-fynd-stadieindelning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/diagnostik/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/morfologisk-kategorisering-av-tumoren/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/multidisciplinar-konferens2/2019-12-02 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/primar-behandling/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/behandling-av-aterfall/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/understodjande-vard/2023-07-07 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/palliativ-vard/2019-12-02 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/rehabilitering/2024-06-26 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/psykosocialt-omhandertagande/2023-07-07 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/uppfoljning/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/underlag-for-nivastrukturering/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/uppfoljning-av-cancervarden/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/vardprogramgruppen/2020-01-07 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/referenser/2025-10-15 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardprogram/bilaga-1.-farmakologiskt-behandlingsforslag-vid-klada2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/vardforlopp/2024-11-25 https://kunskapsbanken.cancercentrum.se/diagnoser/gallblase-och-gallvagscancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/2023-09-22 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/2023-09-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/sammanfattning/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/inledning/2020-02-13 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/mal-med-vardprogrammet/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bakgrund-och-orsaker/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/primar-prevention/2020-02-13 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/arftlighet/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/symtom-och-tidig-utredning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/diagnostik/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/kategorisering-av-tumoren/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/multidisciplinar-konferens/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/primar-behandling/2020-02-13 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/behandling-av-aterfall/2020-02-13 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/understodjande-vard/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/sexualitet-fertilitet-och-graviditet/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/palliativ-vard-och-insatser/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/omvardnad-och-rehabilitering/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/egenvard-och-samvard/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/uppfoljning/2020-02-13 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/underlag-for-nivastrukturering/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/kvalitetsregister/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-05-23 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/referenser2/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/forslag-pa-fordjupning/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/vardprogramgruppen/2020-02-13 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-1.-radiologisk-diagnostik2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-1.-radiologisk-diagnostik/mrt-protokoll-for-primar-malign-hjarntumor/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-1.-radiologisk-diagnostik/mrt-protokoll-for-spinala-gliom/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-1.-radiologisk-diagnostik/mrt-protokoll-for-meningeom/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-1.-radiologisk-diagnostik/checklista-for-radiologiskt-utlatande/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/patientpositionering-och-fixation/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/underlag-for-targetdefinition/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/underlag-for-dosplanering-/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/targetvolymer-och-riskorgan/2023-09-20 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/stralbehandlingsteknik/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/dosplanering/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/stralkvalitet/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/verifikation-bildtagning-justering/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandlingsplanering-och--teknik/dosspecifikation-och-fraktionering/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/laggradiga-gliom-who-grad-2/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/gliom-who-grad-3/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/glioblastom-who-grad-4/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/pilocytiska-astrocytom-who-grad-1/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/tumor-i-medulla-spinalis/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/ependymom/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/medulloblastom/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/intrakraniella-germinalcellstumorer/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/meningeom/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/riktlinjer-for-oplanerade-behandlingsuppehall/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/stralbehandling-i-kombination-med-annan-behandling/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-2-stralbehandling/referenser/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bedomningsskalor/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bedomningsskalor/funktionsklass-funktionsstatus/2023-09-06 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bedomningsskalor/bedomning-av-narkosrisk-enligt-asa/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/remissvagar/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/Handhavande-av-TTFields/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/Handhavande-av-TTFields/hantering-av-ttfields-optune/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/Handhavande-av-TTFields/optune--en-medicinteknisk-produkt/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/Handhavande-av-TTFields/instruktioner-kring-anvandningen-av-ttfields/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/mall-egenvardsintyg-ttf/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardprogram/bilaga-7-nanoskalan/2025-05-19 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/hjarna/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/sammanfattning/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/inledning/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/mal-med-vardprogrammet/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bakgrund-och-orsaker/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/arftlighet/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/symtom-och-tidig-utredning/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/diagnostik/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/kategorisering-av-tumoren/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/stadieindelning-och-prognosfaktorer/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/multidisciplinar-konferens/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/primar-behandling/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/responskriterier/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/behandling-av-aterfall-och-refraktar-sjukdom/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/understodjande-vard/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/omvardnad-och-rehabilitering2/2025-03-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/egenvard2/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/palliativ-vard-och-insatser2/2025-03-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/uppfoljning/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/nivastrukturering/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/uppfoljning-av-cancervarden/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-03-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/forslag-pa-fordjupning2/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/vardprogramgruppen2/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/referenser/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-1.-kvalitetsdokument-for-patologi2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/allmant/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/utredning/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/behandling/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/illamaende/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/laga-blodvarden-och-infektionskanslighet/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/tappa-haret/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/kemisk-lunginflammation/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/stickningar-och-domningar/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/paverkad-sexualitet/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/infertilitet/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/trotthet/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/kanslig-hud/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/mag--och-tarmbesvar/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/biverkningar/stralbehandling/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-2.-patientinformation/uppfoljning/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/Bilaga-3.-sammanfattning-av-cancerbehandling2025-03-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma2025-03-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/radiotherapy-protocol-for-hodgkin-lymphoma/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/patient-pre-treatment-preparation/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/pre-treatment-imaging/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/specificationof-treatment-prescription/2024-02-01 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/specificationof-treatment-prescription/volume-specification/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/specificationof-treatment-prescription/absorbed-dose-prescription/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/specificationof-treatment-prescription/fractionation-and-treatment-time/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/specificationof-treatment-prescription/relation-to-other-concomitant-therapies/2025-03-27 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/treatment-planning-and-delivery/2024-02-01 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/treatment-planning-and-delivery/treatment-technique/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/treatment-planning-and-delivery/dose-computation-and-optimization/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/treatment-planning-and-delivery/treatment-plan-evaluation/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/treatment-planning-and-delivery/image-guided-and-adaptive-treatment-delivery/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/treatment-planning-and-delivery/in-vivo-dosimetry/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/quality-management/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/quality-management/preparatory/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/quality-management/pre-treatment-specific-dosimetry/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/references/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-4.-radiotherapy-protocol-for-hodgkin-lymphoma/history-of-versions/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hodgkins-lymfom/vardprogram/bilaga-5-bleomycinkort/2025-03-26 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/2022-02-10 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/2023-09-11 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/sammanfattning/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/inledning/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/mal-med-vardprogrammet/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bakgrund-och-orsaker/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/arftlighet/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/symtom-och-tidig-utredning/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/diagnostik/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/kategorisering-av-tumoren/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/stadieindelning-och-prognosfaktorer/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/multidisciplinar-konferens/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/behandling-av-primart-kutana-t-cellslymfom/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/behandling-av-primart-kutana-b-cellslymfom/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/stralbehandling-vid-primart-kutana-lymfom/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/responskriterier/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/understodjande-vard/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/omvardnad-och-rehabilitering2/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/egenvard2/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/palliativ-vard-och-insatser2/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/uppfoljning/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/nivastrukturering/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/kvalitetsregister/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/referenser/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/vardprogramgruppen/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/vad-ar-hudlymfom-allman-oversikt/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/mycosis-fungoides/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/sezarys-syndrom/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/primart-kutant-anaplastiskt-storcelligt-tcellslymfom/2025-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/lymfomatoid-papulos/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-1-patientinformation/primara-kutana-b-cellslymfom/2025-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-2--kvalitetsdokument-for-patologi/2025-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-3--provtagningsschema/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-4--anmalningsrutiner-for-nmdk-hudlymfom/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/hudlymfom/vardprogram/bilaga-5--anmalan-till-nmdk-hudlymfom/2025-06-16 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/2022-03-09 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/sammanfattning/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/inledning/2021-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/mal-med-vardprogrammet/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/arftlighet/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/symtom-och-tidig-utredning/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/diagnostik/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/behandling/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/kategorisering-av-tumoren/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/multidisciplinar-konferens/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/nfpa--non-functioning-pituitary-adenoma/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/prolaktinom/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/akromegali/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/cushings-sjukdom/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/tsh-producerande-hypofystumorer--tshom/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/kraniofaryngiom/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/cystor/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/aggressiva-hypofystumorer-och-hypofyskarcinom/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/hypofysapoplexi/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/hypofysit/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/hypofyssvikt/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/omvardnad-och-rehabilitering/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/kognitiv-dysfunktion-hos-barn-och-vuxna-patienter-med-hypofystumorer/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/palliativ-vard-och-insatser/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/uppfoljning-av-varden/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/forslag-pa-fordjupning/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/vardprogramgruppen/2024-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/referenser/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/bilaga-1-sjukregler/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/bilaga-2-forslag-pa-behandlingsstart-och-uppfoljning-av-vuxna-som-far-tillvaxthormon-gh/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/bilaga-3-forslag-pa-behandlingsstart-och-uppfoljning-av-barn-som-far-tillvaxthormon-gh/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/hypofystumorer/vardprogram/bilaga-4-etomidatbehandling-vid-cushings-syndrom/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/2022-06-28 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/sammanfattning/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/inledning/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/mal-med-vardprogrammet/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bakgrund-och-orsaker/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/primar--och-sekundarprevention/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/arftlighet/2025-07-09 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/kannetecken-och-tidig-utredning/2024-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/diagnostik/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/kategorisering-av-tumoren/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/multidisciplinar-konferens-mdk/2024-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/kirurgisk-behandling/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/systemisk-behandling/2024-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/stralbehandling/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/omvardnad-och-rehabilitering/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/egenvard/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/palliativ-vard-och-insatser/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/uppfoljning/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/nivastrukturering/2024-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/kvalitetsregister/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-07-09 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/referenser/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/vardprogramgruppen/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/prognosinstrument/2025-11-26 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/2020-02-18 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/syfte/2020-02-18 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/arbetsgrupp/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/forekomst-av-familjart-melanom-i-sverige/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/definition-av-familjart-melanom/2024-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/kanda-melanomassocierade-mutationer/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bakgrund/genomgang-av-svenska-melanomfamiljer-20152020/2024-06-24 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/handlaggning-av-melanomfamiljer/2020-02-18 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/handlaggning-av-melanomfamiljer/familjeutredning-och-pedigree/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/handlaggning-av-melanomfamiljer/vilka-bor-erbjudas-test-for-cdkn2a-mutationer-eller-mutationer-i-andra-gener/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/kontroller-och-screening/2020-02-18 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/kontroller-och-screening/kontroller-och-screening-hos-barare-av-mutation-i-bap1/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/kontroller-och-screening/kontroller-och-screening-hos-barare-av-mutation-i-cdkn2a/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/kontroller-och-screening/kontroller-och-screening-hos-barare-av-mutation-i-pot1-eller-tinf2-telomer-generna/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/kontroller-och-screening/familjer-testade-negativt-for-mutation-i-hogrisk-gen-samt-familjer-med-okant-mutationsstatus/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/forskning/2020-02-25 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/registrering-av-melanomfamiljer/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/registrering-av-melanomfamiljer/familjekodnummer/2024-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/patientinformation-tillganglig-via-internet/2024-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/kontaktpersoner/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/referenser/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bilagor/2020-02-18 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-1.-handlaggning-av-individer-inom-familjer-med-familjart-melanom/bilagor/mall-godkannande-att-begara-in-journalhandling/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi/inledning/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi/bildfallen/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi/rekommenderat-utbildningsmaterial/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi/kliniska-melanomtyper/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi/tidig-diagnostik-av-de-olika-melanomtyperna/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-2.-melanom-kliniska-fall-med-dermatoskopi/referenser/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/inledning/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/aldersfordelning/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/lokalisation-och-riskmarkorer/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/melanomtyper-hos-aldre/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/tjocklek-och-prognos/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/viktiga-kliniska-symtom-for-melanomtyper-vanliga-hos-aldre-personer/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/2019-12-03 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivningar-nodulara-melanom/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivning-akrolentiginosa-melanom-alm/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivningar-lentigo-maligna-lm-och-lentigo-maligna-melanom-lmm/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivningar-dysplastic-nevus-of-the-elderly-eller-atypical-lentiginous-junctional-nevus-of-the-elderly-of-kossard-kossards-nevus/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivning-av-extrafaciell-lentigo-maligna/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivningar-melanom-med-ytligt-vaxtsatt-ssm/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivningar-av-dysplastic-nevus-of-the-elderly--eller-atypical-lentiginous-junctional-nevus-of-the-elderly-of-kossard/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivning-av-extrafaciell-lentigo-maligna2/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/fallbeskrivningar/fallbeskrivningar-av-melanom-med-ytligt-vaxtsatt-ssm/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-3.-melanom-hos-aldre.-kliniska-fall-med-dermatoskopi/referenser/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/bakgrund/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/incidens/2020-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/utredning/2020-10-14 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/histopatologi/2020-10-14 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/prognos/2020-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/behandling/2020-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/systemisk-onkologisk-behandling/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/uppfoljning/2020-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/framtiden/2020-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-4.-mukosala-melanom/referenser/2020-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/bakgrund/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/forstadier-till-uveala-melanom-atypiska-chorioidala-nevi/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/primart-melanom-i-koroidea-och-corpus-ciliare/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/melanom-i-iris/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/prognos-for-patienter-behandlade-for-uvealt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/uppfoljning-av-patienter-som-behandlats-for-uvealt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/uveala-melanom/metastaserande-uvealt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/forstadier-till-konjunktivalt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/primart-konjunktivalt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/prognos-for-patienter-efter-behandling-av-konjunktivalt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/uppfoljning-av-patienter-behandlade-for-konjunktivalt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/behandling-av-patienter-med-spridning-till-lokoregionala-lymfkortlar/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/konjunktivalt-melanom/metastaserande-konjunktivalt-melanom/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-5.-ogonmelanom--uvealt-och-konjunktivalt/referenser/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga2025-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/klinisk-bakgrundsinformation-och-patologins-roll-i-den-diagnostiska-processen/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/hudpreparat-melanom-melanom-in-situ-dysplastiskt-nevus-och-utvidgad-excision/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/portvaktskortel/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/terapeutisk-lymfkortelutrymning/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/excision-av-metastaslymfkortelutrymning-for-bedomning-av-preoperativ-neoadjuvant-behandlingseffekt/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/Immunhistokemi-och-mutationsanalyser/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/rekommenderat-klassifikationssystem/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/koder-och-beteckningar/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/kvalitetsarbete-for-patologin/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/hud-kvast-gruppen/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/rekommenderad-litteratur/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/bilaga-6.-kvalitetsbilaga-for-patologi-kvast-bilaga/referenser/2023-12-01 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/ladda-ner-pdf/2024-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardforlopp/2020-01-30 https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/sammanfattning/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/inledning/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/mal-med-vardprogrammet/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bakgrund-och-orsaker/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/screening/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/arftlighet/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/symtom-och-tidig-utredning/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/diagnostik/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/tumorklassifikation/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/multidisciplinar-konferens/2023-11-21 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/primar-behandling/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/behandling-av-aterfall/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/understodjande-vard/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/palliativ-vard/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/omvardnad-och-rehabilitering/2020-01-11 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/egenvard/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/uppfoljning/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/nivastrukturering/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/diagnosgrupper/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsregister/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-05-10 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/referenser2/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/forslag-pa-fordjupningslitteratur/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/vardprogramgruppen/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who/datortomografi-dt-av-huvud-hals-och-thorax/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who/magnetisk-resonanstomografi-mrt/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who/pet-ct-positronemissionstomografi-ct/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who/portvaktskortelskintigrafi-sentinel-node/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who/kontrastmedel/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-1.-definition-performance-status-enligt-who/referenser/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsdokument-for-patologi/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsdokument-for-patologi/analyser/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2023-11-25 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/kvalitetsdokument-for-patologi/koder-och-beteckningar/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bedomning-av-allmantillstandet-performance-status/2023-11-25 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-3.-kortfattad-preparatoversikt-vid-medicinsk-tumorbehandling2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-5.-behandlingar-under-utveckling2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-5.-behandlingar-under-utveckling/elektrokemoterapi/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-5.-behandlingar-under-utveckling/referenser/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-6-sarskilt-tandvardsbidrag/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-6-sarskilt-tandvardsbidrag/sarskilt-tandvardsbidrag/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardprogram/bilaga-6-sarskilt-tandvardsbidrag/f-tandvard-vid-vissa-langvariga-sjukdomar-eller-funktionsnedsattning/2023-11-18 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/huvud-och-halscancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/sammanfattning/2025-06-05 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/inledning/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/mal-med-vardprogrammet/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/bakgrund-och-orsaker/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/arftlighet/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/symtom-och-tidig-utredning/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/diagnostik/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/patologi/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/multidisciplinar-konferens/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/follikulart-lymfom/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/marginalzonslymfom--oversikt2/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/nodalt-marginalzonslymfom/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/spleniskt-marginalzonslymfom/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/extranodala-marginalzonslymfom-malt/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/indolenta-b-cellslymfom-uns/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/harcellsleukemi/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/responskriterier/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/transformation/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/stamcellstransplantation/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/understodjande-vard/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/omvardnad-och-rehabilitering2/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/egenvard2/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/palliativ-vard-och-insatser2/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/uppfoljning/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/nivastrukturering/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/uppfoljning-av-cancervarden/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/kvalitetsindikatorer/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/referenser/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/vardprogramgruppen/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/indolenta-b-cellslymfom/vardprogram/bilaga-1-termlista/2025-06-04 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/sammanfattning/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/inledning/2020-01-11 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/mal-med-vardprogrammet/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bakgrund-och-orsaker/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/primar-prevention/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/symtom-och-tidig-utredning/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/diagnostik/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/kategorisering-av-tumoren/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/multidisciplinar-konferens/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/behandlingsindikation/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/primarbehandling/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/lakemedelsbehandling-vid-kll--fordjupad-information/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/responsbedomning/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/uppfoljning/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/behandling-vid-aterfall-eller-refraktar-kll/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/understodjande-vard/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/sjukdomsrelaterade-komplikationer/2022-01-25 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/omvardnad-och-rehabilitering/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/egenvard/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/palliativ-vard-och-insatser/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/underlag-for-nivastrukturering/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/uppfoljning-av-cancervarden/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/kvalitetsregister/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/referenser2/2022-01-25 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/vardprogramgruppen/2020-01-11 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bedomning-av-allmantillstandet-funktionsstatus/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-1-information-till-dig-som-har-fatt-diagnosen-kronisk-lymfatisk-leukemi/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-1-information-till-dig-som-har-fatt-diagnosen-kronisk-lymfatisk-leukemi/de-flesta-behover-ingen-behandling-i-borjan/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-1-information-till-dig-som-har-fatt-diagnosen-kronisk-lymfatisk-leukemi/immunforsvaret-kan-bli-samre/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-1-information-till-dig-som-har-fatt-diagnosen-kronisk-lymfatisk-leukemi/det-finns-stod-att-fa-om-du-ar-orolig/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-1-information-till-dig-som-har-fatt-diagnosen-kronisk-lymfatisk-leukemi/ta-hand-om-dig-sjalv/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/malriktad-behandling/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/cytostatikabehandling/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/biverkningar/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/biverkningar/forsamrat-immunforsvar/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/biverkningar/illamaende/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/biverkningar/andra-biverkningar/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/levnadsvanor/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-2-information-till-dig-som-behandlas-for-kronisk-lymfatisk-leukemi/vaccination/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/komplett-remission-cr/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/komplett-remission-med-kvarstaende-cytopeni-cri/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/partiell-remission-med-lymfocytos-pr-l/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/partiell-remission-pr/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/progressiv-sjukdom-pd/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/stabil-sjukdom-sd/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-4.-responsbedomning/referenser/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-5-svenska-kll-gruppens-nationella-biobank/2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/kll/vardprogram/bilaga-6.-definition-av-tumorlys-syndrom-enligt-cairo-bishop2024-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/maligna-lymfom-och-kll/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/maligna-lymfom-och-kll/vardforlopp/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/maligna-lymfom-och-kll/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/sammanfattning/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/inledning/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/mal-med-vardprogrammet/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bakgrund-och-orsaker/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/primar-prevention/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/arftlighet/2023-05-01 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/symtom-kliniska-fynd-och-diagnostik/2023-05-01 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/diagnostik-och-fortsatt-utredning/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/kategorisering-i-sjukdomsfaser-samt-riskgruppering/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/multidisciplinar-konferens/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/kronisk-fas--forsta-linjens-behandling-inklusive-uppfoljning/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/tyrosinkinashammare-for-forsta-linjens-behandling-av-kml-i-kronisk-fas/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/biverkningar/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/forsok-att-avsluta-tki-behandling/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/kardiovaskular-riskvardering-och-uppfoljning/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/kronisk-fas--andra-linjens-behandling-och-senare-inklusive-uppfoljning/2023-05-01 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/Behandling-i-accelererad-fas-och-blastkris/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/konception-graviditet-och-amning/2023-05-01 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/allogen-stamcellstransplantation-vid-kml/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/understodjande-vard/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/Palliativ-vard-och-behandling/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/omvardnad-och-rehabilitering/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/egenvard/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/Underlag/2023-05-01 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/svenska-kml-registret/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/referenser/2023-04-20 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/forslag-pa-fordjupning/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/vardprogramgruppen/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/relevanta-lankar/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bilaga-1/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bilaga-2/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bilaga-2/definition-av-molekylar-respons-vid-rt-qpcr-for-bcrabl1-/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bilaga-2/definition-av-molekylar-respons-vid-rt-qpcr-for-bcrabl1-/internationella-skalan-is/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bilaga-2/definition-av-molekylar-respons-vid-rt-qpcr-for-bcrabl1-/graden-av-molekylar-respons/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/kml/vardprogram/bilaga-2/definition-av-cytogenetisk-respons/2023-04-19 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/2020-08-21 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/sammanfattning/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/inledning/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/mal-med-vardprogrammet/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/Bakgrund-och-orsaker/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/screening--overvakning-surveillance-av-riskgrupper/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/arftlighet/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/symtom-och-tidig-utredning/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/diagnostik/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/kategorisering-av-tumoren/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/multidisciplinar-konferens/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/primar-behandling-inklusive-pre--och-postoperativ-behandling/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/behandling-av-aterfall/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/understodjande-vard/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/omvardnad-och-rehabilitering/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/egenvard/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/palliativ-vard-och-insatser/2025-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/uppfoljning/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/underlag-for-nivastrukturering/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/uppfoljning-av-cancervarden/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/referenser/2022-04-06 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/Vardprogramgruppen/2020-01-23 https://kunskapsbanken.cancercentrum.se/diagnoser/levercellscancer/vardprogram/kvalitetsdokument-for-patologi/2024-12-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/sammanfattning/2024-08-21 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/inledning/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/mal-med-vardprogrammet/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/bakgrund-orsaker-och-prevention/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/symtom/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/utredning/2024-08-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/kategorisering-av-tumoren/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/multidisciplinar-konferens/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/prognos/2024-08-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/primar-behandling/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/primar-vaginalcancer/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/graviditet-och-livmoderhalscancer/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/omvardnad-och-rehabilitering/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/uppfoljning/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandling-av-aterfall/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/palliativ-vard-och-insatser/2024-08-22 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/underlag-for-nivastrukturering/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/kvalitetsregister/2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-08-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/referenser2/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/vardprogramgruppen/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/riktlinjer-for-bestamning-av-ctv-vid-imrtrapid-arcvmat-vid-definitiv-stralbehandling-vid-livmoderhalscancer/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/behandlingsteknik/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/applikatorer/2024-08-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/3d-bildunderlag/2024-08-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/targetinritning-brachyterapi/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/doser-vid-brachyterapi/2024-08-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/dosplanering/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/kvalitetssakring-av-behandling-vid-brachyterapi/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/behandlingsteknik-vid-brachyterapi/referenser/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/targetdefinitioner-vid-bt/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/riktlinjer-for-bestamning-av-ctvn-vid-imrtvmat-vid-postoperativ-radioterapi-av-cervixcancer/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/bildunderlag-for-volymsdefinitioner-och-dosberakning/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/specifikation-av-behandlingsordination/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/targetvolymer/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/riskorgan/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/diagnosspecifik-strukturbenamning-enligt-standard/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/ordinerad-dos-och-behandlingstid/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/kompensation-for-oundvikliga-avbrott-i-planerad-behandling-inkl.-extra-helgdagar2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/relation-till-andra-behandlingar/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/dosplanering-och-behandling/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/kvalitetssakring/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/extern-radioterapi/referenser/2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/checklista-uppfoljning-cervixcancer/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/stadieindelning-av-vaginalcancer-enligt-tnm-och-figo-ar-2002-2022/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/1.-forkortningar2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/2.-patologins-roll-i-den-diagnosiska-processen2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/3.-anvisningar-till-kirurgen2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/4.-klassificering-av-tumoren2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/4.-klassificering-av-tumoren/4.1-icke-invasiva-skivepitelforandringar2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/4.-klassificering-av-tumoren/4.2-adenocarcinom-in-situ2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/4.-klassificering-av-tumoren/4.3-matning-och-bedomning-av-tidig-invasion2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/4.-klassificering-av-tumoren/4.4-invasiv-skivepitelcancer2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/4.-klassificering-av-tumoren/4.5-invasiva-adenocarcinom--subtyper2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/5.-utskarningsanvisningar2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/6.-analyser2020-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/6.-analyser/6.1-rekommenderade-rutin--och-specialfargningar2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/6.-analyser/6.2-rekommenderad-immunhistokemi2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/6.-analyser/6.3-Antal-snitt2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/7.-information-i-remissens-svarsdel2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/7.-information-i-remissens-svarsdel/7.1-allmanna-kommentar-kring-rapportering2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/7.-information-i-remissens-svarsdel/7.2-rapportering-beroende-av-preparat2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/8.-koder-och-beteckningar2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/9.-kvalitetsindikatorer2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/10.-kvast-grupp-gynekologisk-patologi-20162022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/cervix-histopatologi/11.-referenser2022-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/forandringar-jamfort-med-tidigare-version/2024-08-12 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardforlopp/2020-01-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/2022-03-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/inledning/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/mal-med-vardprogrammet/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/socialstyrelsens-rekommendation-om-screening-for-livmoderhalscancer/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/epidemiologi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/humant-papillomvirus/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/primarprevention-och-hpv-vaccination/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/screening-och-formella-krav/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/kallelse-till-gynekologisk-cellprovskontroll/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/screeningpopulation--vilka-ska-kallas-och-nar/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/atgarder-for-att-underlatta-och-stimulera-deltagande/2025-06-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/provtagning-hos-vardgivare/2025-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/laboratorieanalyser-hpv-genotypning-cytologisk-analys-och-histopatologisk-diagnostik/2025-06-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/handlaggning-vid-avvikande-provsvar-inom-gck/2025-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rutiner-och-information-vid-avvikande-provsvar/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/kolposkopi-och-utredning-vid-avvikelser-i-cellprov/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/handlaggning-efter-utredning-som-visar-dysplasi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/uppfoljning-efter-dysplasibehandling/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/screening-utredning-behandling-och-uppfoljning-av-sarskilda-grupper/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/gynekologisk-cellprovskontroll-genom-sjalvprovtagning-med-analys-for-humant-papillomvirus-hpv2/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bieffekter-av-cervixscreening/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/it-system/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/kommunikation-och-information/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/utbildning-av-nyckelgrupper-inom-livmoderhalscancerprevention/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/kvalitetsuppfoljning/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/underlag-for-samordning-och-nivastrukturering/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/referenser/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/vardprogramgruppen/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-1506162022-11-21 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/dokumenthistorik/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/bakgrund/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/inledning/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/inledning/om-specifikationen/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/inledning/krav-pa-det-enskilda-laboratoriet/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/inledning/overforingsrutiner/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/inledning/vilka-hpv-resultat-ska-overforas/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/inledning/ytterligare-information-om-leverans/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/oversikt/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/filnamn/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/filstruktur/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/filstruktur/xml-format/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/filstruktur/exempel-pa-xml-fil/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/filstruktur/semikolonseparerad-fil/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/filformat/filstruktur/2-exempel-pa-poster-i-semikolonseparerad-fil/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/kodtabeller/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/kodtabeller/koder-for-cytologiavdelningar-enligt-sosfs200615/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-1.-specifikation-for-overforing-av-hpv-testresultat.-version-9-150616/kodtabeller/virologlab/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-2.-nationella-standardremisser2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-2.-nationella-standardremisser/remiss-for-gynekologisk-cellprovskontroll-organiserad-screening/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-2.-nationella-standardremisser/klinisk-remiss-vatskebaserat-prov-tidigare-kallad-indicerad-cytologi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-2.-nationella-standardremisser/definitioner-och-ordforklaringar-till-nationell-standardremiss-for-cervixcytologi2/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/terminologi-internationella-kolposkopifederationen/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/utredning-av-atypisk-cervixcytologi-persistent-hpv-och-icke-behandlad-cervixdysplasi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/utredning-av-atypisk-cervixcytologi-persistent-hpv-och-icke-behandlad-cervixdysplasi/lagre-risk-for-utveckling-av-livmoderhalscancer/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/utredning-av-atypisk-cervixcytologi-persistent-hpv-och-icke-behandlad-cervixdysplasi/hogre-risk-for-utveckling-av-livmoderhalscancer/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/uppfoljning-efter-behandlad-cervixdysplasi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/uppfoljning-efter-behandlad-cervixdysplasi/radikal-excision-av-hsil/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/uppfoljning-efter-behandlad-cervixdysplasi/tveksamicke-radikal-excision-hsil/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/rekommendationer-vid-uteblivet-besok-pa-gynmottagning-for-cellprovsavvikelse-eller-cervixdysplasi/uppfoljning-efter-behandlad-cervixdysplasi/efter-excision-av-lsil/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-5.-beskrivning-av-preparatmatning-efter-excision2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-5.-beskrivning-av-preparatmatning-efter-excision/matning-av-konlangd/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler2025-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfiler-for-hpv/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfiler-for-hpv/inklusionskriterier/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfiler-for-hpv/kallelseintervall-for-gck-prov/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfiler-for-hpv/persisterande-hpv/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfiler-for-hpv/negativt-hpv-for-aktuell-grupp-av-onkogena-typer-vid-uppfoljande-prov/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfiler-for-hpv/information-som-behover-delas/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfil-efter-behandling-hsilais-eller-utlakt-pad-verifierad-hsil-keb-u/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfil-efter-behandling-hsilais-eller-utlakt-pad-verifierad-hsil-keb-u/inklusionskriterier/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfil-efter-behandling-hsilais-eller-utlakt-pad-verifierad-hsil-keb-u/kallelseintervall-vid-gck-prov/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-6.-beskrivning-av-kontrollfiler/kontrollfil-efter-behandling-hsilais-eller-utlakt-pad-verifierad-hsil-keb-u/information-som-behover-delas/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/inledning/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/inledning/bakgrund/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/inledning/nulagesbeskrivning/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/inledning/konsekvent-ordval-ger-okad-tydlighet/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/inledning/avgransningar/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/syfte/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/mal/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/kommunikationsstrategi/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/informationspaket-med-tydliga-och-entydiga-budskap/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/kortfattad-och-tydlig-skriftlig-information-i-tidigt-skede/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/tillforlitliga-kallor-med-fordjupad-information-digitalt/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/behov-av-telefonradgivning-som-komplement/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/stod-for-tydlig-och-entydig-kommunikation-mellan-vardgivare-och-kvinnor/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/syfte-mal-och-kommunikationsstrategi/sarskilda-informationsinsatser/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/budskap-malgrupper-och-kanaler/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/budskap-malgrupper-och-kanaler/tydliga-budskap/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/budskap-malgrupper-och-kanaler/malgrupper-och-ambassadorer/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/budskap-malgrupper-och-kanaler/informations--och-kommunikationskanaler/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/budskap-malgrupper-och-kanaler/uppfoljning-av-kommunikationsinsatser/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/ansvarsfordelning/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-7.-nationellt-underlag-till-kommunikationsplan-for-screening-mot-livmoderhalscancer/referenser/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/plan-for-utbildning-av-gynekologer-for-certifiering-inom-kolposkopi-och-livmoderhalscancerprevention-enligt-nationellt-vardprogram-for-livmoderhalscancerprevention/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/plan-for-utbildning-av-gynekologer-for-certifiering-inom-kolposkopi-och-livmoderhalscancerprevention-enligt-nationellt-vardprogram-for-livmoderhalscancerprevention/bakgrund/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/plan-for-utbildning-av-gynekologer-for-certifiering-inom-kolposkopi-och-livmoderhalscancerprevention-enligt-nationellt-vardprogram-for-livmoderhalscancerprevention/bakgrund/larandemal/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/plan-for-utbildning-av-gynekologer-for-certifiering-inom-kolposkopi-och-livmoderhalscancerprevention-enligt-nationellt-vardprogram-for-livmoderhalscancerprevention/bakgrund/innehall/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/plan-for-utbildning-av-gynekologer-for-certifiering-inom-kolposkopi-och-livmoderhalscancerprevention-enligt-nationellt-vardprogram-for-livmoderhalscancerprevention/bakgrund/ovrigt/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/plan-for-utbildning-av-gynekologer-for-certifiering-inom-kolposkopi-och-livmoderhalscancerprevention-enligt-nationellt-vardprogram-for-livmoderhalscancerprevention/sarskilda-utbildningsinsatser/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-8.-sfogs-kurs-inom-kolposkopi-och-livmoderhalscancerprevention/referenser2/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-9.-forteckning-kvalitetsindikatorer2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-9.-forteckning-kvalitetsindikatorer/socialstyrelsens-kvalitetsindikatorer-vid-screening-for-livmoderhalscancer-samt-nacx-nationella-kvalitetsindikatorer/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-9.-forteckning-kvalitetsindikatorer/socialstyrelsens-kvalitetsindikatorer-vid-screening-for-livmoderhalscancer-samt-nacx-nationella-kvalitetsindikatorer/nacx-nationella-kvalitetsindikatorer-for-cervixscreeningprogrammet/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-10.-sammanfattning-av-forslag-fran-nationella-arbetsgruppen-for-nationella-och-regionala-atgarder2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-10.-sammanfattning-av-forslag-fran-nationella-arbetsgruppen-for-nationella-och-regionala-atgarder/forslag-pa-nationell-niva/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-10.-sammanfattning-av-forslag-fran-nationella-arbetsgruppen-for-nationella-och-regionala-atgarder/forslag-pa-sjukvardsregional-niva/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-10.-sammanfattning-av-forslag-fran-nationella-arbetsgruppen-for-nationella-och-regionala-atgarder/forslag-pa-regional-niva/2025-06-09 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhalscancerprevention/vardprogram/bilaga-10.-sammanfattning-av-forslag-fran-nationella-arbetsgruppen-for-nationella-och-regionala-atgarder/referenser/2025-06-03 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/2021-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/sammanfattning/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/inledning/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/mal-med-vardprogrammet/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/bakgrund-och-orsaker/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/primar-prevention/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/screening/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/arftlighet/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/symtom-och-tidig-utredning/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/diagnostik/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/kategorisering-av-tumoren/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/multidisciplinar-konferens-mdk/2024-08-15 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/primar-behandling/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/behandling-av-aterfall/2024-07-31 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/palliativ-vard-och-insatser/2024-07-31 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/omvardnad-och-rehabilitering/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/egenvard2/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/uppfoljning2/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/underlag-for-nivastrukturering2/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/kvalitetsregister2/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/kvalitetsindikatorer-och-malnivaer2/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/referenser/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/vardprogramgruppen/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/bilaga-1-alternativ-sekventiell-molekylar-klassificering/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/postoperativ-behandling.-kirurgiskt-stadium-i-iii.-radikalt-opererade2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/bilaga-3-andringar-tidigare-versioner/2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardprogram/bilaga-4-version-2.0-remissrunda-med-remissvar-fran-regioner-och-organisationer2024-07-30 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/vardforlopp/2025-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderkroppscancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/2023-07-12 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/inledning/2022-05-10 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/epidemiologi/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/etiologi/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/tobaksprevention/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/lungcancerscreening/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/sma-nodulara-forandringar/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/symtom-och-kliniska-fynd/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/kommentarer-till-klassifikationerna-whoiaslc-2004-och-iaslcatsers-2011/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/utredning/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/multidisciplinar-konferens/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/behandling--sammanfattande-rekommendationer/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/kirurgisk-behandling/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/stralbehandling2/2022-05-10 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/lakemedelsbehandling/2022-05-10 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/Palliativa-atgarder/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/16-endobronkiell-terapi/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/Omvardnad-och-rehabilitering/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/psykosocialt-omhandertagande/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/andra-intrathorakala-tumorer/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/uppfoljning-efter-cancerbehandling/2022-05-10 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/underlag-for-nivastrukturering/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/Register/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2021-08-27 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/vardprogramgruppen/2021-08-27 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/24-referenser/2022-05-10 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardprogram/Patientinformation/2024-07-08 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/lungcancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/inledning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/mal-med-vardprogrammet/2024-11-04 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bakgrund-och-orsaker/2024-11-04 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/organisation/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/potentiella-sena-komplikationer-av-cancerbehandling--sammanfattning/2024-11-04 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/livet-efter-avslutad-behandling/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/Sena-komplikationer-perifera-nervsystemet/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/neurologiska-och-kognitiva-biverkningar--centrala-nervsystemet-cns/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/hjarta/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/karl/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/horsel-och-balans/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/lever-och-bukspottkortel/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/njurar-urinvagar-och-urinblasa/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/tander-munhala-och-spottkortlar/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/ogon-och-syn/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/immunsystem/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/lungfunktion/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/gastrointestinalkanalen/2024-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/endokrinologi-hypotalamus-hypofys-och-tyreoidea/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/gonadfunktion-och-fertilitet--flickor/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/gonadfunktion-och-fertilitet--pojkar/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/konsorgan-och-sexuell-funktion/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/metabola-syndromet/2024-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/brostkortlar/2024-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/skelett-muskulatur-och-mjukdelar/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/hud/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/efterfoljande-cancer/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/nationellt-kvalitetsregister/2024-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/referenser/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/internationella-uppfoljningsrekommendationer/2024-11-01 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/forslag-till-fordjupning/2024-11-04 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/vardprogramgrupp/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-1-sammanfattning-av-cancerbehandling-med-uppfoljningsrekommendationer/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/malsattning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/mottagningens-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/basstandard-for-resurser-pa-barncancercentrum/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/basstandard-for-resurser-pa-lanssjukhus/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/lakares-och-sjukskoterskas-uppgifter-pa-barncancercentrum/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/lakares-och-sjukskoterskas-uppgifter-pa-barncancercentrum/lakarens-uppgift-pa-barncancercentrum/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/lakares-och-sjukskoterskas-uppgifter-pa-barncancercentrum/sjukskoterskans-uppgift-pa-barncancercentrum/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/lakares-och-sjukskoterskas-uppgifter-pa-lanssjukhus/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/lakares-och-sjukskoterskas-uppgifter-pa-lanssjukhus/lakarens-uppgifter-pa-lanssjukhus/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/lakares-och-sjukskoterskas-uppgifter-pa-lanssjukhus/sjukskoterskans-uppgifter-pa-lanssjukhus/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/beskrivning-av-nyckelbesok/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/beskrivning-av-nyckelbesok/nyckelbesok-1-vid-ca-1314-ars-alder/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/beskrivning-av-nyckelbesok/nyckelbesok-2-vid-ca-1617-ars-alder/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/beskrivning-av-nyckelbesok/nyckelbesok-3-vid-18-ars-alder/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-2-basstandard-for-uppfoljningsmottagningar-for-patienter-under-18-ar-s-k-nyckelmottagningar/beskrivning-av-nyckelbesok/ovrigt/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/2024-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/bakgrund/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/malsattning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/information/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/radgivning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/ansvar-for-uppfoljning-enligt-vardprogrammet/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/medicinsk-bedomning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/ovrig-utredning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/natverk/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/medicinsk-utredning-och-behandling/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/intyg/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/rehabilitering/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/kvalitetsregister/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/aktiv-overlamning-fran-barn-till-vuxen/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/aktiv-overlamning-fran-barn-till-vuxen/uppfoljning-pa-ufm/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/beskrivning-av-nyckelbesok/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/behovsanpassad-uppfoljning/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-roll-pa-ufm/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-roll-pa-ufm/lakarens-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-roll-pa-ufm/sjukskoterskans-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-roll-pa-ufm/kuratorns-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-roll-pa-ufm/vardadministratorens-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-roll-pa-ufm/registerkoordinatorns-uppgifter/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-kompetenser-pa-ufm/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-kompetenser-pa-ufm/lakares-kompetens/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-kompetenser-pa-ufm/sjukskoterskans-kompetens/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-kompetenser-pa-ufm/kuratorns-kompetens/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-kompetenser-pa-ufm/vardadministratorens-kompetens/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/langtidsuppfoljning-efter-barncancer/vardprogram/bilaga-3-basstandard-for-uppfoljningsmottagningar-for-vuxna-efter-barncancer/mottagningens-uppgifter/olika-yrkeskategoriers-kompetenser-pa-ufm/registerkoordinatorns-kompetens/2024-10-29 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/sammanfattning/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/inledning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/mal-med-vardprogrammet/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/4-bakgrund-och-orsaker/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/arftlighet/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/symtom-och-tidig-utredning/2020-01-18 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/diagnostik/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/kategorisering-av-tumoren/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/multidisciplinar-konferens/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/primar-behandling/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/behandling-av-aterfall/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/understodjande-vard/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/palliativ-vard-och-insatser/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/omvardnad-och-rehabilitering/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/egenvard/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/uppfoljning/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/underlag-for-nivastrukturering/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/kvalitetsregister/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-07-03 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/forslag-pa-fordjupning2/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/vardprogramgruppen2/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/referenser/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/provtagningsanvisning/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/mellannalsbiopsier-och-sma-biopsier/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/anamnestisk-remissinformation/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/utskarningsanvisningar/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/analyser/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/mantelcellslymfom/vardprogram/bilaga-1--kvalitetsdokument-for-patologi--generellt-for-lymfomdiagnostik/information-i-remissens-svarsdel/2026-04-09 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/sammanfattning/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/inledning/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/mal-med-vardprogrammet/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bakgrund-och-orsaker/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/arftlighet/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/symtom-och-tidig-utredning2/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/diagnostik2/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/kategorisering-av-tumoren2/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/multidisciplinar-konferens2/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/primar-behandling2/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/omvardnad-rehabilitering-och-nutrition/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/egenvard/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/palliativa-onkologiska-kirurgiska-och-endoskopiska-insatser/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/uppfoljning/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/nivastrukturering/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/uppfoljning-av-cancervarden/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/referenser/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/vardprogramgruppen/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/2024-06-25 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/fractionation-schedule/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/simulation/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/positioning-of-the-patient/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/definition-of-target-volumes/2023-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/normal-tissue-contouring/2024-06-13 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/dose-constraints/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/radiation-technique/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/contouring-atlas-heart/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/contouring-atlas-the-elective-lymph-nodes/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardprogram/bilaga-1-radioterapi-for-esofaguscancer/references/2022-09-05 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/matstrups-och-magsackscancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/2023-05-11 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/sammanfattning/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/inledning/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/mal-med-vardprogrammet/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/bakgrund-och-orsaker/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/bakgrund-och-orsaker2/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/symtom-och-tidig-utredning-fram-till-pad-svar/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/fortsatt-utredning-efter-diagnos/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kategorisering-av-tumoren/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/multidisciplinar-konferens/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/primar-behandling/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/behandling-vid-avancerad-sjukdom/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/palliativ-vard-och-insatser/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/omvardnad-och-rehabilitering/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/specifik-omvardnad-och-rehabilitering-vid-merkelcellscancer/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/egenvard/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/uppfoljning/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/underlag-for-nivastrukturering/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsregister/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/referenser/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/vardprogramgruppen/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/klinisk-bakgrundsinformation-och-patologins-roll-i-den-diagnostiska-processen/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/hudpreparat/2022-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/portvaktskortel/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/terapeutisk-lymfkortelutrymning/2023-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/rekommenderat-klassifikationssystem/2023-08-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/forslag-till-mall-for-histopatologiskt-utlatande/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/koder-och-beteckningar/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/kvalitetsarbete-for-patologin/2022-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/hud-kvast-gruppen/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/rekommenderad-litteratur/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga--merkelcellscancer/referenser/2022-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/bilaga-2-bildbilaga/2023-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/merkelcellscancer/vardprogram/bilaga-3-stod-for-adjuvant-cytostatikabehandling-i-litteraturen/2023-08-25 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/inledning/2024-04-02 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/mal-med-vardprogrammet/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/bakgrund-och-orsaker/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/primar-prevention-och-tidig-diagnostik/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/symtom-kliniska-fynd-och-diagnostik/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/kategorisering-av-tumoren/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/mgus/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/multidisciplinar-konferens/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/primar-behandling/2024-04-02 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/behandling-av-primart-plasmocytom/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/uppfoljning-och-responsvardering/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/behandling-av-aterfall/2025-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/behandlingsregimer/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/allogen-stamcellstransplantation/2024-02-09 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/understodjande-vard/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/palliativ-vard/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/omvardnad-och-rehabilitering/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/egenvard/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/underlag-for-nivastrukturering2/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/kvalitetsregister/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/referenser/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/vardprogramgruppens-sammansattning/2024-02-08 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardprogram/bilaga-1-tidigare-revideringar/2025-03-12 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/myelom/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/2023-07-06 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/2023-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/sammanfattning/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/inledning/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/mal-med-vardprogrammet/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/bakgrund-och-orsak/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/arftlighet/2023-07-06 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/symtom-och-tidig-utredning/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/diagnostik/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/kategorisering-av-tumoren/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/prognostiska-system/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/10-mdsmpn-inklusive-kronisk-myelomonocytleukemi-kmml/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/multidisciplinar-konferens/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/behandling-av-mds-med-lagre-risk/2024-09-23 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/behandling-av-mds-med-hogre-risk/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/allogen-stamcellstransplantation/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/understodjande-vard/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/16-omvardnad-och-rehabilitering/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/17-egenvard/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/18-palliativ-vard-och-insatser/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/uppfoljning/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/20-nivastrukturering/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/21-uppfoljning-av-cancervarden/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/kvalitetsindikatorer-och-malnivaer/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/vardprogramgruppen2/2025-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/referenser/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/forslag-pa-fordjupning/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/arftliga-myeloiska-maligniteter/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/bilaga-2--att-tanka-pa-vid-utredning-av-laga-blodvarden/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/bilaga-3---provtagningsanvisning-for-benmarg-och-blod/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/bilaga-4---klassifikation-av-mds/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/bilaga-5---klassifikation-av-mdsmpn/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myelodysplastiskt-syndrom/nationellt-vardprogram-myelodysplastiskt-syndrom-mds/bilaga-6---uppbyggnad-av-ipss-m-och-dess-variabler/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/2022-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardforlopp/2022-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/2022-03-09 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/sammanfattning/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/inledning/2021-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/mal-med-vardprogrammet/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/bakgrund-och-orsaker/2021-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/symtom-och-tidig-utredning/2021-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/diagnostik/2021-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/klassificering-av-mpn/2021-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/multidisciplinar-konferens/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/behandling/2021-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/trombos-och-blodning-vid-mpn/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/speciella-situationer/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/leukemisk-transformation/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/omvardnad-och-rehabilitering/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/egenvard/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/palliativ-vard-och-insatser/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/uppfoljning/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/underlag-for-nivastrukturering/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/uppfoljning-av-cancervarden/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/kvalitetsindikatorer-och-malnivaer/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/forslag-pa-fordjupning/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/vardprogramgruppen/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/referenser2/2022-05-03 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/kvalitetsdokument-for-patologi/2025-06-18 https://kunskapsbanken.cancercentrum.se/diagnoser/myeloproliferativ-neoplasi/vardprogram/bilaga-3---patientinformation-vid-mpn/2025-06-17 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/sammanfattning/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/inledning/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/mal-med-vardprogrammet/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/bakgrund-och-orsaker/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/arftlighet/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/symtom-och-tidig-utredning2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/diagnostik2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/histopatologi2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/multidisciplinar-konferens2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/behandlingsforberedande-diagnostik-behandling-och-uppfoljning2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/behandlingsmetoder2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/palliativ-behandling-vard-och-palliativa-insatser2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/nutrition2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/omvardnad-och-rehabilitering2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/egenvard2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/uppfoljning2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/nivastrukturering2/2025-01-09 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/uppfoljning-av-cancervarden/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/kvalitetsindikatorer2/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/referenser/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/oversikter-och-lankar-som-kompletterar-vardprogrammet/2025-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/vardprogramgruppen/2025-01-08 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardprogram/bilaga-1-behandling-av-diarre/2025-01-09 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/vardforlopp/2025-01-10 https://kunskapsbanken.cancercentrum.se/diagnoser/neuroendokrina-buktumorer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/sammanfattning/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/inledning/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/mal-med-vardprogrammet/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/bakgrund-och-orsaker/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/screening/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/arftlighet/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/symtom-och-tidig-utredning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/diagnostik/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/kategorisering-av-tumoren/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/terapikonferens-och-multidisciplinar-konferens/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/behandling-av-icke-metastaserad-sjukdom/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/behandling-av-metastaserad-sjukdom-eller-av-aterfall/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/understodjande-vard-vid-systemisk-behandling/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/omvardnad-och-rehabilitering/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/egenvard/2020-01-15 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/palliativ-vard-och-insatser/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/uppfoljning/2022-10-20 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/underlag-for-nivastrukturering/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/uppfoljning-av-cancervarden/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/vardprogramgruppen/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/referenser/2022-04-06 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/bilaga-1-min-vardplan/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardprogram/bilaga-3-stadieindelning-uicc-2017-8th-ed/2025-06-11 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/vardforlopp/2020-01-30 https://kunskapsbanken.cancercentrum.se/diagnoser/njurcancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/2021-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/sammanfattning/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/inledning/2021-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/mal-med-vardprogrammet/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/begrepp-och-termer-i-palliativ-vard/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/forutsattningar-for-palliativ-vard/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/palliativ-vard---grunder-och-etisk-plattform/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/existentiella-och-andliga-perspektiv-e/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/samtal-med-patient-och-narstaende2/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/psykosocialt-stod2/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/kloka-palliativa-val-samt-strukturerad-utsattning-av-lakemedel/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/team-inom-palliativ-vard/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/att-arbeta-strukturerat-med-palliativ-vard-och-behandlingsstrategier/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/omvardnad/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/palliativa-vardbehov-ur-olika-sjukdomsperspektiv/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/symtom2/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/palliativa-kirurgiska-endoskopiska-och-interventionella-atgarder/2021-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/nar-doden-ar-nara2/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/kvalitetsindikatorer-och-kvalitetsregister/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/vardprogramgruppen/2021-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/referenser/2023-06-19 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/2022-02-10 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/2021-08-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/sammanfattning/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/inledning/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/mal-med-vardprogrammet/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bakgrund/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/organisation-av-den-palliativa-varden-av-barn/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/6-brytpunktsprocessen--att-klargora-malet-med-varden/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/7-etik-i-barnsjukvarden-och-sjalvbestammande/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/8-kommunikation-med-sjuka-barn/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/9-stod-i-utveckling/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/10-narstaende/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/11-det-doende-barnet/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/12-kulturella-existentiella-och-andliga-aspekter/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/13-narhet-och-intimitet/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/14-symtom/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/15-neurologiska-symtom-och-speciella-symtom-hos-barn-med-neurologiska-sjukdomar/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/16-perinatal-och-neonatal-palliativ-vard/2023-04-13 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/17-kvalitetsregister/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/18-vardprogramgruppen/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/referenser/2021-06-21 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/forord-och-syfte/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/symtomlindring/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/symtomlindring/symtomanalys/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--basbehandling/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/opioidbehandling-uppstart-och-utvardering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/opioider--ekvivalenta-doser-och-konvertering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/vanliga-opioidbiverkningar/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/vanliga-opioidbiverkningar/andningsdepression/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/vanliga-opioidbiverkningar/forstoppning/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/vanliga-opioidbiverkningar/illamaende-och-krakningar/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/vanliga-opioidbiverkningar/klada/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/nociceptiv-smarta--opioider/vanliga-opioidbiverkningar/urinretention/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/neuropatisk-smarta/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/neuropatisk-smarta/nociplastisk-smarta/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/neuropatisk-smarta/visceral-smarta-och-visceral-hyperalgesi/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/adjuvant-smartbehandling/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/smarta/procedursmarta-sedering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/krampanfall/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/krampanfall/behandling-krampanfall/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/somnsvarigheter/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/somnsvarigheter/behandling-somnsvarigheter/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/fatiguetrotthet/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/fatiguetrotthet/behandling-trotthet-fatigue/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/barn-med-neurologisk-sjukdom/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/barn-med-neurologisk-sjukdom/spasticitet-och-dystonier/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/barn-med-neurologisk-sjukdom/myoklonus/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/barn-med-neurologisk-sjukdom/dysautonomi/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/neurologiska-symtom/barn-med-neurologisk-sjukdom/behandling-neurologiska-symtom/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/oro-angest-forvirring-depression/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/oro-angest-forvirring-depression/oro-och-angest/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/oro-angest-forvirring-depression/forvirring/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/oro-angest-forvirring-depression/behandling-oro-angest-forvirring/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/oro-angest-forvirring-depression/depression/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/diarre/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/forstoppning/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/gastrit-gastroesofageal-reflux/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/tarmmotilitetsstimulerande/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/akut-tarmhinder-ileussubileus/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/gastrointestinala-symtom/illamaende-och-krakningar/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/andnod/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/andnod/behandling-dyspne/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/andnod/behandling-rosslighet/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/cirkulation-och-blodning/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/cirkulation-och-blodning/behandling-lungodem-overvatskning/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/andningspaverkan-och-cirkulation/cirkulation-och-blodning/behandling-blodning/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/refraktara-symtom-i-livets-slutskede/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/enteral-administrering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/buckalt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/nasalt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/sublingualt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/rektalt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/transdermalt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/intravenos-administrering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/administreringssatt-for-lakemedel/subkutan-administrering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/indikation-infusionsbehandling/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/administrering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/intravenos-eller-subkutan-administration/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/lakemedelsdosering-infusion--lathund/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/lakemedelskoncentration-vid-infusion/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/dokumentation-och-praktiskt-handhavande/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/kontinuerlig-infusion-palliativt/exempel-pa-startdoser-och-pumpinstallningar-i-palliativ-vard/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/transdermal-behandling/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/transdermal-behandling/applikation/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/transdermal-behandling/dosering-och-utvardering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/allmanna-riktlinjer-symtomatisk-farmakologisk/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/allmanna-riktlinjer-symtomatisk-farmakologisk/symtomskattning/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/allmanna-riktlinjer-symtomatisk-farmakologisk/insattning-av-nytt-lakemedel/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/allmanna-riktlinjer-symtomatisk-farmakologisk/utvardering/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/allmanna-riktlinjer-symtomatisk-farmakologisk/utsattaavbryta-lakemedelsbehandling/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/lakemedelsforskrivningar-extempore-apl-och-licenspreparat/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/lakemedelsforskrivningar-extempore-apl-och-licenspreparat/licenspreparatextempore/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/palliativ-vard-lakemedelsordinationer-i-hemmet/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/palliativ-vard-lakemedelsordinationer-i-hemmet/ordinationsmall/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/palliativ-vard-lakemedelsordinationer-i-hemmet/symtombaserat/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/palliativ-vard-lakemedelsordinationer-i-hemmet/utvardera-och-uppdatera-kontinuerligt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/palliativ-vard-lakemedelsordinationer-i-hemmet/ambulansinformation/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/palliativ-vard-lakemedelsordinationer-i-hemmet/ordinationsmallar-fran-sahlgrenska-och-karolinska/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/referenser/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/referenser/vardprogram-och-palliativa-pediatriska-riktlinjer/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/referenser/artiklar-barn/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/referenser/vardprogram-och-artiklar-vuxna/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/referenser/ovrigt/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard-av-barn/vardprogram/bilaga-1/referenser/bra-lankar/2025-12-04 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/sammanfattning/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/inledning/2020-01-17 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/mal-med-vardprogrammet/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bakgrund-och-orsaker/2020-01-17 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/primar-prevention-och-tidig-diagnostik/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/symtom-kliniska-fynd-och-diagnostik/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/arftlighet/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/kategorisering-av-tumoren/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/multidisciplinar-konferens/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/kurativt-syftande-behandling/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/onkologisk-behandling/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/egenvard/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/omvardnad-och-rehabilitering/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/uppfoljning/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/palliativ-vard-och-insatser/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/underlag-for-nivastrukturering/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/kvalitetsregister/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/referenser/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/forslag-pa-fordjupning/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/vardprogramgruppen/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi/anvisningar-preparathantering/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi/utskarningsanvisningar/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi/hantering-av-prover-pa-laboratorium/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi/analyser/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi/koder-och-beteckningar/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/bilaga-1.-kvalitetsdokument-for-patologi/kvalitetsarbete-for-patologin/2023-06-20 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardforlopp/2020-01-30 https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardforlopp/2023-10-13 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/forandringar-och-forbattringsomraden/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/inledning/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/mal-med-vardprogrammet/2024-10-14 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bakgrund-och-orsaker/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/5-primar-medicinsk-prevention/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/testning-for-tidig-diagnostik/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/klinisk-diagnostik/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/kategorisering-av-tumoren/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/multidisciplinar-konferens-mdk/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/primar-behandling-av-prostatacancer-utan-spridning/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/11-lokalt-aterfall-efter-kurativt-syftande-behandling/2024-10-14 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/primar-behandling-av-prostatacancer-med-spridning/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/kastrationsresistent-prostatacancer/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/palliativ-vard-och-insatser/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/omvardnad-rehabilitering-och-behandling-av-biverkningar/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/egenvard/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/uppfoljning/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/underlag-for-nivastrukturering/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/19-uppfoljning-av-cancervarden/2023-12-08 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/21-forslag-pa-fordjupning/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/vardprogramgruppen2/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/ipo-prostatacancer2/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/referenser/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-1-broschyr-om-psa-prov/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-2-exempel-pa-protokoll-for-mrt-prostata/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-3-mall-for-lokalisering-av-fynd-vid-mrt-prostata/2023-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-4-mall-for-patologiremiss-for-prostatabiopsier/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/klinisk-bakgrundsinformation/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/anvisningar-for-provtagarens-hantering-av-provet/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/utskarningsanvisningar/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/analyser/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/rekommenderade-klassifikationssystem/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/administrativt/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/ovrigt/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/referenser-och-lankar/2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/appendix-1.-immunhistokemi2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-5-kvalitetsdokument-for-patologi/appendix-2.-forslag-pa-standardiserat-svar-av-total-prostatektomi2023-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-6-uppfoljning-av-man-med-prostatacancer/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-7-information-om-patientforeningar/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-8-hyperbar-syrgasbehandling-exempel-pa-bedomningsmall/2024-10-11 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-9-exempel-pa-kardiovaskular-riskbedomning-infor-start-av-arpi-eller-cytostatika-vid-prostatacancer/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-9-exempel-pa-kardiovaskular-riskbedomning-infor-start-av-arpi-eller-cytostatika-vid-prostatacancer/infor-behandling/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-9-exempel-pa-kardiovaskular-riskbedomning-infor-start-av-arpi-eller-cytostatika-vid-prostatacancer/infor-behandling/alla/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-9-exempel-pa-kardiovaskular-riskbedomning-infor-start-av-arpi-eller-cytostatika-vid-prostatacancer/infor-behandling/om-hjartfrisk/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-9-exempel-pa-kardiovaskular-riskbedomning-infor-start-av-arpi-eller-cytostatika-vid-prostatacancer/infor-behandling/om-hjartsjukdom-i-anamnesen-men-inga-symtom-sedan--2-ar-tillbaka/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/bilaga-9-exempel-pa-kardiovaskular-riskbedomning-infor-start-av-arpi-eller-cytostatika-vid-prostatacancer/infor-behandling/om-hjartsjukdom--aktuellt-inom-12-ar/2025-10-27 https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/sammanfattning/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/inledning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/mal-med-vardprogrammet/2020-01-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/bakgrund-och-orsaker/2024-01-17 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/primar-prevention/2020-01-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/arftlighet/2024-01-17 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/symtom-och-tidig-utredning/2020-01-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/diagnostik/2020-01-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/kategorisering-av-tumoren/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/multidisciplinar-konferens/2020-02-05 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/primar-behandling/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/behandling-av-lokala-aterfall/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/behandling-av-avancerad-sjukdom/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/palliativ-vard/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/omvardnad-och-rehabilitering/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/egenvard/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/uppfoljning/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/underlag-for-nivastruktureringnationell-och-regional-organisation/2024-01-17 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/kvalitetsregister/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/kvalitetsindikatorer-och-malnivaer/2022-06-27 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/referenser/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/vardprogramgruppen/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/kvalitetsdokument-for-patologi/2020-01-22 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar-och-hantering-av-prover-pa-laboratorium/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2021-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/nationella-multidisciplinara-konferenser-nmdk-for-sarkom-i-extremiteter-och-balvagg/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/nationella-multidisciplinara-konferenser-nmdk-for-sarkom-i-extremiteter-och-balvagg/mall-for-anmalan-till-nationell-multidisciplinar-sarkomkonferens/2021-09-27 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/vardprogram/forslag-till-dokumentationsmall-nationell-mdk-for-sarkom-i-extremiteter-och-balvagg/2021-09-21 https://kunskapsbanken.cancercentrum.se/diagnoser/sarkom/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/2021-05-24 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/sammanfattning/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/inledning/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/mal-med-vardprogrammet/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/bakgrund-orsaker-riskgrupper-och-arftlighet/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/primar--och-sekundarprevention/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/symtom-och-kliniska-fynd/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/diagnostik-och-utredning/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kategorisering-av-tumoren/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/multidisciplinar-konferens/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/primar-behandling-av-lokal-sjukdom/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/behandling-av-spridd-sjukdom/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/onkologisk-behandling/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/palliativ-vard-och-insatser/2023-06-30 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/omvardnad-och-rehabilitering/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/specifik-omvardnad-vid-skivepitelcancer-i-huden/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/egenvard/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/uppfoljning/2021-09-02 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/underlag-for-nivastrukturering/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsregister/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsindikatorer-och-malnivaer/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/fordjupning/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/referenser/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/vardprogramgruppen/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/klinisk-bakgrundsinformation-och-patologins-roll-i-den-diagnostiska-processen/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/hudpreparat/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/portvaktskortel/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/terapeutisk-lymfkortelutrymning/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/klassifikation-av-primartumoren/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/klassifikation-av-lymfkortelmetastaser/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/snomed-koder/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/kvalitetsarbete-for-patologi/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/hud-kvast-gruppen/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/rekommenderad-litteratur/2021-05-27 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kvalitetsbilaga-for-patologi-kvast-bilaga2/referenser/2021-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/lathund/2021-12-14 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/lathund/diagnostik/2021-12-14 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/lathund/postoperativ-utredning/2021-12-14 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/lathund/behandling/2021-12-14 https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/lathund/uppfoljning/2021-12-14 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/forkortningar/2025-03-17 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/sammanfattning/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/inledning/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/mal-med-vardprogrammet/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bakgrund-och-orsaker/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/primar-prevention/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/arftlighet/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/screening/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/primarvardens-roll/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/symtom-och-tidig-utredning/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/diagnostik/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/kategorisering-av-tumoren/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/multidisciplinar-konferens/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/papillar-och-follikular-tyreoideacancer-behandling/2024-12-19 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/medullar-tyreoideacancer-mtc/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/lagt-differentierad---tyreoideacancer/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/anaplastisk-tyreoideacancer-atc/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/komplikationer-efter-kirurgi/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/behandling-av-aterfall/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/palliativ-vard-och-insatser/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/omvardnad-och-rehabilitering/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/egenvard/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/uppfoljning/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/underlag-for-nivastrukturering/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/kvalitetsregister/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/patientforeningar-och-stodfunktioner/2024-12-06 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/lankar/2025-03-17 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/referenser/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/vardprogramgruppen/2021-09-07 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-1-anatomisk-bild-over-lymfkortelnivaer-pa-halsen/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-2-riktlinjer-for-131i-behandling/2024-12-06 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-3-klassificering-av-tyreoideacytologi-enligt-bethesda/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-5-patientinformation/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-6-patientinformation-gallande-radiojodbehandling/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-7/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-8-illustrationer/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-9-risknivaer-for-biverkan/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-11-vardprogramgruppens-medlemmar-version-1-2012/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-12-beslutsstod-for-ultraljudsledd-cytologi-enligt-eu-tirads/2024-12-09 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/protokoll-tsh-stimulering-utsattningsmetod-for-administrering-av-radiojodbehandling-till-patienter-med-differentierad-tyreoideacancer/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-12-protokoll-for-131i-behandling-med-rhtsh-stimulering/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/vardprogram/bilaga-13-forandringar-i-tidigare-versioner/2024-12-05 https://kunskapsbanken.cancercentrum.se/diagnoser/skoldkortelcancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/2022-04-11 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/sammanfattning/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/inledning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/mal-med-vardprogrammet/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/bakgrund-och-orsaker/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/arftlighet/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/symtom-och-tidig-utredning/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/diagnostik/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kategorisering-av-tumoren/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/stadieindelning-och-prognosfaktorer/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/multidisciplinar-konferens/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/primar-behandling/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/hemofagocyterande-lymfohistiocytos-hlh/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/responskriterier/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/behandling-av-aterfall/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/understodjande-vard/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/omvardnad-och-rehabilitering/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/egenvard/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/palliativ-vard-och-insatser/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/uppfoljning/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/underlag-for-nivastrukturering/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/uppfoljning-av-cancervarden/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/referenser/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/forslag-pa-fordjupning/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/vardprogramgruppen/2021-02-16 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/2021-02-17 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar-och-hantering-av-prover-pa-laboratorium/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/analyser/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/koder-och-beteckningar/2021-02-17 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/kvalitetsdokument-for-patologi/kvalitetsarbete-for-patologin/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/t-cellslymfom/vardprogram/bedomning-av-allmantillstandet-performance-status/2023-10-24 https://kunskapsbanken.cancercentrum.se/diagnoser/testikelcancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/testikelcancer/vardforlopp/2020-01-30 https://kunskapsbanken.cancercentrum.se/diagnoser/testikelcancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/2020-04-17 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/sammanfattning/2025-05-11 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/inledning/2021-07-12 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/mal-med-vardprogrammet/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/bakgrund-och-orsaker/2021-07-12 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/screening-for-kolorektalcancer/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/arftlig-kolorektalcancer/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/symtom/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/bilddiagnostik/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/histo--och-molekylarpatologi2/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/multidisciplinar-konferens/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/neoadjuvant-preoperativ-behandling2/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/kirurgi/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/adjuvant-cytostatikabehandling/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/behandling-av-metastaserad-sjukdom/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/understodjande-vard-omvardnad-och-rehabilitering/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/palliativ-vard-och-insatser/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/uppfoljning/2021-07-12 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/underlag-for-nivastrukturering/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/kvalitetsregister/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/vardprogramgruppen/2021-07-12 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/referenser2/2025-05-11 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/stralbehandling-rektalcancer/2025-05-23 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/stralbehandling-rektalcancer/stralbehandlingsplanering-och--teknik/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/behandlingslinjer-vid-metastaserad-kolorektal-cancer/2025-05-23 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/behandlingslinjer-vid-metastaserad-kolorektal-cancer/bakgrund/2025-05-20 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/beslutsstod-for-preterapeutisk-mdk-vid-diagnos-av-metastaserad-tjock-och-andtarmscancer/2025-05-23 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/2025-05-23 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/bakgrund/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/vagledning-till-vardgivare/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/remisskriterier-for-stallningstagande-till-mojlig-levertransplantation/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/1.-stallningstagande-till-levertransplantation2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/2.-onkologisk-behandling--induktionsbehandling-och-bridging2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/3.-synkron-krlm--remiss-till-nhv-ltx-enhet-infor-kirurgi-av-primartumor2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/4.-metakron-krlm-eller-utvidgad-ltx-bedomning-vid-radikalt-op-primartumor2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/flodesschema-ltx-vid-metakront-metastaserad-krlm-recidiv/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/flodesschema-ltx-vid-synkront-metastaserad-krlm/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/selektionskriterier-for-att-sattas-pa-vantelista-till-ltx/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/5.-handlaggning-vid-klartecken-for-patienten-att-sattas-upp-pa-vantelista-for-levertransplantation2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/6.-levertransplantation2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/7.-handlaggning-postoperativt-uppfoljning-efter-ltx2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/nationella-rekommendationer-for-levertransplantation-vid-kolorektala-levermetastaser/forkortningar/2025-05-21 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/2024-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/sammanfattning/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/inledning/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/mal-med-screeningvardprogrammet/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/socialstyrelsens-rekommendationer/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/bakgrund-och-orsaker-till-tjock--och-andtarmscancer/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/screening--bakgrund-och-principiella-fragor/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/psykosociala-effekter-av-screening/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/screeningprocess-och-ansvarsfordelning/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/screeningpopulation/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/atgarder-for-att-underlatta-och-stimulera-informerat-deltagande/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/provtagning-fit/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/laboratorieanalys-fit/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/koloskopi/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/handlaggning-under-och-efter-koloskopi/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/kommunikation/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/it-system-gas/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/gsk--gemensamt-samordningskansli/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/samordnings-sjukskoterska/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/utbildning/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/kvalitetsuppfoljning/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/referenser/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancerscreening/vardprogram/vardprogramgruppen/2022-09-29 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/sammanfattning2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/inledning2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/mal-med-vardprogrammet2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bakgrund-och-orsaker2/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/primar-prevention-och-riskfaktorer-for-gtd/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/screening/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/arftlighet/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/symtom-och-tidig-utredning/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/diagnostik/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/kategorisering-av-tumoren/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/multidisciplinar-konferens2/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/primar-behandling2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/behandling-av-primar-behandlingssvikt-och-aterfall/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/palliativ-vard-och-insatser/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/omvardnad-och-rehabilitering/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/egenvard/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/uppfoljning-av-gtd/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/fertilitet-och-graviditetsutfall-efter-gtd/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/underlag-for-nivastrukturering2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/kvalitetsregister2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/kvalitetsindikatorer-och-malnivaer2/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/referenser/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/forslag-pa-fordjupning/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/vardprogramgruppen/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/i.-innehallsforteckning2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/ii.-klinisk-bakgrundsinformation2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/iii.-anvisningar-for-provtagarens-hantering-av-provet2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/iv.-anamnestisk-remissinformation2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/v.-hantering-av-prover-pa-patologlaboratorietutskarningsanvisningar2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vi.-analyser2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vi.-analyser/rekommenderade-rutin--och-specialfargningar/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vi.-analyser/specialanalyser/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/benigna-forandringar/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/vii.i-komplett-mola-hydatidosa2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/vii.ii-partiell-mola-hydatidosa2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/vii.iii-invasiv-mola2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/viiiv-koriocarcinom/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/viiv-placental-site-trofoblastic-tumor-pstt/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/vii.-rekommenderade-klassifikationssystem/viivi-epitelioid-trofoblasttumor-ett/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/viii.-information-i-remissens-svarsdel2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/viii.-information-i-remissens-svarsdel/forslag-till-svarsmall-hysterektomi/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/ix.-administrativt2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/ix.-administrativt/a.-snomed-koder2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/ix.-administrativt/b.-kvalitetsindikatorer2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/ix.-administrativt/c.-nationell-hogspecialiserad-vard-inkl.-eftergranskning-av-patologi2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/x.-ovrigt2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/x.-ovrigt/a.-kvast-gruppens-medlemmar2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/x.-ovrigt/b.-klinisk-organisation-som-granskat-och-godkant-dokumentet2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/x.-ovrigt/c.-lank-till-nationellt-vardprogram2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/x.-ovrigt/d.-multidisciplinar-konferens-mdk2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/xi/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-1/xi/referenser/2023-07-04 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-2--bedomning-av-allmantillstandet-performance-status/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/trofoblast/vardprogram/bilaga-3---tidigare-medlemmar-i-vardprogramgruppen/2023-07-05 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/2022-03-09 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/inledning/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/mal-med-vardprogrammet/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bakgrund-och-orsaker/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/screening/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/arftlighet/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/urotelial-cancer-vid-lynchs-syndrom/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/symtom/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/diagnostik/2025-03-06 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/kategorisering-av-tumoren/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/multidisciplinar-konferens/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/primar-behandling/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/behandling-vid-metastatisk-sjukdom/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/omvardnad-och-rehabilitering2/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/palliativ-vard-och-insatser2/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/uppfoljning/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/underlag-for-nivastrukturering/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/uppfoljning-av-cancervarden/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/relevanta-lankar/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/vardprogramgruppen/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/checklista-infor-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/checklista-infor-cystektomi/referenser/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-man-som-genomgar-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-man-som-genomgar-cystektomi/infor-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-man-som-genomgar-cystektomi/efter-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-man-som-genomgar-cystektomi/uppfoljning-efter-insatt-ed-behandling/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-man-som-genomgar-cystektomi/praktiska-tips/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-kvinnor-som-genomgar-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-kvinnor-som-genomgar-cystektomi/infor-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-kvinnor-som-genomgar-cystektomi/efter-cystektomi/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-kvinnor-som-genomgar-cystektomi/uppfoljning-av-sexuell-rehabilitering/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/sexualitet-for-kvinnor-som-genomgar-cystektomi/praktiska-tips/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sexuell-rehabilitering-efter-cystektomi/referenser2/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/transuretral-resektion-av-blastumor-turb/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/transuretral-resektion-av-blastumor-turb/checklista-vid-turb/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/transuretral-resektion-av-blastumor-turb/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/endoskopisk-behandling-av-tumoraterfall-i-lokalbedovning-pa-mottagningen/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/endoskopisk-behandling-av-tumoraterfall-i-lokalbedovning-pa-mottagningen/teknik-enligt-sahlgrenska/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/endoskopisk-behandling-av-tumoraterfall-i-lokalbedovning-pa-mottagningen/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/intravesikal-behandling-med-bcg/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/intravesikal-behandling-med-bcg/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/intravesikal-behandling-med-mitomycin/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/intravesikal-behandling-med-mitomycin/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/adjuvant-instillation-av-epirubicin-eller-mitomycin-i-endos-efter-transuretral-resektion/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/adjuvant-instillation-av-epirubicin-eller-mitomycin-i-endos-efter-transuretral-resektion/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/radikal-cystektomi/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/radikal-cystektomi/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/patienter-ej-lampliga-for-cisplatin/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/intrauretral-cytostatikabehandling/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/intrauretral-cytostatikabehandling/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/en-rok--och-alkoholfri-operation/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/en-rok--och-alkoholfri-operation/rokfri-operation/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/en-rok--och-alkoholfri-operation/alkoholfri-operation/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/en-rok--och-alkoholfri-operation/alkoholfri-operation/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/innehallsforteckning/2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/ii.-klinisk-bakgrundsinformation2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/iii.-anvisningar-for-provtagarens-hantering-av-provet2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/iv.-anamnestisk-remissinformation2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/v.-hantering-av-prover-pa-patologlaboratorietutskarningsanvisningar2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/vi.-analyser2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/vii.-rekommenderade-klassifikationssystem2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/viii.-information-i-remissens-svarsdel2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/ix.-administrativt2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/x.-ovrigt2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/xi.-referenser2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/appendix-1.-immunhistokemiska-fargningar2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/cancer-i-urinvagarna/appendix-2.-forslag-pa-svarsmall-for-cystektomi2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/i.-innehallsforteckning2025-03-07 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/ii.-klinisk-bakgrundsinformation2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/iii.-anvisningar-for-provtagarens-hantering-av-provet2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/iv.-anamnestisk-remissinformation2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/v.-hantering-av-prover-pa-laboratorietanvisningar2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/vi.-analyser2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/vii.-rekommenderade-klassifikationssystem2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/viii.-information-i-remissens-svarsdel2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/ix.-administrativt2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/x.-ovrigt2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/anvisningar-for-cytologi-och-histologi/urinvagscytologi/xi.-referenser2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/prognostisk-modell-for-beraknande-av-progressionsrisk-for-muskelinvasion-for-icke-muskelinvasiva-tumorer-eau-2021/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/antibiotikaprofylax/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/antibiotikaprofylax/urinodling/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/antibiotikaprofylax/vanliga-riskfaktorer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/antibiotikaprofylax/antibiotikaval/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/antibiotikaprofylax/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/anvandningsomraden/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/kontraindikationer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/preterapeutisk-genomgang/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/preparat/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/administrering/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/behandlingsintervall/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/underhallsbehandling/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/biverkningar/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/sekventiell-instillation-med-gemcitabin-och-docetaxel/referenser/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-16.-intravesikal-termokemoterapi-och-emda-electromotive-drug-administration2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-16.-intravesikal-termokemoterapi-och-emda-electromotive-drug-administration/referenser2/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/indikationer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/diagnoskriterier-tis-ovre-urinvagarna/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/kontraindikationer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/instillationstekniker/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/instillationstekniker/a-antegrad-instillation-enligt-m-brehmer/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/instillationstekniker/b-retrograd-instillation-via-uretarkateter-i-trendelenburglage/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/instillationstekniker/c-retrograd-instillation-via-uretra-och-dubbel-j-kateter-i-trendelenburglage/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/uppfoljningsschema/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-17.-instillationsbehandling-iovre-urinvagarna/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-18.-dt-urografi-vid-hematuriutredning2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-18.-dt-urografi-vid-hematuriutredning/protokoll/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-18.-dt-urografi-vid-hematuriutredning/rontgenutlatande-blastumor/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-18.-dt-urografi-vid-hematuriutredning/rontgenutlatande-njurbacken--eller-uretartumor/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-19.-radiologi-vid-uppfoljning-av-urotelial-cancer2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-19.-radiologi-vid-uppfoljning-av-urotelial-cancer/protokoll/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-20.-handlaggning-av-radiologiskt-pavisad-urachusrest-utan-overt-malignt-utseende-med-eller-utan-symptom2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-20.-handlaggning-av-radiologiskt-pavisad-urachusrest-utan-overt-malignt-utseende-med-eller-utan-symptom/referenser/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-21.-stralbehandlingsprotokoll-vid-blascancer2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-21.-stralbehandlingsprotokoll-vid-blascancer/patientforberedelser-innan-behandling/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-21.-stralbehandlingsprotokoll-vid-blascancer/bildtagning-infor-behandlingsplanering/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-21.-stralbehandlingsprotokoll-vid-blascancer/behandlingsordination/2025-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-21.-stralbehandlingsprotokoll-vid-blascancer/andra-terapier/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardprogram/bilaga-21.-stralbehandlingsprotokoll-vid-blascancer/kvalitetskontroll/2025-03-03 https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/forkortat-vardforlopp/2025-11-05 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/sammanfattning/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/inledning/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/mal-med-vardprogrammet/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/epidemiologi-och-riskfaktorer/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/premaligna-tillstand-i-vulva/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/primar-prevention-och-screening/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/symtom-och-tidig-utredning/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/diagnostik/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kategorisering-av-tumoren/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/tumorklassificering/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/multidisciplinar-konferens/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/primar-behandling/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/behandling-av-aterfall/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/malignt-melanom/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/palliativ-vard-och-insatser/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/omvardnad-och-rehabilitering/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/egenvard/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/uppfoljning/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/underlag-for-nivastrukturering/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsregister/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsindikatorer-och-malnivaer/2024-09-23 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/referenser/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/vardprogramgruppen/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/teknisk-och-metodologisk-beskrivning-av-bilddiagnostik/2020-02-06 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/teknisk-och-metodologisk-beskrivning-av-bilddiagnostik/lymfkorteldiagnostik-med-ultraljud/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/teknisk-och-metodologisk-beskrivning-av-bilddiagnostik/magnetresonanstomografi-mrt-av-lilla-backenet-vid-utredning-av-lokal-tumorutbredning-och-regionala-lymfkortlar/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/teknisk-och-metodologisk-beskrivning-av-bilddiagnostik/datortomografi-dt-av-buk/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/teknisk-och-metodologisk-beskrivning-av-bilddiagnostik/positronemissionstomografi-pet-dt/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/teknisk-och-metodologisk-beskrivning-av-bilddiagnostik/referenser/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/lymfkortelkirurgi-vid-olika-scenarier/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/flodesschema-behandlingsval/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/forkortningar/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/klinisk-bakgrundsinformation/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/anvisningar-till-kirurgen/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/anamnestisk-remissinformation/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/utskarningsanvisningar/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/analyser/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/information-i-remissens-svarsdel/2024-10-02 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/rekommenderade-klassifikationssystem/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/administrativt/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/ptnm-klassificering/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/stadieindelning-enligt-figo/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/kvalitetsarbete-for-patologin2/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/ovrigt/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/kvalitetsdokument-for-patologi/referenser/2023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardprogram/vardprogramgruppens-medlemmar-for-version-1.02023-05-04 https://kunskapsbanken.cancercentrum.se/diagnoser/vulvacancer/vardforlopp/2020-01-28 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/2020-02-28 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/sammanfattning/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/inledning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/mal-med-vardprogrammet/2021-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/bakgrund-och-orsaker/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/arftlighet/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/symtom-och-tidig-utredning/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/diagnostik/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/kategorisering-av-tumoren/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/multidisciplinar-konferens/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/primar-behandling/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandling-av-aterfall/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/understodjande-vard/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/omvardnad-och-rehabilitering/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/egenvard/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/palliativ-vard-och-insatser/2021-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/uppfoljning/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/underlag-for-nivastrukturering/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/kvalitetsregister/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/kvalitetsindikatorer-och-malnivaer/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/forslag-pa-fordjupning/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/vardprogramgruppen/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/referenser/2021-09-16 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/patientinformation/2021-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/2021-09-17 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/vad-ar-mgus/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/vad-orsakar-mgus/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/orsakar-mgus-symtom/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/hur-diagnostiserar-man-mgus/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/behover-man-vidare-utredning/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/behover-man-behandling/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/hur-ser-uppfoljningen-ut/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/igm-mgus-monoklonal-gammopati-av-oklar-signifikans/att-leva-med-mgus/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/2025-10-23 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/rituximab-bendamustin-br/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/dexametason-rituximab-cyklofosfamid-drc/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/bortezomib-dexametason-rituximab-bdr/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/ibrutinib/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/zanubrutinib/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/waldenstroms-makroglobulinemi/vardprogram/behandlingsregimer/klorambucil/2025-10-26 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/sammanfattning/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/inledning/2020-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/mal-med-vardprogrammet/2023-03-16 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bakgrund-och-orsaker/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/primar-prevention-och-faktorer-som-paverkar-risken-for-aggstockscancer/2022-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/screening-och-arftlighet/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/symtom-och-tidig-utredning/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/diagnostik/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/kategorisering-av-tumoren/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/multidisciplinar-konferens/2025-05-26 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/primarbehandling/2019-11-27 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/behandling-vid-aterfall/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/borderlinetumorer/2025-05-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/graviditet-och-aggstockscancer/2025-05-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/palliativ-vard-och-insatser/2023-03-17 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/omvardnad-och-rehabilitering/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/egenvard/2020-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/uppfoljning/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/underlag-for-nivastrukturering/2025-05-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/kvalitetsregister/2025-05-30 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/kvalitetsindikatorer-och-malnivaer/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/referenser2/2022-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/lankar-definitioner-forkortningar/2020-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/vardprogramgruppen/2020-01-13 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-1.-bilddiagnostik2022-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-1.-bilddiagnostik/diagnostik-vid-adnexexpansivitet/2023-03-17 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-1.-bilddiagnostik/bild--och-funktionsmedicinsk-preoperativ-utredning-vid-misstankt-aggstockscancer/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-1.-bilddiagnostik/referenser/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt2022-01-20 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/ca-125-vid-epitelial-aggstockscancer/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/provtagningsvariation-och-felkallor-vid-tolkning-av-analysresultat/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/berakning-av-risk-of-malignancy-index-rmi/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/uppfoljning-med-ca-125/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/ca-125-nivaer-vid-mucinos-aggstockscancer-eller-suspekt-tidig-aggstockscancer/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/kompletterande-tumormarkorer-i-preoperativ-differentialdiagnostik/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/fordjupningslitteratur/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-2.-biomarkorer-bt/referenser/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-3.-infertilitet-efter-cytostatikabehandling2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-3.-infertilitet-efter-cytostatikabehandling/profylax-mot-ovariell-insufficiens/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-3.-infertilitet-efter-cytostatikabehandling/fertilitetsbevarande-tekniker/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-3.-infertilitet-efter-cytostatikabehandling/referenser/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-4.-performance-status-enligt-ecogwhozubrod2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-5.-recist-version-1.12023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-5.-recist-version-1.1/referenser/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-6.-tumorutvardering-enligt-gcig-ca-125-och-recist2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-7.-eras-interventioner-innefattar-i-korthet2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/bilaga-7.-eras-interventioner-innefattar-i-korthet/referenser/2023-03-05 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-epitelial/vardprogram/tidigare-revideringar/2025-04-29 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/sammanfattning/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/inledning/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/mal-med-vardprogrammet/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/epidemiologi/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/primar-prevention/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/screening-och-arftlighet/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/symtom-och-tidig-utredning/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/diagnostik/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/histopatologi/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/multidisciplinar-konferens-mdk/2025-03-17 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/primar-behandling/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/tumorutvardering-uppfoljning-och-behandling-av-aterfall/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/understodjande-vard/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/omvardnad-och-rehabilitering2/2025-03-17 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/egenvard2/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/fertilitet-graviditet-och-aggstockscancer/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/palliativ-vard-och-insatser2/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/underlag-for-nivastrukturering/2025-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/kvalitetsregister-och-indikatorer/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/referenser/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/relevanta-lankar/2025-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/vardprogramgruppen/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/dysgerminom/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/omogna-teratom/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/gulesackstumor/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/koriokarcinom/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/granulosacellstumorer/2025-03-14 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/fibrom-fibrotekom-och-tekom/2025-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/sertoli-leydig-tumorer/2025-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/metastaser-till-ovariet/2025-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer-icke-epitelial/vardprogram/bilaga-1-ultraljudsdiagnostik-icke-epiteliala-aggstockscancer/referenser/2025-03-18 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer/2022-04-07 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer/vardforlopp/2022-03-23 https://kunskapsbanken.cancercentrum.se/diagnoser/aggstockscancer/forkortat-vardforlopp/2025-11-06 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/sammanfattning/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/inledning/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/mal-med-vardprogrammet/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/arftlighet/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/genoversikt/2026-01-12 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/utredningsgang/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/genetisk-vagledning/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/diagnostik--genetisk-analys-och-etiska-overvaganden/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/viktiga-begrepp/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/multidisciplinar-konferens/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/primar-behandling/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/transition--overgang-fran-barn--till-vuxensjukvard/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/omvardnad-och-rehabilitering/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/egenvard/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/palliativ-vard/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/nivastrukturering/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/uppfoljning-av-varden/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/forslag-pa-fordjupning/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/vardprogramgruppen/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/referenser/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/bakgrund/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/bakgrund/parad-eller-icke-parad-analys/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/bakgrund/genetisk-vagledning/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/bakgrund/clinical-actionability/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-som-bor-svaras-ut-vid-samtliga-cancerutredningar/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-brostcancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-epitelial-aggstockscancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-prostatacancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-tjock--och-andtarmscancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-livmoderkroppscancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-malignt-melanom/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-magsackscancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/genetiska-fynd-vid-bukspottkortelcancer/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/rekommendationer/ovriga-gener-och-diagnoser/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/dokumentversion-och-uppdateringar/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/innehall-i-tabellen/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/medlemmar-i-arbetsgruppen/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/referenser/2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/pm-rekommendationer-for-aterrapportering-av-konstitutionella-varianter-fran-cancergenetiska-utredningar-inom-klinisk-patologi/bilaga-1.-tabell-med-sammanfattning-av-rekommendationer-i-pm2026-01-14 https://kunskapsbanken.cancercentrum.se/diagnoser/arftliga-tumorrisksyndrom-hos-barn-och-vuxna/vardprogram/bilaga-2-ordlista/2026-01-14 https://kunskapsbanken.cancercentrum.se/uppdatera-kapitelnummer/2021-01-27 https://kunskapsbanken.cancercentrum.se/vardprogram/2022-02-10 https://kunskapsbanken.cancercentrum.se/vardforlopp/2022-02-10 https://kunskapsbanken.cancercentrum.se/uppdateringar/2022-04-07 https://kunskapsbanken.cancercentrum.se/uppdateringar/vardprogram/2022-02-10 https://kunskapsbanken.cancercentrum.se/uppdateringar/vardforlopp/2022-02-10 https://kunskapsbanken.cancercentrum.se/uppdateringar/regimbiblioteket/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/abemaciklib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/abirateron-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/afatinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/aflibercept-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/akalabrutinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/alektinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/alemtuzumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/alpelisib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/amivantamab-intravenos-infusion/2023-12-08 https://kunskapsbanken.cancercentrum.se/basfakta/amsakrin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/anastrozol-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/apalutamid-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/aprepitant-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/anagrelid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/atropin-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/atropin-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/belantamab-mafodotin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cardioxane-dexrazoxan-mot-hjarttoxicitet-intravenos-infusion/2025-01-10 https://kunskapsbanken.cancercentrum.se/basfakta/cyanokobalamin-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cyanokobalamin-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cyanokobalamin-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cytarabin-intratekal-injektion-liposomalt/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/daunorubicin-intravenos-infusion-liposomalt/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dexrazoxan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fosaprepitant-intravenos-infusion2/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/kaliumklorid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kladribin-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/krisantaspas-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/letrozol-per-oral-tablett2/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/mifamurtid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/natriumklorid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/natriumklorid-intravenos-infusion2/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/natriumvatekarbonat-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/natriumvatekarbonat-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/necitumumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ofatumumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/olaparib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/olaratumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pemetrexed-intravenos-infusion2/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/radiumra-223diklorid-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ranitidin-intravenos-infusion/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/ranitidin-intravenos-injektion/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/ranitidin-per-oral-tablett/2022-02-24 https://kunskapsbanken.cancercentrum.se/basfakta/tropisetron-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tropisetron-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinblastin-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/arseniktrioxid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/atezolizumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/atezolizumab-subkutan-injektion/2024-03-06 https://kunskapsbanken.cancercentrum.se/basfakta/avelumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/axitinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/azacitidin-subkutan-injektion-suspension/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bendamustin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/betametason-intravenos-infusion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/betametason-intravenos-injektion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/betametason-per-oral-tablett/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/bevacizumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bexaroten-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bikalutamid-per-oral-tablett/2022-04-01 https://kunskapsbanken.cancercentrum.se/basfakta/binimetinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bleomycin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/blinatumomab-intravenos-infusion-barbar-infusionspump/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bortezomib-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bortezomib-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/bosutinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/brentuximab-vedotin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/brigatinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/buserelin-subkutan-injektion/2023-03-03 https://kunskapsbanken.cancercentrum.se/basfakta/busulfan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/busulfan-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cemiplimab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ceritinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cetuximab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cisplatin-intraperitoneal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cisplatin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cyklofosfamid-peroral-oral-losning/2024-07-22 https://kunskapsbanken.cancercentrum.se/basfakta/cyklofosfamid-monohydrat-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cyklofosfamid-monohydrat-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cytarabin-intratekal-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cytarabin-intravenos-infusion/2023-05-05 https://kunskapsbanken.cancercentrum.se/basfakta/cytarabin-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/cytarabin-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dabrafenib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dakarbazin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dakomitinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/daktinomycin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/daktinomycin-intravenos-injektion/2023-05-27 https://kunskapsbanken.cancercentrum.se/basfakta/daratumumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/daratumumab-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/darolutamid-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dasatinib-vattenfri-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/daunorubicin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/daunorubicincytarabin-intravenos-infusion-liposomalt/2023-06-20 https://kunskapsbanken.cancercentrum.se/basfakta/decitabin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/degarelix-subkutan-injektion/2023-04-20 https://kunskapsbanken.cancercentrum.se/basfakta/denosumab-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dexametason-per-oral-losning/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/dexametason-per-oral-tablett/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/dexrazoxan-intravenos-infusion2/2025-06-18 https://kunskapsbanken.cancercentrum.se/basfakta/dinutuximab-beta-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/docetaxel-vattenfri-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/docetaxel-vattenfri-intravesikal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/dostarlimab-intravenos-infusion/2022-09-11 https://kunskapsbanken.cancercentrum.se/basfakta/doxorubicin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/doxorubicin-intravenos-infusion-barbar-infusionspump/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/doxorubicin-intravenos-infusion-liposomalt/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/durvalumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/elranatamab-subkutan-injektion/2024-08-23 https://kunskapsbanken.cancercentrum.se/basfakta/enfortumab-vedotin-intravenos-infusion/2022-06-30 https://kunskapsbanken.cancercentrum.se/basfakta/enkorafenib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/entrektinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/enzalutamid-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/epirubicin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/epirubicin-intravesikal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/epkoritamab-subkutan-injektion/2025-02-08 https://kunskapsbanken.cancercentrum.se/basfakta/erdafitinib-peroral-tablett/2025-06-18 https://kunskapsbanken.cancercentrum.se/basfakta/eribulin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/erlotinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/estramustinnatriumfosfat-peroral-kapsel/2023-03-29 https://kunskapsbanken.cancercentrum.se/basfakta/etoposid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/etoposid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/etoposidfosfat-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/etoposidfosfat-intravenos-infusion-barbar-infusionspump/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/everolimus-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/exemestan-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/filgrastim-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fludarabin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fludarabin-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fluorouracil-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fluorouracil-intravenos-infusion-barbar-infusionspump/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fluorouracil-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/fosaprepitant-intravenos-infusion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/frukintinib-peroral-kapsel/2026-01-09 https://kunskapsbanken.cancercentrum.se/basfakta/fulvestrant-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/furosemid-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/furosemid-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/gefitinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/gemcitabin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/gemcitabin-intravesikal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/gemtuzumabozogamicin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/gilteritinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/glofitamab-intravenos-infusion/2024-05-24 https://kunskapsbanken.cancercentrum.se/basfakta/goserelin-subkutan-injektion/2022-03-11 https://kunskapsbanken.cancercentrum.se/basfakta/granisetron-intravenos-injektion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/granisetron-per-oral-tablett/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/hydrokortison-intravenos-injektion/2023-01-06 https://kunskapsbanken.cancercentrum.se/basfakta/hydroxikarbamid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/hydroxokobalamin-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/hydroxokobalamin-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ibrutinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/idarubicin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/idarubicin-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/idelalisib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ifosfamid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/imatinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/infliximab-intravenos-infusion/2025-06-18 https://kunskapsbanken.cancercentrum.se/basfakta/infusion-av-stamceller-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/inotuzumabozogamicin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ipilimumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/irinotekan-intraperitoneal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/irinotekan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/irinotekan-intravenos-infusion-liposomalt/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/isatuximab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ixazomib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kabazitaxel-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kabozantinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kabozantinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kalciumfolinat-vattenfritt-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kalciumfolinat-vattenfritt-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kalciumfolinat-vattenfritt-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kapecitabin-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/karboplatin-intraperitoneal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/karboplatin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/karfilzomib-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/karmustin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ketokonazol-peroral-tablett/2023-03-29 https://kunskapsbanken.cancercentrum.se/basfakta/kizartinib-peroral-tablett/2025-11-28 https://kunskapsbanken.cancercentrum.se/basfakta/kladribin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/klemastin-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/klemastin-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/klofarabin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/klorambucil-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/kobimetinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/krisantaspas-intramuskular-injektion2/2026-02-27 https://kunskapsbanken.cancercentrum.se/basfakta/krisantaspas-intravenos-infusion/2026-04-23 https://kunskapsbanken.cancercentrum.se/basfakta/krizotinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/lanreotid-subkutan-injektion/2022-05-11 https://kunskapsbanken.cancercentrum.se/basfakta/lapatinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/larotrektinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/larotrektinib-per-oral-oral-losning/2022-06-10 https://kunskapsbanken.cancercentrum.se/basfakta/lenalidomid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/lenvatinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/letrozol-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/leuprorelin-subkutan-injektion/2023-02-21 https://kunskapsbanken.cancercentrum.se/basfakta/levofolinsyra-intravenos-infusion/2025-08-16 https://kunskapsbanken.cancercentrum.se/basfakta/lomustin-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/lonkastuximabtesirin-intravenos-infusion/2024-03-06 https://kunskapsbanken.cancercentrum.se/basfakta/lorazepam-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/lorlatinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/medroxiprogesteronacetat-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/medroxiprogesteronacetat-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/meklozin-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/melfalan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/melfalan-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/merkaptopurin-monohydrat-per-oral-losning/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/merkaptopurin-monohydrat-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mesna-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mesna-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mesna-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/metoklopramid-intravenos-infusion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/metoklopramid-intravenos-injektion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/metoklopramid-per-rektum-suppositorium/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/metoklopramid-per-oral-tablett/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/metotrexat-via-dosa-intraventrikular-injektion/2024-07-22 https://kunskapsbanken.cancercentrum.se/basfakta/metotrexat-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/metotrexat-intratekal-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/metotrexat-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/metotrexat-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/metylprednisolon-intravenos-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/midostaurin-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mitomycin-intraperitoneal-infusion/2026-01-13 https://kunskapsbanken.cancercentrum.se/basfakta/mitomycin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mitomycin-intravesikal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mitotan-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mitoxantron-intraperikardiell-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mitoxantron-intraperitoneal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mitoxantron-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mogamulizumab-intravenos-infusion/2022-04-20 https://kunskapsbanken.cancercentrum.se/basfakta/mosunetuzumab-l01fx25-intravenos-infusion/2024-11-22 https://kunskapsbanken.cancercentrum.se/basfakta/mycobacterium-bovis-bacillus-calmette-guerin-bcg-rivm-deriverad-stam-1173-p2-levande-forsvagad-intravesikal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/mycobacterium-bovis-bacillus-calmette-guerin-bcg-stam-tice-levande-forsvagad-intravesikal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/natriumtiosulfat-intravenos-infusion/2025-06-20 https://kunskapsbanken.cancercentrum.se/basfakta/nelarabin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/neratinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/netupitant-palonosetron-per-oral-kapsel/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/nilotinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/nintedanib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/niraparib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/niraparib-peroral-tablett/2023-02-15 https://kunskapsbanken.cancercentrum.se/basfakta/nivolumab-relatlimab-opdualag-intravenos-infusion/2025-03-12 https://kunskapsbanken.cancercentrum.se/basfakta/nivolumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/nivolumab-subkutan-injektion/2025-09-09 https://kunskapsbanken.cancercentrum.se/basfakta/obinutuzumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/oktreotid-subkutan-injektion/2022-11-01 https://kunskapsbanken.cancercentrum.se/basfakta/olanzapin-per-oral-tablett/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/olaparib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ondansetron-intravenos-infusion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/ondansetron-intravenos-injektion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/ondansetron-per-oral-tablett/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/osimertinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/oxaliplatin-intraperitoneal-instillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/oxaliplatin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/paklitaxel-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/paklitaxel-intravenos-infusion-micellar/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/paklitaxel-intravenos-infusion-nab/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/palbociklib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/palbociklib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/palonosetron-intravenos-injektion/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/palonosetron-per-oral-kapsel/2024-04-22 https://kunskapsbanken.cancercentrum.se/basfakta/panitumumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/panobinostat-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pazopanib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pegaspargas-intramuskular-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pegaspargas-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pegfilgrastim-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pembrolizumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pemetrexed-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pemigatinib-peroral-tablett/2024-10-15 https://kunskapsbanken.cancercentrum.se/basfakta/pertuzumab-trastuzumab-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pertuzumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/polatuzumab-vedotin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/pomalidomid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ponatinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ponatinib-peroral-tablett/2026-01-09 https://kunskapsbanken.cancercentrum.se/basfakta/pralsetinib-per-oral-kapsel/2022-05-12 https://kunskapsbanken.cancercentrum.se/basfakta/prednisolon-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/prednisolonnatriumsuccinat-intratekal-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/prednison-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/prokarbazin-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/propranolol-peroral-tablett/2022-11-08 https://kunskapsbanken.cancercentrum.se/basfakta/quizantinib-peroral-oral-losning/2025-10-30 https://kunskapsbanken.cancercentrum.se/basfakta/radiumra-223diklorid-intravenos-injektion2/2023-08-11 https://kunskapsbanken.cancercentrum.se/basfakta/ramucirumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/rasburikas-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/regorafenib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/relugolix-peroral-tablett/2025-09-05 https://kunskapsbanken.cancercentrum.se/basfakta/ribociklib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/rituximab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/rituximab-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/rukaparib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/ruxolitinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/sacituzumabgovitekan-intravenos-infusion/2022-07-02 https://kunskapsbanken.cancercentrum.se/basfakta/selperkatinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/serplulimab-intravenos-infusion/2026-03-27 https://kunskapsbanken.cancercentrum.se/basfakta/sirolimus-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/sonidegib-peroral-kapsel/2024-07-22 https://kunskapsbanken.cancercentrum.se/basfakta/sorafenib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/sotorasib-peroral-tablett/2022-09-05 https://kunskapsbanken.cancercentrum.se/basfakta/streptozocin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/sunitinib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tafasitamab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/talazoparib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/talidomid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tamoxifen-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tebentafusp-intravenos-infusion/2024-11-13 https://kunskapsbanken.cancercentrum.se/basfakta/tegafur-gimeracil-oteracil-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/teklistamab-subkutan-injektion/2024-03-01 https://kunskapsbanken.cancercentrum.se/basfakta/temozolomid-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/temozolomid-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/temsirolimus-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tepotinib-peroral-tablett/2023-05-16 https://kunskapsbanken.cancercentrum.se/basfakta/tioguanin-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tiotepa-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tislelizumab-intravenos-infusion/2025-12-16 https://kunskapsbanken.cancercentrum.se/basfakta/tivozanib-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tocilizumab-intravenos-infusion/2025-07-04 https://kunskapsbanken.cancercentrum.se/basfakta/topotekan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/topotekan-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/toremifen-peroral-tablett/2024-05-24 https://kunskapsbanken.cancercentrum.se/basfakta/toripalimab-intravenos-infusion/2026-03-18 https://kunskapsbanken.cancercentrum.se/basfakta/trabektedin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/trametinib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/trastuzumab-deruxtekan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/trastuzumab-emtansin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/trastuzumab-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/trastuzumab-subkutan-injektion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tremelimumab-intravenos-infusion/2023-08-11 https://kunskapsbanken.cancercentrum.se/basfakta/treosulfan-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tretinoin-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/trifluridin-tipiracilhydroklorid-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/triptorelin-intramuskular-injektion/2023-04-21 https://kunskapsbanken.cancercentrum.se/basfakta/trofosfamid-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/tukatinib-per-oral-tablett/2022-05-12 https://kunskapsbanken.cancercentrum.se/basfakta/vandetanib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vedolizumab-intravenos-infusion/2025-07-12 https://kunskapsbanken.cancercentrum.se/basfakta/vemurafenib-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/venetoklax-per-oral-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinblastin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vindesin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinflunin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinkristin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinkristin-intravenos-infusion-barbar-infusionspump/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinorelbin-intravenos-infusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vinorelbin-per-oral-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/basfakta/vismodegib-peroral-kapsel/2024-05-24 https://kunskapsbanken.cancercentrum.se/basfakta/zanubrutinib-peroral-kapsel/2023-10-03 https://kunskapsbanken.cancercentrum.se/basfakta/zolbetuximab-intravenos-infusion/2025-12-05 https://kunskapsbanken.cancercentrum.se/basfakta/zoledronsyra-vattenfri-intravenos-infusion/2024-07-22 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/2022-04-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-lymfatisk-leukemi-all/2024-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-lymfatisk-leukemi-all/nopho-all-2008-hr-18-45-ar-induktion/2024-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-lymfatisk-leukemi-all/nopho-all-2008-sr-och-ir-18-45-ar-induktion/2024-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-ace/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-induktion-atraato-lag--och-intermediar-risk/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-konsolidering-123-lag--och-intermediar-risk/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-konsolidering-4-lag--och-intermediar-risk/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-preinduktion-hogrisk/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-a-5/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-ace/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-d-idac/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-da-25/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-da-34/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-da-35/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-fa-ida/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-ham/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2012-idac/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-a-5/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-a-5-reducerad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-ace/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-da-25/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-da-25-reducerad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-da-34-reducerad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-da-35/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-fa-ida/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2014-ham/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-ham/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-induktion-enligt-aida-hogrisk/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-konsolidering-i-enligt-aida-protokoll/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-konsolidering-ii-enligt-aida-protokoll/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-konsolidering-iii-enligt-aida-protokoll/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-underhallsbehandling-kur-1-6-enligt-aida-protokoll/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/apl-underhallsbehandling-kur-7-enligt-aida-protokoll/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/azacitidin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/azacitidin-venetoklax-kur-1/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/azacitidin-venetoklax-kur-2-osv/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-a-5/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/cytarabin--midostaurin/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-a-5-reducerad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-da-34-reducerad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-da-25/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/cytarabin-daunorubicin-52-d--midostaurin/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-da-25-reducerad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-da-35/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/cytarabin-daunorubicin-53-d--midostaurin/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-da-35-med-mylotarg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/fav-ida-induktion/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/aml2019-fa-ida/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/akut-myeloisk-leukemi-aml/gilteritinib-singel/2023-07-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/analcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/analcancer/cisplatin-mitomycin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/analcancer/fluorouracil-4-dygnsinfusion-mitomycin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/analcancer/kapecitabin-mitomycin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/analcancer/karboplatin-paklitaxel-dag-1-8-15-28-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/analcancer/karboplatin-paklitaxel-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/2024-05-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-1/2025-02-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/ae-steg-2a-1-dag.-ondansetron-olanzapin2024-09-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2a-2dgr/2025-02-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2a-3d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2a-4d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2a-5d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2b-1d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2b-2d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2b-3d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2b-4d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-2b-5d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-3-1d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-3-2d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-3-3d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-3-4dgr/2025-02-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-3-5d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-4-1d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-4-2d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-4-3d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-4-4d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-4-5d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/ae-steg-5a-1-dag.-palonostetron-betametason-olanzapin2024-09-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5a-2d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5a-3d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5a-4d/2025-02-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5a-5d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/steg-5b-1-dag/2024-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5b-2d/2025-02-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5b-3d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5b-4d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-5b-5d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/steg-6-1-dag/2024-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-6-2dgr/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-6-3d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-6-4d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-6-5d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-7-1d/2025-02-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-7-2d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-7-3d/2025-02-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-7-4d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/antiemetika/forebyggande-mot-illamaende-steg-7-5d/2025-02-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/abemaciklib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/alpelisib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/anastrozol/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/atezolizumab---paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/bevacizumab2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/bevacizumab/2025-01-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-metotrexat-po2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-75-dose-dense2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/gemcitabin-karboplatin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-iv-pertuzumab-laddningsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-iv-pertuzumab-underhallsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-sc-pertuzumab-laddningsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-sc-pertuzumab-underhallsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/atezolizumab--nab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/bevacizumab-paklitaxel-28-d/2025-01-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-docetaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-docetaxel-doxorubicin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-metotrexat-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/cyklofosfamid-metotrexat-fluorouracil/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-100/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-75-dose-dense/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-80/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-epirubicin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/docetaxel-karboplatin-auc-5/2023-06-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/doxorubicin-liposomalt/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ec-100/2024-03-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ec-60/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ec-75/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ec-90/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ec-90-dose-dense/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/epirubicin-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/epirubicin-kapecitabin-cyklofosfamid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/eribulin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/everolimus-exemestan/2022-11-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/exemestan/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/fec-100/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/fec-60/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/fec-75/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/fulvestrant/2024-12-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/gemcitabin-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/gemcitabin-karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/goserelin-zoladex/2024-12-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/kapecitabin-1000/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/kapecitabin-1250/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/kapecitabin-vinorelbin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/karboplatin-paklitaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/karboplatin-paklitaxel-veckovis-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/karboplatin-veckovis/2023-03-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/lapatinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/letrozol/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/nab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/nab-paklitaxel-veckovis/2024-01-31 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/neratinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/olaparib-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/paklitaxel-veckovis-21-dagar-kontinuerlig/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/paklitaxel-veckovis-21-dagar-med-paus/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/paklitaxel-veckovis-28-dagar-med-paus/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/palbociklib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/palbociklib---tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab--karboplatin-paklitaxel-veckovis/2022-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-var-6e-vecka-ec-90-dd/2024-01-31 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-ec-90/2022-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-karboplatin-auc-5-nabpaklitaxel/2024-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-karboplatin-auc-2--gemcitabin/2022-03-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-karboplatin-auc-5--gemcitabin/2022-03-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-nab-paklitaxel-veckovis-21-dagar-med-paus/2022-03-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/pembrolizumab-paklitaxel-veckovis-21-dagar-med-paus/2022-03-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ribociklib-400/2025-01-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/ribociklib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/sacituzumabgovitekan/2022-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/talazoparib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/tamoxifen/2022-04-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-pertuzumab-sc-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-pertuzumab-sc-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-emtansine/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-iv-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-iv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-iv-pertuzumab-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-iv-pertuzumab-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-sc/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-sc-pertuzumab-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-sc-pertuzumab-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-deruxtekan/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-kapecitabin-tukatinib-laddningsdos-kur-1/2022-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/trastuzumab-kapecitabin-tukatinib-underhallsdos-kur-2-osv/2022-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/vinorelbin-iv-25-och-po-60-kontinuerlig/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/vinorelbin-iv-30/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/vinorelbin-iv-30-och-po-80-med-paus/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/brostcancer/vinorelbin-po-60-veckovis-21-dagar-kontinuerlig/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/gemcitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/gemcitabin-kapecitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/gemcitabin-nab-paklitaxel2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/folfirinox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/gemcitabin-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/gemcitabin-nab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/bukspottkortelcancer/mfolfirinox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/2023-05-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/capox/2024-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/cisplatin-gemcitabin/2023-05-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/durvalumab-cisplatin-gemcitabin/2024-09-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/fliri/2024-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/flox/2024-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/flv/2024-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/folfiri/2024-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/folfox/2024-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/gemcitabin-kapecitabin/2023-05-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/gemcitabin-oxaliplatin/2023-05-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/kapecitabin/2023-05-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/pembrolizumab-cisplatin-gemcitabin/2024-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/pemigatinib/2025-10-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/gallblase--och-gallvagscancer/teysuno-tegafur-gimeracil-oteracil/2024-07-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/bevacizumab-lomustin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/bevacizumab-monoterapi/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/karmustin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/lomustin-monoterapi2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/pcv2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-monoterapi-underhallsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-konkomitant-med-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-monoterapi-startdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/bevacizumab-lomustin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/ccv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/karbo-ei/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/karmustin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/lomustin-monoterapi/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/lomustin-temozolomid-konkomitant-med-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/pcv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/pei/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-konkomitant-med-stralbehandling-40-gy-perry/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-konkomitant-med-stralbehandling-60-gy-stupp/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-monoterapi-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/hjarntumorer/temozolomid-monoterapi-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/nivolumab-subkutant-var-4e-vecka/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/nivolumab-subkutant-varannan-vecka/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cap/2024-11-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-infor-stralbehandling-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-veckovis-under-stralbehandling-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-cisplatin-fluorouracil-4-dygn-kur-1-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-cisplatin-fluorouracil-4-dygn-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-cisplatin-fluorouracil-5-dygn-kur-1-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-cisplatin-fluorouracil-5-dygn-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-karboplatin-fluorouracil-4-dygn-kur-1-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-karboplatin-fluorouracil-4-dygn-kur-2-osv.-underhallsdos2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-karboplatin-paklitaxel-kur-1-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cetuximab-karboplatin-paklitaxel-kur-2-osv.-underhallsbehandling2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-100-var-3e-vecka-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-80-var-3e-vecka-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-veckovis-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-veckovis-under-stralbehandling-50-mg-fast-dos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-docetaxel/2024-09-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-etoposid-iv-dag-1-3/2023-11-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-etoposid-iv-dag-1-kapslar-dag-2-3/2023-11-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-fluorouracil-4-dygn/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-fluorouracil-5-dygn/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/cisplatin-kapecitabin/2023-05-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/docetaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/docetaxel-veckovis-konkomitant-med-stralbehandling/2024-09-03 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/docetaxel-cisplatin-fluorouracil-4-dygn/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/docetaxel-karboplatin-fluorouracil-4-dygn/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/gemcitabin/2023-05-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/kapecitabin/2023-05-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin---etoposid-iv-dag-1---3/2023-12-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin---etoposid-iv-dag-1-kapslar-dag-2-3/2023-11-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin-auc-6-paklitaxel-200/2023-05-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin-fluorouracil-4-dygn/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin-fluorouracil-5-dygn/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin-kapecitabin/2023-05-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/karboplatin-veckovis-under-stralbehandling/2023-05-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/metotrexat-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/nivolumab-subkutant-var-4e-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/nivolumab-var-4e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/paklitaxel-veckovis-21-dagar-kontinuerlig/2023-05-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pax/2024-11-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pembrolizumab-cis-fluorouracil/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pembrolizumab-karboplatin-auc-6-paklitaxel-200/2023-11-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pembrolizumab-karboplatin-auc5--paklitaxel-175/2023-11-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/pembrolizumab-karboplatin-fluorouracil/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/tislelizumab-200mg/2026-02-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/tislelizumab-cisplatin-gemcitabin/2026-02-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/toripalimab-240mg/2026-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/huvud--och-halscancer/toripalimab-cisplatin-gemcitabin/2026-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/akalabrutinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/akalabrutinib---venetoklax-400--kur-4-14/2025-12-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/akalabrutinib--venetoklax--kur-3-dostitrering/2025-12-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/akalabrutinib-obinutuzumab-kur-2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/akalabrutinib-obinutuzumab-kur-3-7/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/fc-intravenos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/fc-peroral/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/ibrutinib2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/klorambucil-14-dagar-1-dos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/obinutuzumab-klorambucil-28-dagar-klorambucil-2-doser-kur-1-startdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/obinutuzumab-klorambucil-28-dagar-klorambucil-2-doser-kur-2-osv-underhallsdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/obinutuzumab-venetoklax-kur-1-startdoser/2024-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/obinutuzumab-venetoklax-kur-2/2024-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/obinutuzumab-venetoklax-kur-3-6/2024-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/ofatumumab-klorambucil-28-dagar-klorambucil-7-doser-kur-1-startdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/ofatumumab-klorambucil-28-dagar-klorambucil-7-doser-kur-2-osv-underhallsdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-cyklofosfamid-dexametason-14-dagar-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-cyklofosfamid-dexametason-14-dagar-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-cyklofosfamid-dexametason-28-dagar-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-cyklofosfamid-dexametason-28-dagar-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-f-intravenos-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-f-intravenos-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-fc-intravenos-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-fc-intravenos-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-fc-peroral-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-fc-peroral-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-klorambucil-kur-1-startdos/2022-02-25 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-klorambucil-kur-2-osv-underhallsdos/2022-02-25 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/ibrutinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-bendamustin-70-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-bendamustin-70-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-bendamustin-90-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-bendamustin-90-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-idelalisib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-venetoklax-kur-1-startdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/rituximab-venetoklax-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/venetoklax/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/venetoklax-400---obinituzumab-1000/2024-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/venetoklax-400-obinutuzumab-start/2024-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/venetoklax-dostitrering/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/kronisk-lymfatisk-leukemi-kll/zanubrutinib/2024-01-24 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/atezolizumab-bevacizumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/durvalumab-var-4e-vecka/2024-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/durvalumab-tremelimumab/2024-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/lenvatinib/2023-04-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/ramucirumab/2025-02-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/regorafenib/2025-02-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/levercellscancer/sorafenib/2023-04-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/bevacizumab-15-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cemiplimab/2023-03-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cisplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cisplatin-veckovis-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cisplatin-etoposid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cisplatin-etoposid-iv-dag-1-po-dag-2-3/2025-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cisplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/cisplatin-topotekan-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/karboplatin-etoposid-iv-dag-1-3/2025-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/karboplatin-etoposid-iv-dag-1-po-dag-2-3/2025-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/karboplatin-veckovis-under-stralbehandling/2025-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/paklitaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/paklitaxel-topotekan/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/pembrolizumab-var-3e-vecka/2022-10-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/pembrolizumab-var-6e-vecka/2022-10-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/pembrolizumab-cisplatin-paklitaxel/2022-11-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderhals--och-vaginalcancer/pembrolizumab-karboplatin-paklitaxel/2022-10-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/doxorubicin-liposomalt-caelyx2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/cisplatin-doxorubicin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/dostarlimab-monoterapi--kur-1-4/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/dostarlimab-monoterapi-kur-5-osv/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/dostarlimab-karboplatin-paklitaxel/2024-03-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/karboplatin-doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/paklitaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/pembrolizumab-var-3e-vecka-lenvatinib/2023-05-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/livmoderkroppscancer/pembrolizumab-var-6e-vecka-lenvatinib/2024-03-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/afatinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/alektinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/amivantamab-karboplatin-pemetrexed--kur-1-och-2--80-kg-och-over/2026-04-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/amivantamab-karboplatin-pemetrexed--kur-1-och-2-under-80-kg/2026-04-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/amivantamab-karboplatin-pemetrexed--kur-3-och-4--80-kg-och-over/2026-04-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/amivantamab-karboplatin-pemetrexed--kur-3-och-4-under-80-kg/2026-04-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/amivantamab-pemetrexed--kur-5-och-sa-vidare--80-kg-och-over/2026-04-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/amivantamab-pemetrexed--kur-5-och-sa-vidare--under-80-kg/2026-04-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-bevacizumab2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-bevacizumab-karboplatin-paklitaxel2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-cisplatin-pemetrexed-i-glukos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-karboplatin-gemcitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-karboplatin-paklitaxel2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/ceritinib2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-veckovis-under-stralbehandling2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-etoposid-iv-dag-1-po-dag-2-32/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-pemetrexed-i-glukos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-etoposid2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-etoposid-iv-dag-1-po-dag-2-32/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-etoposid-iv-dag-1-po-dag-2-33/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-gemcitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-irinotekan2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-paklitaxel2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-pemetrexed-i-glukos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-pemetrexed-i-glukos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-pemetrexed-i-natriumklorid2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-vinorelbin-iv2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-vinorelbin-iv-dag-1-po-dag-82/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-vinorelbin-po2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-subkutant-varannan-vecka/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-andra-linjen/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pemetrexed-i-glukos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-s.c.-var-3e-vecka2024-03-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-var-4e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-bevacizumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-bevacizumab-karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-etoposid-karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-karboplatin-etoposid-iv-dag-1-po-dag-2-3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/atezolizumab-karboplatin-nab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-cisplatin-pemetrexed-i-natriumklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-cisplatin-vinorelbin-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-erlotinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-karboplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/bevacizumab-karboplatin-pemetrexed-i-natriumklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/binimetinib-enkorafenib/2025-02-25 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/brigatinib-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/brigatinib-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cemiplimab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cemiplimab-cisplatin-pemetrexed/2023-06-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cemiplimab-karboplatin-paklitaxel/2023-06-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cemiplimab-karboplatin-pemetrexed/2023-06-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cemiplimab-pemetrexed/2024-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/ceritinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-veckovis-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-docetaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-etoposid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-etoposid-iv-dag-1-po-dag-2-3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-pemetrexed-i-natriumklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-vinorelbin-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-vinorelbin-iv-dag-1-po-dag-8/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/cisplatin-vinorelbin-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/coav/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/dabrafenib-trametinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/dakomitinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/docetaxel-75/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/docetaxel-nintedanib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-karbo-eto-iv-dag-1-po-dag-2-3/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-peme/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-trem/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-trem-cis-peme/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-trem-karbo-gem/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-trem-karbo-peme/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durva-trem-peme/2025-04-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durvalumab-var-4e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/durvalumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/entrektinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/erlotinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/gefitinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/gemcitabin-vinorelbin-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/ipilimumab-nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/ipilimumab-nivolumab-cisplatin-pemetrexed/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/ipilimumab-nivolumab-karbo-pemetrexed/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/ipilimumab-nivolumab-karpak/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin---nab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-etoposid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-etoposid-iv-dag-1-po-dag-2-3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-irinotekan/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-pemetrexed-i-natriumklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-vinorelbin-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-vinorelbin-iv-dag-1-po-dag-8/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/karboplatin-vinorelbin-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/krizotinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/larotrektinib/2022-06-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/lorlatinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/mitoxantron-intraperikardiellt/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nintedanib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-cisplatin-gemcitabin/2024-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-cisplatin-pemetrexed/2024-10-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-gemcitabin--karboplatin/2024-06-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/nivolumab-karboplatin-pemetrexed/2024-10-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/osimertinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-cisplatin-pemetrexed/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-karboplatin-nab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-karboplatin-pemetrexed/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pembrolizumab-pemetrexed/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pemetrexed-i-natriumklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/pralsetinib/2022-06-02 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/selperkatinib/2023-02-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/sotorasib-singel/2022-09-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/tepotinib/2023-06-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/tislelizumab-200mg/2026-02-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/tislelizumab-400mg/2026-02-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/topotekan-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/topotekan-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/trastuzumab-deruxtekan-54-mgkg/2025-12-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/vinorelbin-iv-25-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/vinorelbin-iv-30/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/vinorelbin-iv-30-och-po-80/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/vinorelbin-po-60-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lungcancer/vinorelbin-po-80-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/abvd/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beac/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-14/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-142/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-143/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-eskalerad-dosintensiv2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-eskalerad-dosintensiv3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-standard-baseline/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beam2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bendamustin-1002/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bendamustin-1202/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bendamustin-120/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-a24/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-a24-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-a4/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-aa24/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-aa24-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-b24/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-b24-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-b4/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-bb24/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-bb24-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-cc/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-cc-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/chap-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/choep-142/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cisplatin-gemcitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cisplatin-gemcitabin3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cyklofosfamid-hogdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cytarabin-hogdos-cns-profylax2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cytarabin-etoposid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cyve-60-ar-eller-aldre/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cyve-yngre-an-60-ar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/dhap2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/arkiverad-epkoritamab-underhall-var-4e-vecka/2025-08-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/forbehandling-gmall---cyklofosfamid-prednisolon/2022-12-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gemcitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gemcitabin-oxaliplatin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gemcitabin-oxaliplatin3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ike2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ime--mie2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/karmustin-tiotepa/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/lcal-99-block-a/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/lcal-99-block-b/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/lcal-99-block-p-forbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/lvpp/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/matrix2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/metotrexat-hogdos-cns-profylax2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/nivolumab-subkutant-varannan-vecka/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/obinutuzumab-kur-1-startdoser2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/obinutuzumab-kur-2-osv-underhallsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-acvbp/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-1002/2022-06-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-702/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-70/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-902/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-cytarabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-choep-142/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-choep-212/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-212/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-mini2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-hdmtx-212/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-cisplatin-gemcitabin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-cytarabin-hogdos-kur-2-4-62/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-cytarabin-hogdos-kur-2-4-63/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-dhap2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-dhax2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-fc-intravenos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-fc-peroral2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-lenalidomid-enligt-sakknlg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-maxi-chop-kur-1-3-52/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-mpv-kur-13572/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-mpv-kur-1357/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-mpv-kur-246/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-mpv-kur-2462/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-temozolomid-fore-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/avd/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopdac-eskalerad/2022-12-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beacopp-eskalerad-dosintensiv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/beam/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bendamustin-100/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bendamustin-brentuximab-vedotin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-a4-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-b4-rituximab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bfm-2004-forbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/brecadd-dosintensiv/2024-05-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/brentuximab-vedotin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bv-chep-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/bv-chp/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ceop-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/choep-14/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/choep-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/chop-14/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/chop-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cisplatin-gemcitabin-pegaspargas-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/comla/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/fludarabin-30-cyklofosfamid-300---konditionering-infor-car-t-med-liso-cel/2024-11-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cyklofosfamid-500--fludarabin-30---konditionering-infor-car-t-med--axi-cel-eller-brexu-cel/2024-11-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cytarabin-hogdos-cns-profylax/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cytarabin-hogdos-primart-cns-lymfom/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/da-teddi-r/2026-05-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/dhap/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/epkoritamab-startdoser---kur-1-dlbcl/2025-07-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/epkoritamab-varannan-vecka-kur-4-9/2025-07-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/epkoritamab-veckovis-kur-2-3/2025-07-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/etoposid-vid-hlh/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/fc-intravenos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/fc-peroral/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/cisplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gemcitabin-oxaliplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/glofitamab-kur-2-12/2025-06-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/glofitamab-startdoser-kur-1/2025-06-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/glofitamab-gemox-kur-2-8/2026-05-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/glofitamab-gemox-startdoser-kur-1/2026-05-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-forbehandling---cyklofosfamid-prednisolon/2024-02-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-b-allnhl-02---kur-a/2022-12-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-b-allnhl-02---kur-a---aldre/2023-03-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-b-allnhl-02---kur-b/2022-12-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-b-allnhl-02---kur-b---aldre/2023-03-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-b-allnhl-02---kur-c/2022-12-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/gmall-b-allnhl-02---rituximab/2022-12-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/hyper-cvad-kur-1357/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/mtxhidac-kur-2468/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ibrutinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ike/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ike-polikliniskt/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/ime--mie/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/karmustin-tiotepa-konditionering/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/klorambucil-po-enligt-lister/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/lenalidomid-enligt-augment-kur-6-12/2024-08-24 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/matrix/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/metotrexat-hogdos-cns-profylax/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/metotrexat-po-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/mogamulizumab-kur-1-startdoser/2025-06-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/mogamulizumab-kur-2-osv/2025-06-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/metotrexat-prokarbazin-vinkristin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/nivolumab-avd/2025-05-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/obinutuzumab-kur-1-startdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/obinutuzumab-kur-2-osv-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/obinutuzumab-underhallsdos-varannan-manad/2024-02-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/polatuzumab-vedotin-rituximab-bendamustin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-100/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-90/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-bendamustin-cytarabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-ceop-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-choep-14/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-choep-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-14/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-mini/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-chop-hdmtx-21/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-ciep-oral/2022-06-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-cytarabin-hogdos-kur-2-4-6/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-da-epoch/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-dhap/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-dhax/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-fc-intravenos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-fc-peroral/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-cisplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-gemox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-ike/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-ike-polikliniskt/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-ime--mie/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-klorambucil/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-lenalidomid-enligt-augment-kur-1-startdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-lenalidomid-enligt-augment-kur-2-osv-underhallsdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-lenalidomid-enligt-sakknlg-18-veckor/2024-01-03 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-maxi-chop-kur-1-3-5/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-mpv-kur-13573/2023-03-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-mpv-kur-2463/2023-03-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-temozolomid-fore-stralbehandling2/2025-04-03 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-underhallsdos-var-3e-manad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/rituximab-underhallsdos-varannan-manad/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/smile/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/temozolomid-konkomitant-med-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/temozolomid-monoterapi---underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/vacop-b/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/vinblastin-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/vipor-kur-1-startdos/2025-10-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/vipor-kur-2-osv/2025-10-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/vr-cap/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/wollner-induktion-konsolidering/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/lymfom/wollner-underhallsbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/ipilimumab-nivolumab3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/ipilimumab-nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/ipilimumab-nivolumab-1--3-mgkg2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab/2022-04-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-subkutant-var-4e-vecka/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-subkutant-varannan-vecka/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/pembrolizumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/binimetinib-enkorafenib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/dabrafenib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/dabrafenib-trametinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/dakarbazin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/ipilimumab-nivolumab2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/ipilimumab-nivolumab-1--3-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-subkutant-var-4e-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-var-4e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/nivolumab-relatlimab/2025-03-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/tebentafusp-startdoser-kur-1/2025-01-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/tebentafusp-underhallsbehandling-kur-2-osv/2025-01-29 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/malignt-melanom/temozolomid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/capox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/eox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/epirubicin-oxaliplatin-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flot2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flot3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flot/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flot-pump2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flot-pump3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folfiri2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folfox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-subkutant-var-4e-vecka/2025-10-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-subkutant-varannan-vecka/2025-10-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/oxaliplatin-fluorouracil-5-x-24-tim/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/oxaliplatin-fluorouracil-5-x-24-tim-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/oxaliplatin-fluorouracil-5-dygnsinfusion2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/oxaliplatin-fluorouracil-5-dygnsinfusion-under-stralbehandling2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/paklitaxel2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/ramucirumab-paklitaxel2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/sox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/xelox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/capox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/cisplatin-fluorouracil-5-x-24-timmar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/cisplatin-fluorouracil-5-dygnsinfusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/docetaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/docetaxel-flv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/durvalumab-var-4e-vecka/2026-05-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/durvalumab-flot/2026-05-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/ecf/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/eox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/fliri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flot-pump/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/flv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folf/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folfiri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folfox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folfox-4-modifierad-vid-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/folftax/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/ipilimumab-1-mgkg--nivolumab-3-mgkg/2022-05-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/ipilimumab-1-mgkg--nivolumab-360-mg/2022-05-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/irinotekan/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/kapecitabin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/karboplatin-fluorouracil-5-x-24-timmar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/karboplatin-fluorouracil-5-dygnsinfusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/karboplatin-paklitaxel-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/lonsurf-trifluridin-tipiracilhydroklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivo-capox/2025-10-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivo-folfox/2025-10-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-6-mgkg-var-4e-vecka/2025-10-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-subkutant-var-4e-vecka2/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-subkutant-varannan-vecka2/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-tillagg-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-tillagg-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/oxaliplatin-fluorouracil-5-dygnsinfusion/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/oxaliplatin-fluorouracil-5-dygnsinfusion-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembro-capox/2025-10-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembro-folfox/2025-10-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembro-trastu-iv-laddningsdos-6mgkg-dag-1---folfox/2025-11-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembro-trastu-iv-underhallsdos-4mgkg---folfox/2025-11-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembrolizumab-trastuzumab-iv-laddningsdos-8mgkg---capox/2025-11-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/pembrolizumab-trastuzumab-iv-underhallsdos-6mgkg---capox/2025-11-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/ramucirumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/ramucirumab-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/siri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/sox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/teysuno-tegafur-gimeracil-oteracil/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/tfox-pump/2023-12-19 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/tislelizumab-200mg/2026-02-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/tislelizumab-400mg/2026-02-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/tislelizumab-capox/2026-02-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/tislelizumab-folfox/2026-02-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-laddningsdos-6-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-laddningsdos-8-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-underhallsdos-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-underhallsdos-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-laddningsdos-6mgkg---folfox/2025-10-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-laddningsdos-8mgkg---capox/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-underhallsdos-4mgkg---folfox/2025-10-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-iv-underhallsdos-6-mgkg---capox/2025-10-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/trastuzumab-deruxtekan-64-mgkg/2025-12-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab-laddningsdos/2026-01-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab-capox/2026-02-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab-capox-kur-1/2026-02-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab-folfox/2026-02-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab-folfox-kur-1/2026-02-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab400-underhallsdos/2026-01-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/matstrups--och-magsackscancer/zolbetuximab600-underhallsdos/2026-01-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-daratumumab-iv-talidomid-dexametason-induktion-kur-1-2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-daratumumab-iv-talidomid-dexametason-induktion-kur-3-4/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-daratumumab-iv-talidomid-dexametason-konsolidering-kur-5-6/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-melfalan-prednison/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-vecka-1-8/2022-06-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-vecka-9-24/2022-06-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-dexametason-kur-1-startdoser2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-dexametason-kur-2-osv-underhallsdoser2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/melfalan-prednison/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/melfalan-prednison-talidomid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-cyklofosfamid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-daratumumab-sc-talidomid-dexametason-induktion-kur-1-2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-daratumumab-sc-talidomid-dexametason-induktion-kur-3-4/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-daratumumab-sc-talidomid-dexametason-konsolidering-kur-5-6/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-dexametason-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-dexametason-35-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-lenalidomid-dexametason-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-lenalidomid-dexametason-28-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-melfalan-prednisolon/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/bortezomib-talidomid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/cyklofosfamid-stamcellsmobilisering/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/cyklofosfamid-talidomid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumab-underhallsdos-manadsvis/2022-03-03 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-vecka-1-82/2022-06-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-vecka-9-242/2022-06-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-bortezomib-dexametason-21-dagar-kur-1-3/2024-11-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-lenalidomid-dexametason-kur-1-2/2022-07-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-lenalidomid-dexametason-kur-3-6/2022-07-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-lenalidomid-dexametason-kur-7-osv/2023-01-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-lenalidomid-underhallsdoser/2022-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumab-mpv-kur-1/2022-03-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumab-mpv-kur-2-9/2022-03-03 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-vrd-induktion-kur-1-4/2022-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/daratumumab-vrd-konsolidering-kur-5-6/2022-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/ixazomib-lenalidomid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-1v-cyklofosfamid-dexametason-kur-1-startdoser/2024-11-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-1v-cyklofosfamid-dexametason-kur-2-osv-underhallsdoser/2024-11-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-2v-cyklofosfamid-dexametason-kur-2-osv-underhallsdoser/2024-11-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-dexametason-kur-1-startdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/karfilzomib-dexametason-kur-2-osv-underhallsdoser/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/lenalidomid-cyklofosfamid-dexametason/2024-11-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/lenalidomid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/melfalan-prednisolon/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/melfalan-prednisolon-talidomid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/pomalidomid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/myelom/talidomid-dexametason/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/karboplatin---etoposid-iv-dag-1---32/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/karboplatin---etoposid-iv-dag-1-po-dag-2-32/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-laddningsdos2/2022-03-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-underhallsdos-2-dagar-streptozocin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-underhallsdos-2-dagar-streptozocin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-underhallsdos-2-dagar-streptozocin3/2022-03-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-underhallsdos2/2022-03-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---doxorubicin-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---fluorouracil-laddningsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---fluorouracil-underhallsdos-2-dagar-streptozocin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---fluorouracil-underhallsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin-laddningsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin-underhallsdos-2-dagar-streptozocin2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin-underhallsdos2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/everolimus/2025-12-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/karboplatin---etoposid-iv-dag-1---3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/karboplatin---etoposid-iv-dag-1-po-dag-2-3/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---fluorouracil-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---fluorouracil-underhallsdos-2-dagar-streptozocin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin---fluorouracil-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin-underhallsdos-2-dagar-streptozocin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/streptozocin-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/sunitinib-375-kontinuerlig/2025-12-17 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/temozolomid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/neuroendokrina-tumorer/temozolomid---kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/arkiverad-everolimus/2025-01-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/nivolumab-subkutant-var-4e-vecka/2025-11-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/nivolumab-subkutant-varannan-vecka/2025-11-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/avelumab-axitinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/axitinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/axitinib-pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/axitinib-pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/everolimus/2025-01-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/ipilimumab-nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/kabozantinib/2025-01-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/kabozantinib-nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/nivolumab-subkutant-var-4e-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/nivolumab-var-4e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/pazopanib/2025-01-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/pembrolizumab-var-3e-vecka/2022-04-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/pembrolizumab-var-3e-vecka-lenvatinib/2023-07-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/pembrolizumab-var-6e-vecka/2022-04-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/pembrolizumab-var-6e-vecka-lenvatinib/2024-04-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/njurcancer/sunitinib/2023-07-14 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/peniscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/peniscancer/cisplatin-docetaxel-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/peniscancer/cisplatin-kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/peniscancer/cisplatin-veckovis-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/peniscancer/pic/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/abirateron/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/apalutamid/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/bikalutamid/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/buserelin/2023-09-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/cyklofosfamid-prednisolon-po/2023-08-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/darolutamid/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/degarelix/2023-09-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/docetaxel-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/docetaxel-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/docetaxel-varannan-vecka2/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/docetaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/enzalutamid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/goserelin/2023-09-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/kabazitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/karboplatin---etoposid-iv-dag-1---3/2023-09-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/karboplatin---etoposid-iv-dag-1-po-dag-2-3/2023-09-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/leuprorelin/2023-09-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/olaparib-tablett/2023-09-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/triptorelin/2023-09-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/prostatacancer/xofigo/2025-02-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/2024-04-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cevaie---i2va-cws-2014-kur-1-och-2/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cevaie---i2va-cws-2014-kur-3-och-4/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euramos-i---a/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroewing-2012-ie/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroewing-2012-vdc/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroewing-2012-vdc2/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/nivolumab-subkutant-var-4e-vecka/2025-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/nivolumab-subkutant-varannan-vecka/2025-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/bevacizumab-temozolomid/2022-12-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cws-2014---i2va-kur-1-och-2/2023-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cws-2014---i2va-kur-3-och-4/2023-09-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cws-2014---i2vad-kur-1/2023-08-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cws-2014---i2vad-kur-2-osv/2023-08-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cws-2014---va/2023-08-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/cyklofosfamid-topotekan/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/dakarbazin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/docetaxel-100-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/docetaxel-80-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/doxorubicin-60/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/doxorubicin-75/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/doxorubicin-dakarbazin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/doxorubicin-ifosfamid-enl-ssg-xx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/doxorubicin-ifosfamid-enl-ssg-xx-poliklinisk/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/eribulin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/etoposid-trofosfamid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euramos-i---ma/2023-01-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/map/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroboss-i---cisplatin-doxorubicin/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroboss-i---ifosfamid-cisplatin/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroboss-i---ifosfamid-doxorubicin/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroboss-i---metotrexat/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroewing-2012-ie2/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/euroewing-2012-vdc3/2023-06-03 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/ifosfamid-hogdos/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/imatinib/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/ipilimumab-nivolumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/kabozantinib/2023-08-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/maid/2023-08-26 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/metotrexat-propranolol-vinblastin/2022-12-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/nivolumab-subkutant-var-4e-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/nivolumab-var-4e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/paklitaxel-veckovis/2023-03-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/pazopanib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/pembrolizumab-var-3e-vecka/2023-03-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/pembrolizumab-var-6e-vecka/2023-03-30 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/pembrolizumab-axitinib/2024-04-25 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/regorafenib/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/sorafenib/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/sunitinib/2022-10-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/trabektedin-yondelis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/sarkom/trofosfamid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/doxorubicin-veckobehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/kabozantinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/kabozantinib-tabletter/2024-08-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/lenvatinib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/paklitaxel-postop-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/paklitaxel-postop-veckovis-28-dagar-med-paus/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/paklitaxel-veckovis-konkomitant-med-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/sorafenib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/skoldkortelcancer/vandetanib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/stodregimer/2025-06-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/stodregimer/dexrazoxan/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/stodregimer/filgrastim-subkutant/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/stodregimer/pegfilgrastim-subcutant/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/stodregimer/zoledronsyra-4-mg/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/ema-co/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/bep/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/bep-ifosfamid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/ema-co2/2022-04-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/ep/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/gop/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/irinotekan-oxaliplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/karboplatin-etoposid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/pei/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/testikelcancer-och-extragonadal-konscellstumor/tip/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/aflibercept/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-folfiri-14-dagar2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-folfox-14-dagar2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-kapecitabin-21-dagar2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/capox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-7-dagar-laddningsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-7-dagar-underhallsdos/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/flox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folfirinox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folfoxiri2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/nivolumab-subkutant-var-4e-vecka/2025-10-31 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/sox2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/xeliri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/xelox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-capiri/2025-11-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-capox/2024-04-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-fliri/2023-09-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-flox/2023-09-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-flv/2023-09-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-folf/2023-09-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-folfiri-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-folfox-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-folfoxiri/2025-11-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-kapecitabin-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-lonsurf-dag-1-5-15-19/2024-12-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-lonsurf-dag1-5-8-12/2024-12-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-siri/2025-12-16 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-sox/2025-11-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/bevacizumab-teysuno-tegafur-gimeracil-oteracil/2023-08-13 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/capiri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/capox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetux-enko-folfox/2025-07-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-enkorafenib/2023-11-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-folf/2025-11-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-folfiri-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-folfox-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/cetuximab-irinotekan-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/fliri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/flox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/flv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folf/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folfiri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folfirinox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folfox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/folfoxiri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/frukintinib/2026-01-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/hipec-mit/2026-04-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/hipec-irinotekan-ip-flv-iv-dag1/2026-04-28 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/hipec-oxaliplatin-ip-flv-iv-dag1/2025-07-12 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/ipilimumab-nivolumab-1mgkg--3-mgkg/2024-11-27 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/irinotekan-14-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/irinotekan-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/irox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/kapecitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/kapecitabin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/kapecitabin900-5dv-under-stralbehandling/2025-05-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/lonsurf-trifluridin-tipiracilhydroklorid/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/nivolumab-6-mgkg-var-4e-vecka/2025-07-09 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/nivolumab-subkutant-var-4e-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/panitumumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/panitumumab-folf/2025-11-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/panitumumab-folfiri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/panitumumab-folfox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/panitumumab-irinotekan-14-dagar/2025-11-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/pembrolizumab-4-mgkg-var-6e-vecka/2025-05-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/pembrolizumab-var-3e-vecka/2023-09-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/regorafenib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/siri/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/sox/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/tjock--och-andtarmscancer/teysuno-tegafur-gimeracil-oteracil/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/daktinomycin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/ema-cns-co/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/ema-cns-ep/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/ema-coa/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/ema-cob/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/ep-induktionsbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/ep-ema/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/metotrexat-im/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/metotrexat-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/trofoblastsjukdomar/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/cisplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/cisplatin-gemcitabin-21-dagar2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/cisplatin-gemcitabin-28-dagar2/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/gemcitabin-docetaxel-intravesikal-flerdosinstillation/2023-01-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-subkutant-var-4e-vecka/2025-11-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-subkutant-varannan-vecka/2025-11-21 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/atezolizumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/avelumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/bcg-intravesikal-flerdosinstillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/cisplatin-dag-1-och-2-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/cisplatin-gemcitabin-21-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/cisplatin-gemcitabin-28-dagar/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/docetaxel-75/2026-03-31 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/enfortumab-vedotin/2023-01-31 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/pembro-ev/2025-07-01 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/epirubicin-intravesikal-endosinstillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/erdafitinib/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/fluorouracil-4-dygnsinfusion-mitomycin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/fluorouracil-5-dygnsinfusion-mitomycin-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/gemcitabin-intravesikal-flerdosinstillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/gemcitabin-docetaxel-intravesikal-flerdosinstillation2/2023-01-04 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/gemcitabin-karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/gemcitabin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/m-vac-14/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/mitomycin-intravesikal-endosinstillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/mitomycin-intravesikal-flerdosinstillation/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-subkutant-var-4e-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-subkutant-varannan-vecka3/2026-04-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-var-4e-vecka/2024-10-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-varannan-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/nivolumab-cisplatin-gemcitabin/2024-10-11 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/pembrolizumab-var-3e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/pembrolizumab-var-6e-vecka/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/vinflunin-200/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/vinflunin-250/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/vinflunin-280/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/urinblase--och-urinvagscancer/vinflunin-320/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/vulvacancer/2022-10-05 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/vulvacancer/cisplatin-veckovis-under-stralbehandling/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/ip-cisplatin-intraperitonealt/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/doxorubicin-liposomalt-caelyx-trabektedin-yondelis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/etoposid-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/extended-karboplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/ip-mitoxantron-intraperitonealt/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/niraparib/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/olaparib-kapsel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/topotekan-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/bep/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/bevacizumab-10-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/bevacizumab-15-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/bevacizumab-75-mgkg/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/cisplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/cisplatin-doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/cisplatin-gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/cisplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/cyklofosfamid-po/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/docetaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/extended-karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/extended-karboplatin-docetaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/extended-karboplatin-doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/extended-karboplatin-gemcitabin2/2026-02-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/extended-karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/gemcitabin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin-docetaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin-doxorubicin-liposomalt-caelyx-21-dagar/2022-04-06 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin-doxorubicin-liposomalt-caelyx/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin-gemcitabin2/2026-02-23 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/karboplatin-paklitaxel/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/letrozol/2023-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/niraparib-tabletter/2023-03-15 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/olaparib-tablett/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/paklitaxel-veckovis/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/pei/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/rukaparib/2025-05-08 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/tip/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/topotekan-iv/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/aggstockscancer/trametinib/2024-01-20 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/oppet-arkiv/2022-04-07 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovrig-hudcancer/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovrig-hudcancer/avelumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovrig-hudcancer/cemiplimab/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovrig-hudcancer/sonidegib/2025-06-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovrig-hudcancer/vismodegib/2025-06-18 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovriga/2022-02-10 https://kunskapsbanken.cancercentrum.se/lakemedelsregimer/ovriga/avelumab/2022-02-10 https://kunskapsbanken.cancercentrum.se/barncancer/2024-03-25 https://kunskapsbanken.cancercentrum.se/barncancer/akut-lymfatisk-leukemi-all/2024-03-11 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/2024-03-11 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/ade--1-ar-eller--10-kg/2026-01-21 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/ade--1-ar-eller--10-kg2/2026-01-21 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/fla--1-ar-eller--10-kg/2026-01-21 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/fla--1-ar-eller--10-kg2/2026-01-21 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/ha3e--1-ar-eller--10-kg2/2026-01-21 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/ha3e--1-ar-eller--10-kg/2025-12-18 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/ham--1-ar-eller--10-kg2/2026-01-21 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/ham--1-ar-eller--10-kg/2025-12-18 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/intratekal-trippel/2025-11-08 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/mec--go--1-ar-eller--10-kg/2025-11-08 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/mec--go--1-ar-eller--10-kg2/2025-11-08 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/mec--1-ar-eller--10-kg/2025-11-08 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/mec--1-ar-eller--10-kg2/2025-11-08 https://kunskapsbanken.cancercentrum.se/barncancer/akut-myeloisk-leukemi-aml/mec--1-ar-eller--10-kg--quizartinib/2026-02-12 https://kunskapsbanken.cancercentrum.se/barncancer/binjuretumorer/2024-04-04 https://kunskapsbanken.cancercentrum.se/barncancer/cns-tumorer/2024-03-11 https://kunskapsbanken.cancercentrum.se/barncancer/hodgkin/2024-03-11 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/2024-03-25 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/a--dexrazoxan/2025-06-20 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/ap--dexrazoxan/2025-06-20 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/ie---ieuroewing/2025-11-06 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/vc/2025-05-07 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/vdcdexrazoxan/2025-05-07 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/vinkristine-15-mgm2-far-rms/2024-03-14 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/vinocyc-iv/2025-05-07 https://kunskapsbanken.cancercentrum.se/barncancer/sarkom/vinocyc-po/2025-05-07 https://kunskapsbanken.cancercentrum.se/barncancer/neuroblastom/2024-03-11 https://kunskapsbanken.cancercentrum.se/barncancer/njurtumorer/2026-03-11 https://kunskapsbanken.cancercentrum.se/barncancer/njurtumorer/wilms-preop-cytostatika--1-ar-ocheller--12-kg/2026-03-11 https://kunskapsbanken.cancercentrum.se/kontakt/2022-02-10 https://kunskapsbanken.cancercentrum.se/stoddokument/2025-06-02 https://kunskapsbanken.cancercentrum.se/stoddokument/infusionsrelaterade-reaktioner-irr/2025-11-04 https://kunskapsbanken.cancercentrum.se/stoddokument/alarmsymtom-vid-misstanke-om-cancer-hos-barn-och-ungdom/2025-03-25 https://kunskapsbanken.cancercentrum.se/stoddokument/cancer-under-graviditet/2024-09-19 https://kunskapsbanken.cancercentrum.se/stoddokument/cytostatikaorsakad-perifer-neuropati/2024-07-06 https://kunskapsbanken.cancercentrum.se/stoddokument/bedomning-och-hantering-av-biverkningar-vid-behandling-med-checkpointhammare/2025-01-22 https://kunskapsbanken.cancercentrum.se/stoddokument/diagnostik-och-behandling-av-kronisk-gvhd/2024-02-16 https://kunskapsbanken.cancercentrum.se/stoddokument/antiemetika-vuxen/2024-10-08 https://kunskapsbanken.cancercentrum.se/stoddokument/extravasering/2025-03-19 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/2025-05-27 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/atom-trial3/2026-05-07 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/atom-trial2/2026-05-07 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/periscope-/2026-05-06 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca244-0012--izabright-bladder01/2026-05-04 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/testigo-/2026-05-04 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/next-gem/2026-04-26 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/secar-1c/2026-04-20 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hovon-177/2026-03-18 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magmen-ii/2026-03-17 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pet-mri/2026-03-17 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/future/2026-03-13 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sarkomtest-studien/2026-03-13 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kompxx/2026-03-11 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lut-aea/2026-03-10 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/beamion-lung03-1479-0032/2026-03-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/evoparprostate02/2026-03-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bnt323-01-engot-en2/2026-03-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pantodon/2026-03-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/padl1nk-005/2026-03-06 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/power/2026-03-06 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/atom-trial/2026-02-24 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hera-eras/2026-02-24 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bgb-16673-304/2026-02-23 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hypo-rt-pc-boost/2026-02-23 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trofuse--036mk-2870/2026-02-13 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ovhipec-2/2026-02-11 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny-endometrial014/2026-02-10 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/j3m-mc-jzqh/2026-02-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sentineo-22.02026-02-04 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gsk-223674/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca2400030-pmrt5/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bgb-11417-303/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/renew-ker-050-d301/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/folero/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/darsh/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny-ovarian01-ds8201-772/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kogni-thyr/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/vidar-1/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/embold/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny-endometrial01/2026-01-29 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sgntv-003/2026-01-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/globryte/2026-01-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fex-can/2026-01-15 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/katsis-1/2026-01-15 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/plato/2026-01-14 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/intratumoralt-tryck-intratumoralt-partiellt-syrgastryck-och-inflammatoriska-cytokiner-vid-behandling-med-antisekretorisk-faktor-vid-glioblastom-/2026-01-12 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/star-lung/2026-01-12 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca240-0030-bms-pankreas/2026-01-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/afgbm2/2026-01-07 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca236-0001-herkules/2025-12-18 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/neoprime2/2025-12-17 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kandlelit-014/2025-12-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca240-0029/2025-12-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca2440008-izabright-breast012/2025-12-11 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk2870trofuse--033/2025-12-08 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/international-euro-ewing-trial-for-treatment-optimisation-in-patients-with-ewing-sarcoma/2025-12-08 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/itranslate/2025-12-04 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trofuse-012-mk2870-012/2025-12-04 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ipa-gastric/2025-12-01 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/paraply2/2025-11-30 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/v940-009/2025-11-30 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pantha-22049/2025-11-25 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prima-22931/2025-11-25 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ritz2/2025-11-25 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/paris-bio/2025-11-20 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/en-fas-1-oppen-first-in-human-multicenter-studie-for-att-utvardera-sakerhet-tolerabilitet-farmakokinetik-och-antitumoraktivitet-av-225ac-psma-trillium-hos-studiedeltagare-med-avancerad-metastaserad-kastrationsresistent-prostatacancer-mcrpc--/2025-11-20 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nlg-fl7-flirt/2025-11-10 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lumina-3/2025-10-21 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk2870-032-trofuse-032/2025-10-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/eik1001-006/2025-10-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mariane/2025-10-14 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca240-0009/2025-10-14 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dibh-app/2025-10-14 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cartitude-5/2025-10-13 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/spcg-19/2025-10-09 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cll18/2025-10-02 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hovon--173/2025-10-02 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/majestec-3/2025-09-30 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magnetismm-5/2025-09-30 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/vex-aza/2025-09-30 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dsc-broms-1/2025-09-30 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trofuse-012mk2870-012/2025-09-11 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/behold-2-223559/2025-09-07 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sunray-01/2025-08-12 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca0881007-myelom/2025-07-31 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hilos/2025-07-31 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ev-hcc-studien/2025-07-31 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/go43860/2025-07-31 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/c5901001-helix/2025-07-31 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk2400-001-ideate-prostate01/2025-07-22 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/swe-neo/2025-07-22 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/groinss-v-iii/2025-07-21 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/her2-ex-pet/2025-06-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/harmoni-3-smt112-3003/2025-06-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/flirt-studien/2025-06-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fourlight-3--c4391024/2025-06-10 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca071-1000-recharge/2025-06-10 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ker-050-d301/2025-05-18 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hpb-multiomik/2025-05-16 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/soundtrack-b/2025-05-15 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/xaluteamgen20230005/2025-05-15 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/aby271-1012/2025-05-08 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/allo-hpv/2025-05-07 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/car-t-cellsprovtagning/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pereli/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/quantum-wild-ac220-168/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/on-call/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dellphi-306-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/noac-9/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mevpro-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/codebreak301/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mevpro-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/orig-ami-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/direktstart/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/galaxies-lung-301-gsk4428859a/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/treat-ctdna/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny-her2-low/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/correct-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/origami-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/akir-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tilvance-301-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dareon-7/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/melody/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/orig-ami2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/uso---bc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/qpl---brostcancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/swe-switch/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imcode004--bo45230/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fourlight-2-c4391025/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ipa-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sgndv-001kn-d74/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gsk-222730-spartacus--b7-h4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk2870-010/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hyperion/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/grand-slam/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/temozolomide-plus-lomustine-versus-temozolomide-for--mgmt-promoter-methylated-glioblastoma/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/artscan-vi/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magstage/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/allvos/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/efs-frailty-in-lung-cancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sarong-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/jazz--zanihertwo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/solucom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk3543/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/alxn1210-tma-313/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scandium-iii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lion/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/adiuvo-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bellwave-011-mk1026-011/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/seqcureneo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/golseek-1--ca073-1020/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sprintr-real/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trofuse-020/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sgncea5c-001-ceacam5/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/odx-mm-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/idunn/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/chro761a12101-michro/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/medal/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/guide.mrd2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/robocop/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fatigue-pet-studie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/rocknrol-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/channel/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imcode-003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cmlstop/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/espac-6/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prisma-prism-mel-301/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/relativity-127/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/beamion-lung-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/jade-studien--219885/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-2870-009/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-2870-005/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bgb-11417-301/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/golden-gate-20190360/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mdt-bridge/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/selsa/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/waveline-006/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cartitude-6/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/carma-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/v940-005/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/omaha-004/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/omaha-003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/abbvie-m18-868/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bi1808-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/veritac-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ewall/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/predict-hpv-hnc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/monumental-6/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pipn/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/teneriffa-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/caaa617a12402/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/arastep-21492/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/22-bi-1910-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/beamion-lung-1-1479-0001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/important/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/melbank-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pred-hh-markstudien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/azur2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/meteroid/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/horizon-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/merlin/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/onkovir/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/-m20-621/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/breton-bgb-16673-101/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cardiocare/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/andromeda-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bnt-113-01-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/triplex-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/haitils-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bo44426---krascendo-lung-170---studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fortitude101-amgen-552-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bio-me-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/-f8394-201-fore/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/swecraniol/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/svep53-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/v940-001-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/harbor-blu263-1201/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/effipec/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/eris/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kartos-studien-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kandova/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keyvibe-010/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dwell-time/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/piscatin/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/commodore-bo42161/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scan-all/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/decidualcellstudien2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/providhe/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ariadne-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/k-sab/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imole/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/peak-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tropion-breast032/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/spc11-01-110/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ac220-a-u202/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/asf-bc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/itcc-101apal2020d/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/profertil/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mesacapp/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca055-026/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ld-venex-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mimir-studien-89zr-atezolizumab-petct/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-6482-022/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cloudin-6-bnt211-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nmdsg14-b-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fapi-46fapi-pet/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/zuma-4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/19-bi-1808-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/eros/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prevent-a-call/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bi-1206-03-monkey/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cctl019g2201j--cassiopeja/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/libretto-432-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/firefly-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prodigyn/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/arm/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bnt122-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny-12/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/salfladmet/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/espac-4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ascend--4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/eucharis/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ascape/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/i-conic-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/optimering-infor-stor-kolorektalcancer-kirurgi/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/majestec-9/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prias/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/optunebehandling-for-patienter-med-glioblastom--patienternas-narstaendes-och-personalens-uppfattning-av-behandlingen---en-kvalitativ-intervju-samt-enkat-studie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fibroneer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ironman/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/primordium/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cancerrehabilitering-vid-matstrups-eller-magsackscancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/advantage/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/serom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/first-rly-4008-101/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/asc4first/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sirpa-ca059-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/allovir-adeno-alvr105-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magnetismm-7-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/certis-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/majestec-7/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/neogap-neogap-crc-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biwac-bi-1403-0001--brightline/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/in-mind/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/loxo-20022-btk/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dovacc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/asab/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk2140-004/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/postmonarche/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/neo-act/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bgb3111-lte1-roll-overstudie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/seamark/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/xnk-urotelialcancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/columbus-ad/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/brightline-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sensi-ex/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bio-melanom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/avanzar/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gemore/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/-isga-studien-pre-gat01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pro-glio/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tabanetoc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/colon-z/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/crlm-z/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dragon-sarcopenia-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mariposa-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/taormina-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/preopanc-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scanpan-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/t-rex/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/palbociclib/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nsgo-ctu-hero-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cnis793b12301/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/relativity-123/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keyform-008/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/popcorn/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/metro/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-c93gog-3064engot-en15/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lidera/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/halo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biobladder/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tropics-04/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk6482-012/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pris/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pelvex-ii-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/breakwater/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cirkos/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/costar/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/g-definer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sens-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prep-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/axsana/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/star-trec/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/salflac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/incb81776-101-axl-mer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mo41552/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/rm26/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sgns40-002-seasam/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kartlaggning-av-hematologiska-maligniteter-hos-patienter-med-mojlig-arftlig-predisposition/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/en-fas-1b2-first-in-human-doseskalerings--och-expansionsstudie-av-xmt-1536-hos-patienter-med-solida-tumorer-som-sannolikt-uttrycker-napi2b/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/script-aml-studying-conditioning-regimen-in-pediatric-transplantation-aml/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/telepik2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/miltenyi-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cc-90010-gbm-002/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hypo-m1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/start-net/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ago-ovar-2.292025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/inotuzumab/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ludo-n/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/carfilzomib/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ponatinib/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/polargo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/inform2-nivent/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ipmn/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/parpanc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/relativity-098/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/altamira/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lbl-2018/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/b-nhl-2013/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/en-undersokning-om-smartrelaterade-erfarenheter-hos-svenska-vuxna-med-cancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ccs1477-02/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ccs1477-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/onc001-cl-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/psmaddition/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gct3013-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/modelle-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/soulmate/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/asac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/timepoint/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-365/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/enrgy/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/transcend/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/evi-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cell-protect---isa-hc-nk/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/loxo-btk-18001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/immu-lc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tinca-ii--njurcancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mypal/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dsa-ll-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gct-3013-05/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ros-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/immunologisk-aktivitet-hos-melanomtumorer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nex-18/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fas-i-studie-incb-99318-122-incyte/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/swedish-anal-carcinoma-study/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sgntuc-016/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ruby-del-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny-breast09/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bite-u-20190505/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ipcm/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scan-mi/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magsnow/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sentineo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/postmagmri/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/erfarenheter-av-vakuumassisterade-excisioner-av-forandringar-i-brost-vae/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magtotal/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/breastcc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sentinot-2.02025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/paced/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/summist/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scandium-ii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-b21-gog.30532025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/psma-fore/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-b49/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nipu-studien--ca209-7h4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biobanksstudien-lungcancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk6482-015/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gct-3013-022/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/spencer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk6482-005/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hexabody-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/capitello-292/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/listo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prevalence/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scout/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pdm-mbc-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bio-muse/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/proper-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/navigate/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pcr1001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prommel-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/covaxid-kll/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prorect-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pacos/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/amplitude/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gsk-209012/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/transform-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/transform-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/zeal-1l-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prepec-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mermaid-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mr-divide/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-866/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/code-break-200/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/exclaim2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/phys-can-styrketraningsstudie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/genomikstudien-brost/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/induce-4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/blu-667-2303/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bite-cc93269-mm-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/heat-aml/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/momentum-sra-mmb-301/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/adore/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/re-screen/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/neo-aegis/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/needs/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/optima/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny06/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ameera/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tas-120-202-soffa/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tak788-3001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/webbaserad-symtomovervaktning-vid-avancerad-lungcancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/megalit/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ho156-aml/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/polar-bear/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-a18--engot-cx11/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nordictripnbg-19-01-swebcg-19-01/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biolungstudien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/rhovac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dalia/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ipla/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cccs-covid-cast-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cor10012/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/induce-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/effect/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-7339-007-agent/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/thyro-nuke/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ruby/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/advance-ii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-76k-ca20976k/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/the-fiol-study-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ho150-aml/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/assure/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pro-hodgkin/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nordcml013/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hd21/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/beatcc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/breclim/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/psma-recidiv/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/direct/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lokon003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-73l-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lxh254x2102/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nivo-ilp/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pcia-laserstudie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/artscan-iv/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/psff-blodburna-vavnadsprov/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/exintric/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pantumime/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/down-stagingstudie-lever/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/orchard/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/karmma-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mbg453-mds/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kllvacc-2017/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tatoo2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/relapc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ator-1017/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pcyc-1145/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/synkron-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/vigas/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imfdhac_impact-of-fixed-dentures-in-head-and-neck-cancer-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dbcg-rt-natural-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-937/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/intrigue-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/alltogether-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dream-5/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/canopy-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca209-171/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-905/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prove-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bh-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mateeo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/talapro-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ace-cl-311/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/205801-entree/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/canova/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/capitello-290/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/athena/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nucog-vi/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bgg-311-305/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bob/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/brigatinib-3001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/brigatinib-2002/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-555/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/transform/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kiadis/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/graphite/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/a.r.r.o.w-22025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/destiny/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/clee011a2207/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/commands-ace-536-mds-002/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/probio2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/voc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fight-302/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bosupeg/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/norpact-12/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biome-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/viden/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/entree/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mir-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/racc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/iloc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/solstice/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/predix-ii-her2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/panfam1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ctc---cirkulerande-tumorcellsstudien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ipep/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tadpole-g/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gen-esofagus-studie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pilgrim/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pavo-mmy1004/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bright-b1371019/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/iso-cc-007-agent/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biobank-esofagusventrikel/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cando/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cyst-studie-saliv-studie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cyststud/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fimmun-pancreas-tumor/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/frosenor/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/adoele/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-7902-003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/predicting-fatigue-after-allo-hsct/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/matterhorn/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/-pneu-stem-v114-022/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hapirect/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/qolicol/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/watch-and-wait/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/con-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nmdsg14b/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nmdsg14a/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pci-32765can3001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/2215-cl-0302/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tempo-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/zeus/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/magnitude/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/onconova-04-302/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/54767414amy3001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bo39813/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/allopurinol-all2.02025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/seal-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/methronomic/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/asa-crclm-2014/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nmsg2415-ked/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ird-nmsg2315/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bcma-mmy1001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-7902-004/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nor-graspall-2016-akut-lymfatiskt-leukemi-all/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/phrancesca-mo40628/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prothym/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biolymph/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/expacd/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/psma-primar-prostatacancer2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ben-r/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ben-c/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/c16029-takeda-millenium/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/impower030/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ator-1015/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/eortc-vu34/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/exceptional-responders/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/canfour/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/artscan-v/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-9132/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/stop-gist-ssg-xxv/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ibru-on-off-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/valeria/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/citadel-203/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nz-dtx-001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-3475-587/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/atevacc2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/melanom-provtagning/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/glow-cll3011/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/can3001/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/javelin-blasa/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/proceed2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/vision/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/psma-pet-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/embark-mdv-3100-12/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/combi-aplus3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/intense/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/zuma-7/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pemborlizumab-mk-3475-051/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/graspanc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/17403-bay-1163877/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/achiles/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/who-cares/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/larct-us/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bemp/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/secombit/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/illuminate/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/opinion/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bgb-3111-304/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/act-on-me/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/s-ramp/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trust2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/az-odin-pet2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/scan-b/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pemdac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/affibody-3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/genmab-gct1015-04/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/embrace-ii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/17-bi-1206-02/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca224-047/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-789/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cat-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pac203/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tulip/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/repomed/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/car-19/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hovon-141/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/b-701-u21/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imagyn050/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cpkc412a2408/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lokon002/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca017-003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/enrich/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imroz/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-908/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/aurora/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/monarche/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-5222/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tahoe-_-m16-2892/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/adaura/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/asteroid/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bold-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prodat/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-901-ca209-901/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/combi-i/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/secar-i/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dastop-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/artemids-cc-4047-mm-015/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nmsg-2013/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/opacin/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dursab/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pasiphae2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/glag/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/panorama-3-clbh589d2222/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prefer-preserve-fertility/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/onconova-04-30/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/quazar-aza-mds-003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/javelin-renal-1018/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/exelixis-xl184-401/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trim/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/direktstudien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/prima-_-pr-30-5017-c/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/auto-lymfom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sakk-3514/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/compleement-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/iliad/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/arasens/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/profound/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cv006-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/geometry-mono-cinc280a2201/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-522/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/inspire_onconova-04-30/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-602-ca209-602/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pallas/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pepacaka/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-714/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/puma-ner-1301/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/preben/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/viable/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/solar-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/panorama_3/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cpdr001e2201/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-057/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mastiff/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mars/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-051/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lasec-studien-lymphedema-after-surgery-for-endometrial-cancer2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/alt-gist/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/podec/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lume-bionis/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/proper/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-274/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/spcg-17-pcastt/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/triangle/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/livskvalitet-for-patienter-med-malignt-melanom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/c-inc280-a2108/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/swea-studien4/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pet-boost/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/pro-cns/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nordic-8/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nordic-9/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/testiscab/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/avanova/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/melmart/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/melanomprovtagning/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cirkulerande-tumor-dna/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/icap/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/arches-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/titan-pcr3002-/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/embark--mdv-3100-13/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/rethink/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tumorfaktorers-betydelse-vid-behandling-av-malignt-melanom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/minimalinvasiv-isolerad-hyperterm-perfusion-mi-ilp/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/analys-av-exosomer-i-samband-med-isolerad-hyperterm-perfusion-for-behandling-av-metastaserande-malignt-melanom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/immunologiska-effekter-vid-behandling-av-metastaser-fran-malignt-melanom/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/aramis/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/iobt-kohortstudie/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/physsurg-b/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-451-ca209-451/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mistral/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/artscan-iii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bayer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/dna-pkinhib2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/roar2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/galahad/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fandango/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/abc-se/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/morris2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/gen701/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/i4t-mc-jvcz2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-170-pmbcl-och-richter-phase-ii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/maverric/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca209238/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/palaestra/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/phys-can/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mateo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sirt-net/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-177/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/jsbf/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/iluminet/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/et-nec/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/spcg-15/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/altaii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tailordose-ii/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/trem/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ca209067/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/male-breast-cancer-study/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/breast-cancer-in-pregnancy/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/micro-rnactc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-3475-181/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/the-scandium-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/neape_nordic-extended-abdominoperineal-excision-study--/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/paola-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nt-probnp/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/engot-ov-23ewoc-1/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/kaitlin/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/grace/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/alascca/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-199/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/abc-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-3475-252-keynote-252/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-ca-209-548/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-ca209-498/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/atlas/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/checkmate-209-401/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/m12-914-brocade/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ssgxx/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nintedanib/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-204/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mk-3475-048-keynote-048/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hovon-132-aml/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lymrit-3701/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/senomic/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/antibiotika-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/adm-studien/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/b-cap/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bevmar/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/im-201/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ici-pcrb/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/sandpiper/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/alpharadinabiraterone/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/vinsor/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/modul/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/fluoheart/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-100-mk-3475/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/ip-ov/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/engot/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-173-fas-i/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/keynote-119/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/olympia/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cobc/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/predix-her-2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bi-breeast/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/picc-pac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/neptune/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/thora/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/oligo/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/repac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/odx-003/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/artforce-headneck/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/cetmet2/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/imilt/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/rosett/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/phoneme/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/mat02/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/senomac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/tarzel/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/lumb/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/bevpac/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/impassion-130/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/flt-pet.mr2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/predix-luma/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/hilus/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/nucog-i-vingem/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/paraply/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/studier/biomarkorer-under-behandling-av-prostatacancer/2025-05-05 https://kunskapsbanken.cancercentrum.se/cancerstudier-i-sverige/anvandaradministration/2025-05-05 https://kunskapsbanken.cancercentrum.se/publiceringsmanual2/2025-11-04 https://kunskapsbanken.cancercentrum.se/sok-sida-for-kort-svf/2025-11-06 https://kunskapsbanken.cancercentrum.se/patientinformation--barn/2026-02-16 https://kunskapsbanken.cancercentrum.se/patientinformation/2026-04-20 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/kontaktuppgifter/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/om-min-vardplan-aggstockscancer/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/vad-ar-min-vardplan/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/infor-ditt-besok-hos-varden/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/kallkritik/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/inloggad-pa-1177/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/roller-i-varden/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/ordlista/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/individuell-patientoversikt-ipo/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/vad-ar-viktigt-for-mig/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/motet-med-varden/mina-bokade-tider/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/utredning2/2026-04-27 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/utredning2/genetisk-utredning/2026-04-29 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/utredning2/arftlighetsutredning/2026-04-29 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/utredning2/att-vanta-pa-besked-och-eventuell-behandling/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/undersokningar/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/undersokningar/datortomografi-dt/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/undersokningar/magnetkameraundersokning-mrt/2026-05-07 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/undersokningar/pet-kameraundersokning/2026-05-07 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/diagnos/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/diagnos/om-cancer/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/utredning-undersokning-och-diagnos/diagnos/d-aggstockscancer/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/behandling/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/behandling/behandling/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/behandling/behandling/d-sa-beslutas-vilken-behandling-du-far/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/aggstockscancer/behandling/behandling/d-fertilitet-och-cancerbehandling/2026-04-30 https://kunskapsbanken.cancercentrum.se/patientinformation/brostcancer/2026-04-20 https://kunskapsbanken.cancercentrum.se/patientinformation/brostcancer/motet-med-varden/2026-02-09 https://kunskapsbanken.cancercentrum.se/patientinformation/brostcancer/motet-med-varden/vad-ar-min-vardplan/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/brostcancer/motet-med-varden/infor-ditt-besok-hos-varden/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/brostcancer/motet-med-varden/kallkritik/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/2026-04-20 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/2026-03-18 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/vad-ar-min-vardplan/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/infor-ditt-besok-hos-varden/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/kallkritik/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/inloggad-pa-1177/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/roller-i-varden/2026-03-18 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/ordlista/2026-03-18 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/motet-med-varden/vad-ar-viktigt-for-mig/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/att-fa-behandling/2026-05-05 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/att-fa-behandling/om-cancer/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/att-fa-behandling/malet-med-min-behandling/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/att-fa-behandling/sa-beslutas-vilken-behandling-du-far/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/att-fa-behandling/komplementar-alternativ-och-integrativ-medicin-vid-cancer/2026-05-06 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/2026-02-09 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/utredning/2026-02-09 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/utredning/arftlighetsutredning/2026-02-09 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/utredning/utredningavprostatacancer/2026-02-09 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/diagnos/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/diagnos/om-cancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/diagnos/prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/utredning-och-diagnos-utredning/diagnos/sa-beskrivs-en-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/fakta-om-min-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/cystoskopi/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/datortomografi-dt/2026-03-19 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/magnetkameraundersokning-av-prostatan/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/matning-av-resturin-med-blasscanner--bladderscan/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/pet-kameraundersokning/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/skelettskintigrafi/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/ultraljudsundersokning/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/rontgen-och-bilddiagnostik/urodynamisk-undersokning/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/blod--cell--och-vavnadsprov/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/blod--cell--och-vavnadsprov/blodprov-psa/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/blod--cell--och-vavnadsprov/vavnadsprov-fran-prostatan--prostatabiopsi/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/ovriga-undersokningar/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/undersokningar-och-provtagningar-rontgen-och-bilddiagnostik/ovriga-undersokningar/prostatapalpation/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/malet-med-min-behandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/malet-med-min-behandling/palliativ-vard/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/malet-med-min-behandling/onkologisk-behandling-med-palliativt-syfte/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/malet-med-min-behandling/behandling-med-botande-syfte/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/malet-med-min-behandling/palliativ-vard-i-livets-slutskede/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/sa-beslutas-vilken-behandling-du-far/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/behandling-av-prostatacancer/2026-02-25 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/att-valja-behandling-vid-tidigt-upptackt-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/biverkningar-vid-behandling-av-tidigt-upptackt-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/paverkan-pa-sexualiteten-vid-tidigt-upptackt-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/paverkan-pa-fertiliteten-vid-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/aktiv-monitorering/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/behandling/symtomstyrd-behandling--exspektans/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/levnadsvanor-infor-en-operation-v/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/forberedelser-infor-en-operation-i-narkos/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/sa-gar-det-till-att-sovas/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/ryggbedovning/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/operation-av-prostatacancer--radikal-prostatektomi/2026-02-25 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/allmanna-biverkningar-och-komplikationer-efter-en-operation/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/biverkningar-och-komplikationer-efter-en-operation-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/skotsel-av-urinkateter-efter-en-operation-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/sa-satter-du-dig-upp-efter-en-operation-i-magen/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/fysisk-aktivitet-efter-en-operation-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/operation-av-lymfkortlar--lymfkortelutrymning/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/Sarvard-efter-en-operation/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/operation-av-testiklarna--ablation-testis/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/operation/hyvling-av-prostatan--transuretral-resektion-av-prostata-tur-p/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/lakemedelsbehandling-vid-cancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/cytostatikabehandling/2026-04-21 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/behandling-mot-illamaende-under-cytostatikabehandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/till-dig-som-ska-fa-lakemedelsbehandling-pa-sjukhuset/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/hormonell-behandling-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/hormonell-behandling-med-bikalutamid/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/hormonell-behandling-med-spruta-gnrh-antagonist/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/hormonell-behandling-med-spruta-och-tabletter/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/hormonell-behandling-med-gnrh-agonist/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/immunterapi/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/behandling-med-blodfortunnande-lakemedel/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/att-ta-sprutor-sjalv/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/behandling-med-kortison/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/lakemedel-mot-smarta/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/skelettstarkande-behandling-med-denosumab/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/lakemedelsbehandling/skelettstarkande-behandling-med-bisfosfonater/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/levnadsvanor-infor-stralbehandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/stralbehandling-med-bromsande-och-lindrande-syfte/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/stralbehandling-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/forberedelser-infor-stralbehandling-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/biverkningar-av-stralbehandling-mot-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/yttre-stralbehandling-av-prostatacancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/yttre-stralbehandling-av-prostatacancer-kombinerat-med-hormonell-behandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/yttre-stralbehandling-efter-operation-av-prostatacancer--salvage/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/inre-stralbehandling-av-prostatacancer--brachyterapi-hogdosrat/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/stralbehandling/radioaktiv-behandling-med-xofigo--radionuklidbehandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/annan-behandling/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/annan-behandling/komplementar-alternativ-och-integrativ-medicin-vid-cancer/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/infart/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/infart/perifert-inlagd-central-venkateter-picc-line/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/infart/subkutan-venport-svp/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/infart/central-venkateter-cvk/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/kateter/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/kateter/kvarliggande-kateter-i-urinblasan/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/kateter/skotsel-av-kvarliggande-kateter-i-urinblasan/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/kateter/tappningskateter-eller-engangskateter/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/kateter/urinkateter-fran-njuren--nefrostomi/2026-02-10 https://kunskapsbanken.cancercentrum.se/patientinformation/prostatacancer/behandling/kateter/urinkateter-fran-urinblasan-genom-huden--suprapubisk-kateter/2026-02-10 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/infor-ditt-besok-hos-varden/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/kallkritik/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/inloggad-pa-1177/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/roller-i-varden/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/ordlista/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/individuell-patientoversikt-ipo/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/rattigheter/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/att-delta-i-en-forskningsstudie/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/nationella-kvalitetsregister/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/motet-med-varden/cancerregistret/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/att-fa-behandling/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/att-fa-behandling/om-cancer/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/att-fa-behandling/malet-med-min-behandling/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/att-fa-behandling/sa-beslutas-vilken-behandling-du-far/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/att-fa-behandling/komplementar-alternativ-och-integrativ-medicin-vid-cancer/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/att-fa-ett-cancerbesked/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/arbeta-studera-eller-vara-sjukskriven/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/narstaende-kan-behova-stod/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/har-kan-du-och-dina-narstaende-fa-stod/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/patientforeningar/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/kraftens-hus/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/att-stodja-barn-som-narstaende/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/har-kan-barn-ungdomar-och-unga-vuxna-fa-stod/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/ekonomiskt-stod-for-dig-som-ar-sjuk/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/ekonomiskt-stod-for-narstaende/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/hogkostnadsskydd/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/kosttillagg/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/patienthotell/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/sjukresor/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/tandvard/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/hur-kan-jag-fa-stod/hjalp-hemma-och-i-vardagen/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/2026-05-04 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/cancerrehabilitering--for-att-ma-sa-bra-som-mojligt-fore-under-och-efter-behandlingen/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/halsosamma-levnadsvanor-infor-och-under-behandling/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/tips-for-att-sluta-roka/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/medveten-narvaro-och-mediyoga-mot-stress-och-oro/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/livsstilsverktyget--digitalt-verktyg-for-att-ma-battre/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/kognitiva-forandringar--svarare-med-koncentration-minne-och-planering/2026-05-05 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/oro-och-angest/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/smarta/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/somnsvarigheter/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-kan-jag-gora-sjalv/trotthet-vid-sjukdom--fatigue/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/kontaktuppgifter/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-ar-viktigt-for-mig/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/mina-bokade-tider/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/vad-ar-min-vardplan/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/utredning-av-cancer/2026-05-07 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/arftlighetsutredning/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/att-vanta-pa-besked-och-eventuell-behandling/2026-05-07 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/cytostatikabehandling/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/datortomografi-dt/2026-05-06 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/magnetkameraundersokning-mrt/2026-05-07 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/pet-kameraundersokning/2026-05-07 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/fertilitet-och-cancerbehandling/2026-05-07 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/ryggbedovning/2026-04-20 https://kunskapsbanken.cancercentrum.se/min-vardplan-generellt-innehall/sa-gar-det-till-att-sovas/2026-04-20